井上 治久

Last Update: 2020/07/20 11:08:36

Print

Name(Kanji/Kana/Abecedarium Latinum)
井上 治久/イノウエ ハルヒサ/Inoue, Haruhisa
Primary Affiliation(Org1/Job title)
iPS細胞研究所/Professor
Affiliated programs (koza)
Org1 Job title
医学研究科/Graduate School of Medicine 教授/Professor
医学研究科/Graduate School of Medicine 教授/Professor
Academic Organizations You are Affiliated to in Japan
Organization name(Japanese) Organization name(English)
日本神経学会 Japanese Society of Neurology
日本神経科学学会 The Japan Neuroscience Society
日本老年医学学会 The Japan Geriatrics Society
日本内科学会 The Japanese Society of Internal Medicine
日本遺伝子細胞治療学会 The Japan Society of Gene and Cell Therpy
Academic Organizations Overaseas You are Affiliated to
Organization name Country
The International Society for Stem Cell Research 米国
Society for Neuroscience 米国
Academic Degree
Field(Japanese) Field(English) University(Japanese) University(English) Method
博士(医学) M.D., Ph.D. 京都大学 Kyoto University
Undergraduate School / Major(s)
University(Japanese) University(English) Faculty(Japanese) Faculty(English) Major(s)(Japanese) Major(s)(English) Degree
京都大学 医学部医学科 卒業
Work Experience
Period Organization(Japanese) Organization(English) Job title(Japanese) Job title(English)
1992-1993 京都大学医学部附属病院神経内科 Department of Neurology, Kyoto University Hospital 研修医 Resident
1993-1997 財団法人住友病院神経内科 Department of Neurology, Sumitomo Hospital 研修医 Resident
1997-1998 国立精神・神経センター神経研究所 National Institute of Neuroscience 研究生 Research Student
1997- ペイチ医科大学神経病理学教室 Laboratory for Neuropathology, University Medical School of Pecs, Hungary 研究員 Research Fellow
1998-1999 国立精神・神経センター神経研究所 National Institute of Neuroscience 流動研究員
1999-2004 理化学研究所脳科学総合研究センター Brain Science Institute, RIKEN at Wako 研究員 Staff Scientist
2004-2005 ハーバード大学医学部マクリーン病院 Neuroregeneraion Laboratory, McLean Hospital/Harvard Medical School, Boston, MA, USA 博士研究員 Postdoctoral Fellow
2005-2009 京都大学大学院医学研究科脳病態生理学講座臨床神経学 Department of Neurology, Graduate School of Medicine, Kyoto University 助手/助教 Assistant Professor
2009-2010 京都大学物質-細胞統合システム拠点iPS細胞研究センター CiRA, iCeMS, Kyoto University 特定拠点准教授 Associate Professor
2010-2014 京都大学iPS細胞研究所 CiRA, Kyoto University 准教授 Associate Professor
2014- 京都大学iPS細胞研究所 CiRA, Kyoto University 教授 Professor
2017/04/01- 理化学研究所バイオリソース研究センター iPS創薬基盤開発チーム RIKEN BioResource Research Center iPSC-based Drug Discovery and Development Team チームリーダー Team Leader
2017/11/01- 理化学研究所 革新知能統合研究センター iPS細胞連携医学的リスク回避チーム RIKEN Center for Advanced Intelligence Project Medical-risk Avoidance based on iPS Cells Team 客員主管研究員 Senior Visiting Scientist
2019- 京都大学医学部附属病院先端医療研究開発機構医療開発部(臨床研究総合センターから名称変更) Institute for Advancement of Clinical and Translational Science (iACT), Kyoto University Hospital プロジェクトリーダー Project Leader

  • <<
  • >>
Language of Instruction
Language(japanese) Language(english) Code
日本語 Japanese jpn
英語 English eng
Personal Website(s) (URL(s))
URL
http://www.cira.kyoto-u.ac.jp/inoue/e/
https://www.scopus.com/authid/detail.uri?authorId=55461444200
researchmap URL
https://researchmap.jp/InoueH
Research Topics
(Japanese)
幹細胞を用いた神経科学トレンスレーショナルリサーチ
(English)
Translational neuroscience based on stem cells technology
Overview of the research
(Japanese)
筋萎縮性側索硬化症(ALS)やアルツハイマー病など、中枢神経系の細胞が変性・消失することで引き起こされる難治性神経変性疾患の治療法開発は、特に高齢化社会では喫緊の課題の一つとなっています。分子生物学的研究等の進展により、このような疾患に関して、その分子機構の理解は深まりつつあります。しかしながら、未だ根本的な予防・治療法は確立されていません。 私達の研究室では、iPS細胞作製技術の発見によって作り出すことが可能になった、これまでは手にいれることが全く不可能であった患者さん由来の細胞を用いることによって、分子機構のさらなる理解に基づく、ALSなど難治性神経変性疾患の制圧を目指しています。
(English)
Molecular-biological analyses are advancing our understanding of intractable neurodegenerative diseases including amyotrophic lateral sclerosis (ALS), but radical care is still to be established. This laboratory aims to perform basic scientific research for further understanding of the disease mechanisms using patient-specific iPS cells, with the perspective of translating the findings into developing methods of treatment and/or prevention of the diseases.
Fields of research (key words)
Key words(Japanese) Key words(English)
ALS、認知症、アルツハイマー病、iPS細胞、遺伝子治療、ワクチン
Published Papers
Author Author(Japanese) Author(English) Title Title(Japanese) Title(English) Bibliography Bibliography(Japanese) Bibliography(English) Publication date Refereed paper Language Publishing type Disclose
Kamata K, Otsuka Y, Imamura K, Oishi A, Kondo T, Suga M, Shibukawa R, Okanishi Y, Sagara Y, Tsukita K, Yasukawa T, Usui H, Muguruma K, Tsujikawa A, Inoue H Kamata K, Otsuka Y, Imamura K, Oishi A, Kondo T, Suga M, Shibukawa R, Okanishi Y, Sagara Y, Tsukita K, Yasukawa T, Usui H, Muguruma K, Tsujikawa A, Inoue H Kamata K, Otsuka Y, Imamura K, Oishi A, Kondo T, Suga M, Shibukawa R, Okanishi Y, Sagara Y, Tsukita K, Yasukawa T, Usui H, Muguruma K, Tsujikawa A, Inoue H Generation of a Human Induced Pluripotent Stem Cell Line, BRCi005-A, Derived From a Best Disease Patient With BEST1 Mutations Generation of a Human Induced Pluripotent Stem Cell Line, BRCi005-A, Derived From a Best Disease Patient With BEST1 Mutations Generation of a Human Induced Pluripotent Stem Cell Line, BRCi005-A, Derived From a Best Disease Patient With BEST1 Mutations Stem Cell Res., 101782 Stem Cell Res., 101782 Stem Cell Res., 101782 2020 Refereed Disclose to all
Kamata K, Otsuka Y, Imamura K, Oishi A, Kondo T, Suga M, Shibukawa R, Okanishi Y, Sagara Y, Tsukita K, Yasukawa T, Usui H, Muguruma K, Tsujikawa A, Inoue H Kamata K, Otsuka Y, Imamura K, Oishi A, Kondo T, Suga M, Shibukawa R, Okanishi Y, Sagara Y, Tsukita K, Yasukawa T, Usui H, Muguruma K, Tsujikawa A, Inoue H Kamata K, Otsuka Y, Imamura K, Oishi A, Kondo T, Suga M, Shibukawa R, Okanishi Y, Sagara Y, Tsukita K, Yasukawa T, Usui H, Muguruma K, Tsujikawa A, Inoue H Generation of a human induced pluripotent stem cell line, BRCi004-A, derived from a patient with age-related macular degeneration Generation of a human induced pluripotent stem cell line, BRCi004-A, derived from a patient with age-related macular degeneration Generation of a human induced pluripotent stem cell line, BRCi004-A, derived from a patient with age-related macular degeneration Stem Cell Res., 45, 101787 Stem Cell Res., 45, 101787 Stem Cell Res., 45, 101787 2020 Refereed Disclose to all
Suzuki H, Egawa N, Kondo T, Imamura K, Enami T, Tsukita K, Suga M, Shibukawa R, Okanishi Y, Uchiyama T, Inoue H, Takahashi R Suzuki H, Egawa N, Kondo T, Imamura K, Enami T, Tsukita K, Suga M, Shibukawa R, Okanishi Y, Uchiyama T, Inoue H, Takahashi R Suzuki H, Egawa N, Kondo T, Imamura K, Enami T, Tsukita K, Suga M, Shibukawa R, Okanishi Y, Uchiyama T, Inoue H, Takahashi R Generation of a Human Induced Pluripotent Stem Cell Line Derived From a Parkinson's Disease Patient Carrying SNCA Duplication Generation of a Human Induced Pluripotent Stem Cell Line Derived From a Parkinson's Disease Patient Carrying SNCA Duplication Generation of a Human Induced Pluripotent Stem Cell Line Derived From a Parkinson's Disease Patient Carrying SNCA Duplication Stem Cell Res., 101828 Stem Cell Res., 101828 Stem Cell Res., 101828 2020 Refereed Disclose to all
Egawa N, Suzuki H, Takahashi R, Hayakawa K, Li W, Lo E H, Arai K, Inoue H Egawa N, Suzuki H, Takahashi R, Hayakawa K, Li W, Lo E H, Arai K, Inoue H Egawa N, Suzuki H, Takahashi R, Hayakawa K, Li W, Lo E H, Arai K, Inoue H From in vitro to in vivo reprogramming for neural transdifferentiation: An approach for CNS tissue remodeling using stem cell technology From in vitro to in vivo reprogramming for neural transdifferentiation: An approach for CNS tissue remodeling using stem cell technology From in vitro to in vivo reprogramming for neural transdifferentiation: An approach for CNS tissue remodeling using stem cell technology J Cereb Blood Flow Metab., 271678X20910324 J Cereb Blood Flow Metab., 271678X20910324 J Cereb Blood Flow Metab., 271678X20910324 2020 Refereed Disclose to all
Murakami K, Yoshimura M, Nakagawa S, Kume T, Kondo T, Inoue H, Irie K Murakami K, Yoshimura M, Nakagawa S, Kume T, Kondo T, Inoue H, Irie K Murakami K, Yoshimura M, Nakagawa S, Kume T, Kondo T, Inoue H, Irie K Evaluation of Toxic Amyloid β42 Oligomers in Rat Primary Cerebral Cortex Cells and Human iPS-derived Neurons Treated with 10-Me-Aplog-1, a New PKC Activator Evaluation of Toxic Amyloid β42 Oligomers in Rat Primary Cerebral Cortex Cells and Human iPS-derived Neurons Treated with 10-Me-Aplog-1, a New PKC Activator Evaluation of Toxic Amyloid β42 Oligomers in Rat Primary Cerebral Cortex Cells and Human iPS-derived Neurons Treated with 10-Me-Aplog-1, a New PKC Activator Int J Mol Sci., 21, 4, E1179 Int J Mol Sci., 21, 4, E1179 Int J Mol Sci., 21, 4, E1179 2020 Refereed Disclose to all
Yamamoto Y, Kojima K, Taura D, Sone M, Washida K, Egawa N, Kondo T, Minakawa E, Tsukita K, Enami T, Tomimoto H, Mizuno T, Kalaria N R, Inagaki N, Takahashi R, Shiba Harada M, Ihara M, Inoue H Yamamoto Y, Kojima K, Taura D, Sone M, Washida K, Egawa N, Kondo T, Minakawa E, Tsukita K, Enami T, Tomimoto H, Mizuno T, Kalaria N R, Inagaki N, Takahashi R, Shiba Harada M, Ihara M, Inoue H Yamamoto Y, Kojima K, Taura D, Sone M, Washida K, Egawa N, Kondo T, Minakawa E, Tsukita K, Enami T, Tomimoto H, Mizuno T, Kalaria N R, Inagaki N, Takahashi R, Shiba Harada M, Ihara M, Inoue H Human iPS cell-derived mural cells as an in vitro model of hereditary cerebral small vessel disease Human iPS cell-derived mural cells as an in vitro model of hereditary cerebral small vessel disease Human iPS cell-derived mural cells as an in vitro model of hereditary cerebral small vessel disease Mol Brain., 13, 1, 38 Mol Brain., 13, 1, 38 Mol Brain., 13, 1, 38 2020 Refereed Disclose to all
Takeuchi H, Imamura K, Ji B, Tsukita K, Enami T, Takao K, Miyakawa T, Hasegawa M, Sahara N, Iwata N, Inoue M, Tabira T, Hara H, Ono M, Trojanowski J, Lee V, Takahashi R, Suhara T, Higuchi M, Inoue H Takeuchi H, Imamura K, Ji B, Tsukita K, Enami T, Takao K, Miyakawa T, Hasegawa M, Sahara N, Iwata N, Inoue M, Tabira T, Hara H, Ono M, Trojanowski J, Lee V, Takahashi R, Suhara T, Higuchi M, Inoue H Takeuchi H, Imamura K, Ji B, Tsukita K, Enami T, Takao K, Miyakawa T, Hasegawa M, Sahara N, Iwata N, Inoue M, Tabira T, Hara H, Ono M, Trojanowski J, Lee V, Takahashi R, Suhara T, Higuchi M, Inoue H Nasal vaccine delivery attenuates brain pathology and cognitive impairment in tauopathy model mice Nasal vaccine delivery attenuates brain pathology and cognitive impairment in tauopathy model mice Nasal vaccine delivery attenuates brain pathology and cognitive impairment in tauopathy model mice NPJ Vaccines., 5, 28 NPJ Vaccines., 5, 28 NPJ Vaccines., 5, 28 2020 Refereed English Disclose to all
Seki T, Kanagawa M, Kobayashi K, Kowa H, Yahata N, Maruyama K, Iwata N, Inoue H, Toda T Seki T, Kanagawa M, Kobayashi K, Kowa H, Yahata N, Maruyama K, Iwata N, Inoue H, Toda T Seki T, Kanagawa M, Kobayashi K, Kowa H, Yahata N, Maruyama K, Iwata N, Inoue H, Toda T Galectin 3-binding protein suppresses amyloid-β production by modulating β-cleavage of amyloid precursor protein Galectin 3-binding protein suppresses amyloid-β production by modulating β-cleavage of amyloid precursor protein Galectin 3-binding protein suppresses amyloid-β production by modulating β-cleavage of amyloid precursor protein J Biol Chem., 295, 11, 3678-3691 J Biol Chem., 295, 11, 3678-3691 J Biol Chem., 295, 11, 3678-3691 2020 Refereed English Disclose to all
Suga M, Kondo T, Inoue H Suga M, Kondo T, Inoue H Suga M, Kondo T, Inoue H Modeling Neurological Disorders With Human Pluripotent Stem Cell-Derived Astrocytes Modeling Neurological Disorders With Human Pluripotent Stem Cell-Derived Astrocytes Modeling Neurological Disorders With Human Pluripotent Stem Cell-Derived Astrocytes Int J Mol Sci., 20, 16, 3862 Int J Mol Sci., 20, 16, 3862 Int J Mol Sci., 20, 16, 3862 2019 Refereed Disclose to all
Egawa N, Chung KK, Takahashi R, Lo EH, InoueH, Arai K Egawa N, Chung KK, Takahashi R, Lo EH, InoueH, Arai K Egawa N, Chung KK, Takahashi R, Lo EH, InoueH, Arai K Brief review: Can modulating DNA methylation state help the clinical application of oligodendrocyte precursor cells as a source of stem cell therapy? Brief review: Can modulating DNA methylation state help the clinical application of oligodendrocyte precursor cells as a source of stem cell therapy? Brief review: Can modulating DNA methylation state help the clinical application of oligodendrocyte precursor cells as a source of stem cell therapy? Brain Res., 1723, 146480 Brain Res., 1723, 146480 Brain Res., 1723, 146480 2019 Refereed Disclose to all
Niki T, Imamura K, Enami T, Kinoshita M, Inoue H Niki T, Imamura K, Enami T, Kinoshita M, Inoue H Niki T, Imamura K, Enami T, Kinoshita M, Inoue H Establishment of human induced pluripotent stem cell line from a patient with Angelman syndrome carrying the deletion of maternal chromosome 15q11.2-q13 Establishment of human induced pluripotent stem cell line from a patient with Angelman syndrome carrying the deletion of maternal chromosome 15q11.2-q13 Establishment of human induced pluripotent stem cell line from a patient with Angelman syndrome carrying the deletion of maternal chromosome 15q11.2-q13 Stem Cell Res., 34, 101363 Stem Cell Res., 34, 101363 Stem Cell Res., 34, 101363 2019 Refereed Disclose to all
Sekine S, Kaneko M, Tanaka M, Ninomiya Y, Kurita H, Inden M, Yamada M, Hayashi Y, Inuzuka T, Mitsui J, Ishiura H, Iwata A, Fujigasaki H, Tamaki H, Tamaki R, Kito S, Taguchi Y, Tanaka K, Atsuta N, Sobue G, Kondo T, Inoue H, Tsuji S, Hozumi I Sekine S, Kaneko M, Tanaka M, Ninomiya Y, Kurita H, Inden M, Yamada M, Hayashi Y, Inuzuka T, Mitsui J, Ishiura H, Iwata A, Fujigasaki H, Tamaki H, Tamaki R, Kito S, Taguchi Y, Tanaka K, Atsuta N, Sobue G, Kondo T, Inoue H, Tsuji S, Hozumi I Sekine S, Kaneko M, Tanaka M, Ninomiya Y, Kurita H, Inden M, Yamada M, Hayashi Y, Inuzuka T, Mitsui J, Ishiura H, Iwata A, Fujigasaki H, Tamaki H, Tamaki R, Kito S, Taguchi Y, Tanaka K, Atsuta N, Sobue G, Kondo T, Inoue H, Tsuji S, Hozumi I Functional evaluation of PDGFB-variants in idiopathic basal ganglia calcification, using patient-derived iPS cells Functional evaluation of PDGFB-variants in idiopathic basal ganglia calcification, using patient-derived iPS cells Functional evaluation of PDGFB-variants in idiopathic basal ganglia calcification, using patient-derived iPS cells Sci Rep., 9, 1, 5698-5698 Sci Rep., 9, 1, 5698-5698 Sci Rep., 9, 1, 5698-5698 2019 Refereed English Disclose to all
Yasumoto T, Takamura Y, Tsuji M, Watanabe-Nakayama T, Imamura K, Inoue H, Nakamura S, Inoue T, Kimura A, Yano S, Nishijo H, Kiuchi Y, David B Yasumoto T, Takamura Y, Tsuji M, Watanabe-Nakayama T, Imamura K, Inoue H, Nakamura S, Inoue T, Kimura A, Yano S, Nishijo H, Kiuchi Y, David B Yasumoto T, Takamura Y, Tsuji M, Watanabe-Nakayama T, Imamura K, Inoue H, Nakamura S, Inoue T, Kimura A, Yano S, Nishijo H, Kiuchi Y, David B High molecular weight amyloid β1-42 oligomers induceneurotoxicity via plasma membrane damage High molecular weight amyloid β1-42 oligomers induceneurotoxicity via plasma membrane damage High molecular weight amyloid β1-42 oligomers induceneurotoxicity via plasma membrane damage FASEB J., 33, 8, 9220-9234 FASEB J., 33, 8, 9220-9234 FASEB J., 33, 8, 9220-9234 2019 Refereed Disclose to all
Imamura K, Izumi Y, Banno H, Uozumi R, Morita S, Egawa N, Ayaki T, Nagai M, Nishiyama K, Watanabe Y, Hanajima R, Oki R, Fujita K, Takahashi N, Ikeda T, Shimizu A, Morinaga A, Hirohashi T, Fujii Y, Takahashi R, Inoue H Imamura K, Izumi Y, Banno H, Uozumi R, Morita S, Egawa N, Ayaki T, Nagai M, Nishiyama K, Watanabe Y, Hanajima R, Oki R, Fujita K, Takahashi N, Ikeda T, Shimizu A, Morinaga A, Hirohashi T, Fujii Y, Takahashi R, Inoue H Imamura K, Izumi Y, Banno H, Uozumi R, Morita S, Egawa N, Ayaki T, Nagai M, Nishiyama K, Watanabe Y, Hanajima R, Oki R, Fujita K, Takahashi N, Ikeda T, Shimizu A, Morinaga A, Hirohashi T, Fujii Y, Takahashi R, Inoue H Induced pluripotent stem cell-based Drug Repurposing for Amyotrophic lateral sclerosis Medicine (iDReAM) study: protocol for a phase I dose escalation study of bosutinib for amyotrophic lateral sclerosis patients Induced pluripotent stem cell-based Drug Repurposing for Amyotrophic lateral sclerosis Medicine (iDReAM) study: protocol for a phase I dose escalation study of bosutinib for amyotrophic lateral sclerosis patients Induced pluripotent stem cell-based Drug Repurposing for Amyotrophic lateral sclerosis Medicine (iDReAM) study: protocol for a phase I dose escalation study of bosutinib for amyotrophic lateral sclerosis patients BMJ Open., 9, 12, e033131 BMJ Open., 9, 12, e033131 BMJ Open., 9, 12, e033131 2019 Refereed English Disclose to all
Suga, M, Kondo, T, Imamura, K, Shibukawa, R, Okanishi, Y, Sagara, Y, Tsukita, K, Enami, T, Furujo, M, Saijo, K, Nakamura, Y, Osawa, M, Saito, M.K, Yamanaka, S, Inoue, H Suga, M, Kondo, T, Imamura, K, Shibukawa, R, Okanishi, Y, Sagara, Y, Tsukita, K, Enami, T, Furujo, M, Saijo, K, Nakamura, Y, Osawa, M, Saito, M.K, Yamanaka, S, Inoue, H Suga, M, Kondo, T, Imamura, K, Shibukawa, R, Okanishi, Y, Sagara, Y, Tsukita, K, Enami, T, Furujo, M, Saijo, K, Nakamura, Y, Osawa, M, Saito, M.K, Yamanaka, S, Inoue, H Generation of a human induced pluripotent stem cell line, BRCi001-A, derived from a patient with mucopolysaccharidosis type I Generation of a human induced pluripotent stem cell line, BRCi001-A, derived from a patient with mucopolysaccharidosis type I Generation of a human induced pluripotent stem cell line, BRCi001-A, derived from a patient with mucopolysaccharidosis type I Stem Cell Res., 36, 101406 Stem Cell Res., 36, 101406 Stem Cell Res., 36, 101406 2019 Refereed Disclose to all
Nakazeki F, Tsuge I, Horie T, Imamura K, Tsukita K, Hotta A, Baba O, Kuwabara Y, Nishino T, Nakao T, Nishiga M, Nishi H, Nakashima Y, Ide Y, Koyama S, Kimura M, Tsuji S, Naitoh M, Suzuki S, Izumi Y, Kawarai T, Kaji R, Kimura T, Inoue H, Ono K Nakazeki F, Tsuge I, Horie T, Imamura K, Tsukita K, Hotta A, Baba O, Kuwabara Y, Nishino T, Nakao T, Nishiga M, Nishi H, Nakashima Y, Ide Y, Koyama S, Kimura M, Tsuji S, Naitoh M, Suzuki S, Isumi Y, Kawarai T, Kaji R, Kimura T, Inoue H, Ono K Nakazeki F, Tsuge I, Horie T, Imamura K, Tsukita K, Hotta A, Baba O, Kuwabara Y, Nishino T, Nakao T, Nishiga M, Nishi H, Nakashima Y, Ide Y, Koyama S, Kimura M, Tsuji S, Naitoh M, Suzuki S, Izumi Y, Kawarai T, Kaji R, Kimura T, Inoue H, Ono K MiR-33a is a therapeutic target in SPG4-related hereditary spastic paraplegia human neurons MiR-33a is a therapeutic target in SPG4-related hereditary spastic paraplegia human neurons MiR-33a is a therapeutic target in SPG4-related hereditary spastic paraplegia human neurons Clin Sci (Lond)., 133, 4, 583-595 Clin Sci (Lond)., 133, 4, 583-595 Clin Sci (Lond)., 133, 4, 583-595 2019 Refereed Disclose to all
Karagiannis P, Takahashi K, Saito M, Yoshida Y, Okita K, Watanabe A, Inoue H, Yamashita JK, Todani M, Nakagawa M, Osawa M, Yashiro Y, Yamanaka S, Osafune K Karagiannis P, Takahashi K, Saito M, Yoshida Y, Okita K, Watanabe A, Inoue H, Yamashita JK, Todani M, Nakagwa M, Osawa M, Yashiro Y, Yamanaka S, Osafune K Karagiannis P, Takahashi K, Saito M, Yoshida Y, Okita K, Watanabe A, Inoue H, Yamashita JK, Todani M, Nakagawa M, Osawa M, Yashiro Y, Yamanaka S, Osafune K Induced Pluripotent Stem Cells and Their Use in Human Models of Disease and Development Induced Pluripotent Stem Cells and Their Use in Human Models of Disease and Development Induced Pluripotent Stem Cells and Their Use in Human Models of Disease and Development Physiol Rev., 99, 1, 79-114 Physiol Rev., 99, 1, 79-114 Physiol Rev., 99, 1, 79-114 2019 Refereed Disclose to all
Tsuburaya N, Homma K, Higuchi T, Balia A, Yamakoshi H, Shibata N, Nakamura S, Nakagawa H, Ikeda SI, Umezawa N, Kato N, Yokoshima S, Shibuya M, Shimonishi M, Kojima H, Okabe T, Nagano T, Naguro I, Imamura K, Inoue H, Fujisawa T, Ichijo H Tsuburaya N, Homma K, Higuchi T, Balia A, Yamakoshi H, Shibata N, Nakamura S, Nakagawa H, Ikeda SI, Umezawa N, Kato N, Yokoshima S, Shibuya M, Shimonishi M, Kojima H, Okabe T, Nahano T, Naguro I, Imamura K, Inoue H, Fujisawa T, Ichijo H Tsuburaya N, Homma K, Higuchi T, Balia A, Yamakoshi H, Shibata N, Nakamura S, Nakagawa H, Ikeda SI, Umezawa N, Kato N, Yokoshima S, Shibuya M, Shimonishi M, Kojima H, Okabe T, Nagano T, Naguro I, Imamura K, Inoue H, Fujisawa T, Ichijo H A small-molecule inhibitor of SOD1-Derlin-1 interaction ameliorates pathology in an ALS mouse model A small-molecule inhibitor of SOD1-Derlin-1 interaction ameliorates pathology in an ALS mouse model A small-molecule inhibitor of SOD1-Derlin-1 interaction ameliorates pathology in an ALS mouse model Nat Commun., 9, 1, 2668-2668 Nat Commun., 9, 1, 2668-2668 Nat Commun., 9, 1, 2668-2668 2018 Disclose to all
Komatsu K, Imamura K, Yamashita H, Julien JP, Takahashi R, Inoue H Komatsu K, Imamura K, Yamashita H, Julien JP, Takahashi R, Inoue H Komatsu K, Imamura K, Yamashita H, Julien JP, Takahashi R, Inoue H Overexpressed wild-type superoxide dismutase 1 exhibits amyotrophic lateral sclerosis-related misfolded conformation in induced pluripotent stem cell-derived spinal motor neurons Overexpressed wild-type superoxide dismutase 1 exhibits amyotrophic lateral sclerosis-related misfolded conformation in induced pluripotent stem cell-derived spinal motor neurons Overexpressed wild-type superoxide dismutase 1 exhibits amyotrophic lateral sclerosis-related misfolded conformation in induced pluripotent stem cell-derived spinal motor neurons Neuroreport., 29, 1, 25-29 Neuroreport., 29, 1, 25-29 Neuroreport., 29, 1, 25-29 2018 Refereed Disclose to all
Kawakami H, Kitajima H, Nishiyama A, Sasai Y, Inoue H, Muguruma K Ishida, Y, Kawakami H, Kitajima H, Nishiyama A, Sasai Y, Inoue H, Muguruma K Kawakami H, Kitajima H, Nishiyama A, Sasai Y, Inoue H, Muguruma K Erratum: Vulnerability of Purkinje Cells Generated from Spinocerebellar Ataxia Type 6 Patient-Derived iPSCs (Cell Reports (2016) 17(6) (1482–1490)(S2211124716314292)(10.1016/j.celrep.2016.10.026)) Erratum: Vulnerability of Purkinje Cells Generated from Spinocerebellar Ataxia Type 6 Patient-Derived iPSCs (Cell Reports (2016) 17(6) (1482–1490)(S2211124716314292)(10.1016/j.celrep.2016.10.026)) Erratum: Vulnerability of Purkinje Cells Generated from Spinocerebellar Ataxia Type 6 Patient-Derived iPSCs (Cell Reports (2016) 17(6) (1482–1490)(S2211124716314292)(10.1016/j.celrep.2016.10.026)) Cell Rep., 18, 4, 1075-1076 Cell Rep., 18, 4, 1075-1076 Cell Rep., 18, 4, 1075-1076 2017 Refereed Disclose to all
Murakamia N, Ishikawa T, Kondo T, Imamura K, Tsukita K, Enami T, Funayama M, Shibukawa R, Matsumoto S, Izumi Y, Ohta E, Obata F, Kaji R, Inoue H Murakamia N, Ishikawa T, Kondo T, Imamura K, Tsukita K, Enami T, Funayama M, Shibukawa R, Matsumoto S, Izumi Y, Ohta E, Obata F, Kaji R, Inoue H Murakamia N, Ishikawa T, Kondo T, Imamura K, Tsukita K, Enami T, Funayama M, Shibukawa R, Matsumoto S, Izumi Y, Ohta E, Obata F, Kaji R, Inoue H Establishment of DYT5 patient-specific induced pluripotent stem cells with a GCH1 mutation Establishment of DYT5 patient-specific induced pluripotent stem cells with a GCH1 mutation Establishment of DYT5 patient-specific induced pluripotent stem cells with a GCH1 mutation Stem Cell Res., 24, 36-39 Stem Cell Res., 24, 36-39 Stem Cell Res., 24, 36-39 2017 Refereed English Research paper(scientific journal) Disclose to all
Sekine S, Kondo T, Murakami N, Imamura K, Enami T, Shibukawa R, Tsukita K, Funayama M, Inden M, Kurita H, Hozumi I, Inoue H Sekine S, Kondo T, Murakami N, Imamura K, Enami T, Shibukawa R, Tsukita K, Funayama M, Inden M, Kurita H, Hozumi I, Inoue H Sekine S, Kondo T, Murakami N, Imamura K, Enami T, Shibukawa R, Tsukita K, Funayama M, Inden M, Kurita H, Hozumi I, Inoue H Induced pluripotent stem cells derived from a patient with familial idiopathic basal ganglia calcification (IBGC) caused by a mutation in SLC20A2 gene Induced pluripotent stem cells derived from a patient with familial idiopathic basal ganglia calcification (IBGC) caused by a mutation in SLC20A2 gene Induced pluripotent stem cells derived from a patient with familial idiopathic basal ganglia calcification (IBGC) caused by a mutation in SLC20A2 gene Stem Cell Res., 24, 40-43 Stem Cell Res., 24, 40-43 Stem Cell Res., 24, 40-43 2017 Refereed English Research paper(scientific journal) Disclose to all
Izumikawa K, Nobe Y, Yoshikawa H, Ishikawa H, Miura Y, Nakayama H, Nonaka T, Hasegawa M, Egawa N, Inoue H, Nishikawa K, Yamano K, Simpson R, Taoka M, Yamauchi Y, Isobe T, Takahashi N Izumikawa K, Nobe Y, Yoshikawa H, Ishikawa H, Miura Y, Nakayama H, Nonaka T, Hasegawa M, Egawa N, Inoue H, Nishikawa K, Yamano K, Simpson R, Taoka M, Yamauchi Y, Isobe T, Takahashi N Izumikawa K, Nobe Y, Yoshikawa H, Ishikawa H, Miura Y, Nakayama H, Nonaka T, Hasegawa M, Egawa N, Inoue H, Nishikawa K, Yamano K, Simpson R, Taoka M, Yamauchi Y, Isobe T, Takahashi N TDP-43 stabilises the processing intermediates of mitochondrial transcripts TDP-43 stabilises the processing intermediates of mitochondrial transcripts TDP-43 stabilises the processing intermediates of mitochondrial transcripts Sci Rep., 7, 1, 7709 Sci Rep., 7, 1, 7709 Sci Rep., 7, 1, 7709 2017 Refereed English Research paper(scientific journal) Disclose to all
Ohara R, Imamura K, Morii F, Egawa N, Tsukita K, Enami T, Shibukawa R, Mizuno T, Nakagawa M, Inoue H Ohara R, Imamura K, Morii F, Egawa N, Tsukita K, Enami T, Shibukawa R, Mizuno T, Nakagawa M, Inoue H Ohara R, Imamura K, Morii F, Egawa N, Tsukita K, Enami T, Shibukawa R, Mizuno T, Nakagawa M, Inoue H Modeling drug-induced neuropathy using human iPSCs for predictive toxicology Modeling drug-induced neuropathy using human iPSCs for predictive toxicology Modeling drug-induced neuropathy using human iPSCs for predictive toxicology Clin Pharmacol Ther., 101, 6, 754-762 Clin Pharmacol Ther., 101, 6, 754-762 Clin Pharmacol Ther., 101, 6, 754-762 2017 Refereed English Research paper(scientific journal) Disclose to all
Shirotani K, Matsuo K, Ohtsuki S, Masuda T, Asai M, Kutoku Y, Ohsawa Y, Sunada Y, Kondo T, Inoue H, Iwata N Shirotani K, Matsuo K, Ohtsuki S, Masuda T, Asai M, Kutoku Y, Ohsawa Y, Sunada Y, Kondo T, Inoue H, Iwata N Shirotani K, Matsuo K, Ohtsuki S, Masuda T, Asai M, Kutoku Y, Ohsawa Y, Sunada Y, Kondo T, Inoue H, Iwata N A simplified and sensitive method to identify Alzheimer's disease biomarker candidates using patient-derived induced pluripotent stem cells (iPSCs) A simplified and sensitive method to identify Alzheimer's disease biomarker candidates using patient-derived induced pluripotent stem cells (iPSCs) A simplified and sensitive method to identify Alzheimer's disease biomarker candidates using patient-derived induced pluripotent stem cells (iPSCs) J Biochem., 162, 6, 391-394 J Biochem., 162, 6, 391-394 J Biochem., 162, 6, 391-394 2017 Refereed English Research paper(scientific journal) Disclose to all
Murakami N, Imamura K, Izumi Y, Egawa N, Tsukita K, Enami T, Yamamoto T, Kawarai T, Kaji R, Inoue H Murakami N, Imamura K, Izumi Y, Egawa N, Tsukita K, Enami T, Yamamoto T, Kawarai T, Kaji R, Inoue H Murakami N, Imamura K, Izumi Y, Egawa N, Tsukita K, Enami T, Yamamoto T, Kawarai T, Kaji R, Inoue H Proteasome impairment in neural cells derived from HMSN-P patient iPSCs Proteasome impairment in neural cells derived from HMSN-P patient iPSCs Proteasome impairment in neural cells derived from HMSN-P patient iPSCs Mol Brain., 10, 1, 7 Mol Brain., 10, 1, 7 Mol Brain., 10, 1, 7 2017 Refereed English Research paper(scientific journal) Disclose to all
Matsuzono K, Imamura K, Murakami N,Tsukita K,Yamamoto T, Izumi Y, Kaji R,Ohta Y, Yamashita T, Abe K, Inoue H Matsuzono K, Imamura K, Murakami N,Tsukita K,Yamamoto T, Izumi Y, Kaji R,Ohta Y, Yamashita T, Abe K, Inoue H Matsuzono K, Imamura K, Murakami N,Tsukita K,Yamamoto T, Izumi Y, Kaji R,Ohta Y, Yamashita T, Abe K, Inoue H Antisense Oligonucleotides Reduce RNA Foci in Spinocerebellar Ataxia 36 Patient iPSCs Antisense Oligonucleotides Reduce RNA Foci in Spinocerebellar Ataxia 36 Patient iPSCs Antisense Oligonucleotides Reduce RNA Foci in Spinocerebellar Ataxia 36 Patient iPSCs Mol Ther Nucleic Acids., 8, 211-219 Mol Ther Nucleic Acids., 8, 211-219 Mol Ther Nucleic Acids., 8, 211-219 2017 Refereed English Disclose to all
akano-Kobayashi A, Awaya T, Kii I, Sumida Okuno Y, Yoshida S, Sumida T, Inoue H, Hosoya T, Hagiwara M akano-Kobayashi A, Awaya T, Kii I, Sumida Okuno Y, Yoshida S, Sumida T, Inoue H, Hosoya T, Hagiwara M akano-Kobayashi A, Awaya T, Kii I, Sumida Okuno Y, Yoshida S, Sumida T, Inoue H, Hosoya T, Hagiwara M Prenatal neurogenesis induction therapy normalizes brain structure and function in Down syndrome mice Prenatal neurogenesis induction therapy normalizes brain structure and function in Down syndrome mice Prenatal neurogenesis induction therapy normalizes brain structure and function in Down syndrome mice Proc Natl Acad Sci U S A., 114, 38, 10268-10273 Proc Natl Acad Sci U S A., 114, 38, 10268-10273 Proc Natl Acad Sci U S A., 114, 38, 10268-10273 2017 Refereed English Research paper(scientific journal) Disclose to all
Kitani-Morii F, Imamura K, Kondo T, Ohara R, Enami T, Shibukawa R, Yamamoto T, Sekiguchi K, Toguchida J, Mizuno T, Nakagawa M, Inoue H Kitani-Morii F, Imamura K, Kondo T, Ohara R, Enami T, Shibukawa R, Yamamoto T, Sekiguchi K, Toguchida J, Mizuno T, Nakagawa M, Inoue H Kitani-Morii F, Imamura K, Kondo T, Ohara R, Enami T, Shibukawa R, Yamamoto T, Sekiguchi K, Toguchida J, Mizuno T, Nakagawa M, Inoue H Analysis of neural crest cells from Charcot-Marie-Tooth disease patients demonstrates disease-relevant molecular signature Analysis of neural crest cells from Charcot-Marie-Tooth disease patients demonstrates disease-relevant molecular signature Analysis of neural crest cells from Charcot-Marie-Tooth disease patients demonstrates disease-relevant molecular signature Neuroreport., 28, 13, 814-821 Neuroreport., 28, 13, 814-821 Neuroreport., 28, 13, 814-821 2017 Refereed English Research paper(scientific journal) Disclose to all
Tan G W, Kondo T, Murakamia N, Imamura K, Enami T, Tsukita K, Shibukawa R, Funayama M, Matsumoto R, Ikeda A, Takahashi R, Inoue H Tan G W, Kondo T, Murakamia N, Imamura K, Enami T, Tsukita K, Shibukawa R, Funayama M, Matsumoto R, Ikeda A, Takahashi R, Inoue H Tan G W, Kondo T, Murakamia N, Imamura K, Enami T, Tsukita K, Shibukawa R, Funayama M, Matsumoto R, Ikeda A, Takahashi R, Inoue H Induced pluripotent stem cells derived from an autosomal dominant lateral temporal epilepsy (ADLTE) patient carrying S473L mutation in leucine-rich glioma inactivated 1 (LGI1) Induced pluripotent stem cells derived from an autosomal dominant lateral temporal epilepsy (ADLTE) patient carrying S473L mutation in leucine-rich glioma inactivated 1 (LGI1) Induced pluripotent stem cells derived from an autosomal dominant lateral temporal epilepsy (ADLTE) patient carrying S473L mutation in leucine-rich glioma inactivated 1 (LGI1) Stem Cell Res., 24, 12-15 Stem Cell Res., 24, 12-15 Stem Cell Res., 24, 12-15 2017 Refereed English Research paper(scientific journal) Disclose to all
Kikuchi T, Morizane A, Doi D, Okita K, Nakagawa M, Yamakado H, Inoue H, Takahashi R, Takahashi J Kikuchi T, Morizane A, Doi D, Okita K, Nakagawa M, Yamakado H, Inoue H, Takahashi R, Takahashi J Kikuchi T, Morizane A, Doi D, Okita K, Nakagawa M, Yamakado H, Inoue H, Takahashi R, Takahashi J Idiopathic Parkinson's disease patient-derived induced pluripotent stem cells function as midbrain dopaminergic neurons in rodent brains Idiopathic Parkinson's disease patient-derived induced pluripotent stem cells function as midbrain dopaminergic neurons in rodent brains Idiopathic Parkinson's disease patient-derived induced pluripotent stem cells function as midbrain dopaminergic neurons in rodent brains J Neurosci Res., 95, 9, 1829-1837 J Neurosci Res., 95, 9, 1829-1837 J Neurosci Res., 95, 9, 1829-1837 2017 Refereed Disclose to all
Goto K, Imamura K, Komatsu K, Mitani K, Aiba K, Nakatsuji N, Inoue M, Kawata A, Yamashita H, Takahashi R, Inoue H Goto K, Imamura K, Komatsu K, Mitani K, Aiba K, Nakatsuji N, Inoue M, Kawata A, Yamashita H, Takahashi R, Inoue H Goto K, Imamura K, Komatsu K, Mitani K, Aiba K, Nakatsuji N, Inoue M, Kawata A, Yamashita H, Takahashi R, Inoue H Simple Derivation of Spinal Motor Neurons from ESCs/iPSCs Using Sendai Virus Vectors Simple Derivation of Spinal Motor Neurons from ESCs/iPSCs Using Sendai Virus Vectors Simple Derivation of Spinal Motor Neurons from ESCs/iPSCs Using Sendai Virus Vectors Mol Ther Methods Clin Dev., 4, 115-125 Mol Ther Methods Clin Dev., 4, 115-125 Mol Ther Methods Clin Dev., 4, 115-125 2017 Refereed Disclose to all
Kikuchi T, Morizane A, Doi D, Magotani H, Onoe H, Hayashi T, Mizuma H, Takara S, Takahashi R, Inoue H, Morita S, Yamamoto M, Okita K, Nakagawa M, Parmar M, Takahashi J Kikuchi T, Morizane A, Doi D, Magotani H, Onoe H, Hayashi T, Mizuma H, Takara S, Takahashi R, Inoue H, Morita S, Yamamoto M, Okita K, Nakagawa M, Parmar M, Takahashi J Kikuchi T, Morizane A, Doi D, Magotani H, Onoe H, Hayashi T, Mizuma H, Takara S, Takahashi R, Inoue H, Morita S, Yamamoto M, Okita K, Nakagawa M, Parmar M, Takahashi J Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model Nature., 548, 7669, 592-596 Nature., 548, 7669, 592-596 Nature., 548, 7669, 592-596 2017 Refereed Disclose to all
Takayuki Kondo, Keiko Imamura, Misato Funayama, Kayoko Tsukita, Michiyo Miyake, Akira Ohta, Knut Woltjen, Masato Nakagawa, Takashi Asada, Tetsuaki Arai, Shinobu Kawakatsu, Yuishin Izumi, Ryuji Kaji, Nobuhisa Iwata, Haruhisa Inoue Kondo T, Imamura K, Funayama M, Tsukita K, Miyake M, Ohta A, Woltjen K, Nakagawa M, Asada T, Arai T, Kawakatsu S, Izumi Y, Kaji R, Iwata N, Inoue H Takayuki Kondo, Keiko Imamura, Misato Funayama, Kayoko Tsukita, Michiyo Miyake, Akira Ohta, Knut Woltjen, Masato Nakagawa, Takashi Asada, Tetsuaki Arai, Shinobu Kawakatsu, Yuishin Izumi, Ryuji Kaji, Nobuhisa Iwata, Haruhisa Inoue iPSC-Based Compound Screening and In Vitro Trials Identify a Synergistic Anti-amyloid beta Combination for Alzheimer's Disease iPSC-Based Compound Screening and In Vitro Trials Identify a Synergistic Anti-amyloid β Combination for Alzheimer’s Disease iPSC-Based Compound Screening and In Vitro Trials Identify a Synergistic Anti-amyloid beta Combination for Alzheimer's Disease Cell Rep., 21, 8, 2304-2312 Cell Rep., 21, 8, 2304-2312 Cell Rep., 21, 8, 2304-2312 2017 Refereed English Research paper(scientific journal) Disclose to all
Shi Y, Inoue H, Wu JC, Yamanaka S Shi Y, Inoue H, Wu JC, Yamanaka S Shi Y, Inoue H, Wu JC, Yamanaka S Induced pluripotent stem cell technology: a decade of progress Induced pluripotent stem cell technology: a decade of progress Induced pluripotent stem cell technology: a decade of progress Nat Rev Drug Discov., 16, 2, 115-130 Nat Rev Drug Discov., 16, 2, 115-130 Nat Rev Drug Discov., 16, 2, 115-130 2017 Refereed English Research paper(scientific journal) Disclose to all
Imamura K, Izumi Y, Watanabe A, Tsukita K, Woltjen K, Yamamoto T, Hotta A, Kondo T, Kitaoka S, Ohta A, Tanaka A, Watanabe D, Morita M, Takuma H, Tamaoka A, Kunath T, Wray S, Furuya H, Era T, Makioka K, Okamoto K, Fujisawa T, Nishitoh H, Homma K, Ichijo H, Julien JP, Obata N, Masato H, Akiyama H, Kaneko S, Ayaki T, Ito H, Kaji R, Takahashi R, Yamanaka S, Inoue H Imamura K, Izumi Y, Watanabe A, Tsukita K, Woltjen K, Yamamoto T, Hotta A, Kondo T, Kitaoka S, Ohta A, Tanaka A, Watanabe D, Morita M, Takuma H, Tamaoka A, Kunath T, Wray S, Furuya H, Era T, Makioka K, Okamoto K, Fujisawa T, Nishitoh H, Homma K, Ichijo H, Julien JP, Obata N, Masato H, Akiyama H, Kaneko S, Ayaki T, Ito H, Kaji R, Takahashi R, Yamanaka S, Inoue H Imamura K, Izumi Y, Watanabe A, Tsukita K, Woltjen K, Yamamoto T, Hotta A, Kondo T, Kitaoka S, Ohta A, Tanaka A, Watanabe D, Morita M, Takuma H, Tamaoka A, Kunath T, Wray S, Furuya H, Era T, Makioka K, Okamoto K, Fujisawa T, Nishitoh H, Homma K, Ichijo H, Julien JP, Obata N, Masato H, Akiyama H, Kaneko S, Ayaki T, Ito H, Kaji R, Takahashi R, Yamanaka S, Inoue H The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis Sci Transl Med., 9, 391, eaaf3962 Sci Transl Med., 9, 391, eaaf3962 Sci Transl Med., 9, 391, eaaf3962 2017 Refereed English Research paper(scientific journal) Disclose to all
Matsuzono K, Abe K, Inoue H Matsuzono K, Abe K, Inoue H Matsuzono K, Abe K, Inoue H [Dementia Study Using Induced Pluripotent Stem Cells] [Dementia Study Using Induced Pluripotent Stem Cells] [Dementia Study Using Induced Pluripotent Stem Cells] Nihon Rinsho., 74, 3, 443-450 Nihon Rinsho., 74, 3, 443-450 Nihon Rinsho., 74, 3, 443-450 2016 Refereed Disclose to all
Ishida Y, Kawakami H, Kitajima H, Nishiyama A, Sasai Y, InoueH, Muguruma K Ishida Y, Kawakami H, Kitajima H, Nishiyama A, Sasai Y, InoueH, Muguruma K Ishida Y, Kawakami H, Kitajima H, Nishiyama A, Sasai Y, InoueH, Muguruma K Vulnerability of Purkinje Cells Generated from Spinocerebellar Ataxia Type 6 Patient-Derived iPSCs Vulnerability of Purkinje Cells Generated from Spinocerebellar Ataxia Type 6 Patient-Derived iPSCs Vulnerability of Purkinje Cells Generated from Spinocerebellar Ataxia Type 6 Patient-Derived iPSCs Cell Rep., 17, 6, 1482-1490 Cell Rep., 17, 6, 1482-1490 Cell Rep., 17, 6, 1482-1490 2016 Refereed English Research paper(scientific journal) Disclose to all
Ji B, Kaneko H, Minamimoto T, Inoue H, Takeuchi H, Kumata K, Zhang M-R, Aoki I, Seki C, Ono M, Tokunaga M, Tsukamoto S, Tanabe K, Shin R-M, Minamihisamitsu T, Kito S, Richmond B J, Suhara T, Higuchi M Ji B, Kaneko H, Minamimoto T, Inoue H, Takeuchi H, Kumata K, Zhang M-R, Aoki I, Seki C, Ono M, Tokunaga M, Tsukamoto S, Tanabe K, Shin R-M, Minamihisamitsu T, Kito S, Richmond B J, Suhara T, Higuchi M Ji B, Kaneko H, Minamimoto T, Inoue H, Takeuchi H, Kumata K, Zhang M-R, Aoki I, Seki C, Ono M, Tokunaga M, Tsukamoto S, Tanabe K, Shin R-M, Minamihisamitsu T, Kito S, Richmond B J, Suhara T, Higuchi M Multimodal Imaging for DREADD-Expressing Neurons in Living Brain and Their Application to Implantation of iPSC-Derived Neural Progenitors Multimodal Imaging for DREADD-Expressing Neurons in Living Brain and Their Application to Implantation of iPSC-Derived Neural Progenitors Multimodal Imaging for DREADD-Expressing Neurons in Living Brain and Their Application to Implantation of iPSC-Derived Neural Progenitors J Neurosci., 36, 45, 11544-11558 J Neurosci., 36, 45, 11544-11558 J Neurosci., 36, 45, 11544-11558 2016 Refereed English Research paper(scientific journal) Disclose to all
Oceguera-Y F, Kim SI, Matsumoto T, Tan GW, Xiang L, Hatani T, Kondo T, Ikeya M, Yoshida Y, Inoue H, Woltjen K Oceguera-Y F, Kim SI, Matsumoto T, Tan GW, Xiang L, Hatani T, Kondo T, Ikeya M, Yoshida Y, Inoue H, Woltjen K Oceguera-Y F, Kim SI, Matsumoto T, Tan GW, Xiang L, Hatani T, Kondo T, Ikeya M, Yoshida Y, Inoue H, Woltjen K Engineering the AAVS1 locus for consistent and scalable transgene expression in human iPSCs and their differentiated derivatives Engineering the AAVS1 locus for consistent and scalable transgene expression in human iPSCs and their differentiated derivatives Engineering the AAVS1 locus for consistent and scalable transgene expression in human iPSCs and their differentiated derivatives Methods., 101, 43-55 Methods., 101, 43-55 Methods., 101, 43-55 2016 Refereed English Research paper(scientific journal) Disclose to all
Mitsushima T, Ishikawa T, Imamura K, Kondo T, Koshiba Y, Tkahashi R, Takahashi J, Watanabe A, Fujii N, Tsuboi Y, Inoue H Mitsushima T, Ishikawa T, Imamura K, Kondo T, Koshiba Y, Tkahashi R, Takahashi J, Watanabe A, Fujii N, Tsuboi Y, Inoue H Mitsushima T, Ishikawa T, Imamura K, Kondo T, Koshiba Y, Tkahashi R, Takahashi J, Watanabe A, Fujii N, Tsuboi Y, Inoue H Cytoplasmic aggregates of dynactin in iPSC-derived tyrosine hydroxylase-positive neurons from a patient with Perry syndrome Cytoplasmic aggregates of dynactin in iPSC-derived tyrosine hydroxylase-positive neurons from a patient with Perry syndrome Cytoplasmic aggregates of dynactin in iPSC-derived tyrosine hydroxylase-positive neurons from a patient with Perry syndrome Parkinsonism Relat Disord., 30, 67-72 Parkinsonism Relat Disord., 30, 67-72 Parkinsonism Relat Disord., 30, 67-72 2016 Refereed English Research paper(scientific journal) Disclose to all
Kondo T, Funayama M, Miyake M, Tsukita K, Era T, Osaka H, Ayaki T, Takahashi R, Inoue H Kondo T, Funayama M, Miyake M, Tsukita K, Era T, Osaka H, Ayaki T, Takahashi R, Inoue H Kondo T, Funayama M, Miyake M, Tsukita K, Era T, Osaka H, Ayaki T, Takahashi R, Inoue H Modeling Alexander disease with patient iPSCs reveals cellular and molecular pathology of astrocytes Modeling Alexander disease with patient iPSCs reveals cellular and molecular pathology of astrocytes Modeling Alexander disease with patient iPSCs reveals cellular and molecular pathology of astrocytes Acta Neuropathol Commun., 4, 1, 69-80 Acta Neuropathol Commun., 4, 1, 69-80 Acta Neuropathol Commun., 4, 1, 69-80 2016 Refereed English Research paper(scientific journal) Disclose to all
Ishikawa T, Imamura K, Koshiba Y, Hara S, Ichinose H, Furujo M, Kinoshita M, Oeda T, Takahashi J, Takahashi R, Inoue H Ishikawa T, Imamura K, Koshiba Y, Hara S, Ichinose H, Furujo M, Kinoshita M, Oeda T, Takahashi J, Takahashi R, Inoue H Ishikawa T, Imamura K, Koshiba Y, Hara S, Ichinose H, Furujo M, Kinoshita M, Oeda T, Takahashi J, Takahashi R, Inoue H Genetic and pharmacological correction of aberrant dopamine synthesis using patient iPSCs with BH4 metabolism disorders Genetic and pharmacological correction of aberrant dopamine synthesis using patient iPSCs with BH4 metabolism disorders Genetic and pharmacological correction of aberrant dopamine synthesis using patient iPSCs with BH4 metabolism disorders Hum Mol Genet., 25, 23, 5188-5197 Hum Mol Genet., 25, 23, 5188-5197 Hum Mol Genet., 25, 23, 5188-5197 2016 Refereed English Research paper(scientific journal) Disclose to all
Imamura K, Sahara N, Kanaan N M., Tsukita K, Kondo T, Kutoku Y, Ohsawa Y, Sunada Y, Kawakami K, Hotta A, Yawata S, Watanabe D, Hasegawa M, Trojanowski J Q., Lee V M.-Y., Suhara T, Higuchi M, Inoue H Imamura K, Sahara N, Kanaan N M., Tsukita K, Kondo T, Kutoku Y, Ohsawa Y, Sunada Y, Kawakami K, Hotta A, Yawata S, Watanabe D, Hasegawa M, Trojanowski J Q., Lee V M.-Y., Suhara T, Higuchi M, Inoue H Imamura K, Sahara N, Kanaan N M., Tsukita K, Kondo T, Kutoku Y, Ohsawa Y, Sunada Y, Kawakami K, Hotta A, Yawata S, Watanabe D, Hasegawa M, Trojanowski J Q., Lee V M.-Y., Suhara T, Higuchi M, Inoue H Calcium dysregulation contributes to neurodegeneration in FTLD patient iPSC-derived neurons Calcium dysregulation contributes to neurodegeneration in FTLD patient iPSC-derived neurons Calcium dysregulation contributes to neurodegeneration in FTLD patient iPSC-derived neurons Sci Rep., 6, 34904 Sci Rep., 6, 34904 Sci Rep., 6, 34904 2016 Refereed English Research paper(scientific journal) Disclose to all
Kutoku Y, Ohsawa Y, Kuwano R, Ikeuchi T, Inoue H, Ataka S, Shimada H, Mori H, Sunada Y Kutoku Y, Ohsawa Y, Kuwano R, Ikeuchi T, Inoue H, Ataka S, Shimada H, Mori H, Sunada Y Kutoku Y, Ohsawa Y, Kuwano R, Ikeuchi T, Inoue H, Ataka S, Shimada H, Mori H, Sunada Y A second pedigree with amyloid-less familial Alzheimer's disease harboring an identical mutation in the amyloid precursor protein gene (E693delta) A second pedigree with amyloid-less familial Alzheimer's disease harboring an identical mutation in the amyloid precursor protein gene (E693delta) A second pedigree with amyloid-less familial Alzheimer's disease harboring an identical mutation in the amyloid precursor protein gene (E693delta) Intern Med., 54, 2, 205-208 Intern Med., 54, 2, 205-208 Intern Med., 54, 2, 205-208 2015 Refereed Disclose to all
Yoshida M, Kitaoka S, Egawa N, Yamane M, Ikeda R, Tsukita K, Amano N, Watanabe A, Morimoto M, Takahashi J, Hosoi H, Nakahatan T, Inoue H, Saito Megumu Yoshida M, Kitaoka S, Egawa N, Yamane M, Ikeda R, Tsukita K, Amano N, Watanabe A, Morimoto M, Takahashi J, Hosoi H, Nakahatan T, Inoue H, Saito Megumu Yoshida M, Kitaoka S, Egawa N, Yamane M, Ikeda R, Tsukita K, Amano N, Watanabe A, Morimoto M, Takahashi J, Hosoi H, Nakahatan T, Inoue H, Saito Megumu Modeling the Early Phenotype at the Neuromuscular Junction of Spinal Muscular Atrophy Using Patient-Derived iPSCs Modeling the Early Phenotype at the Neuromuscular Junction of Spinal Muscular Atrophy Using Patient-Derived iPSCs Modeling the Early Phenotype at the Neuromuscular Junction of Spinal Muscular Atrophy Using Patient-Derived iPSCs Stem Cell Rep., 4, 4, 561-568 Stem Cell Rep., 4, 4, 561-568 Stem Cell Rep., 4, 4, 561-568 2015 Refereed English Research paper(scientific journal) Disclose to all
Shimojima K, Okumura A, Hayashi M, Kondo T, Inoue H, Yamamoto T Shimojima K, Okumura A, Hayashi M, Kondo T, Inoue H, Yamamoto T Shimojima K, Okumura A, Hayashi M, Kondo T, Inoue H, Yamamoto T CHCHD2 is down-regulated in neuronal cells differentiated from iPS cells derived from patients with lissencephaly CHCHD2 is down-regulated in neuronal cells differentiated from iPS cells derived from patients with lissencephaly CHCHD2 is down-regulated in neuronal cells differentiated from iPS cells derived from patients with lissencephaly Genomics., 106, 4, 196-203 Genomics., 106, 4, 196-203 Genomics., 106, 4, 196-203 2015 Refereed English Research paper(scientific journal) Disclose to all
Asai M, Shirotani K, Kondo T, Inoue H, Iwata N Asai M, Shirotani K, Kondo T, Inoue H, Iwata N Asai M, Shirotani K, Kondo T, Inoue H, Iwata N [Cellular Models for Individualized Medicine in Alzheimer's Disease Using Patient-Derived Induced Pluripotent Stem Cells] [Cellular Models for Individualized Medicine in Alzheimer's Disease Using Patient-Derived Induced Pluripotent Stem Cells] [Cellular Models for Individualized Medicine in Alzheimer's Disease Using Patient-Derived Induced Pluripotent Stem Cells] Nihon Yakurigaku Zasshi., 143, 1, 23-26 Nihon Yakurigaku Zasshi., 143, 1, 23-26 Nihon Yakurigaku Zasshi., 143, 1, 23-26 2014 Refereed Disclose to all
Inoue H, Nagata N, Kurokawa H, Yamanaka S Inoue H, Nagata N, Kurokawa H, Yamanaka S Inoue H, Nagata N, Kurokawa H, Yamanaka S IPS cells: A game changer for future medicine IPS cells: A game changer for future medicine IPS cells: A game changer for future medicine EMBO J., 33, 5, 409-417 EMBO J., 33, 5, 409-417 EMBO J., 33, 5, 409-417 2014 Disclose to all
Hirata N, Nakagawa M, Fujibayashi Y, Yamauchi K, Murata A, Minami I, Tomioka M, Kondo T, Kuo TF, Endo H, Inoue H, Sato S, Ando S, Kawazoe Y, Aiba K, Nagata K, Kawase E, Chang YT, Suemori H, Eto K, Nakauchi H, Yamanaka S, Nakatsuji N, Ueda K, Uesugi M Hirata N, Nakagawa M, Fujibayashi Y, Yamauchi K, Murata A, Minami I, Tomioka M, Kondo T, Kuo TF, Endo H, Inoue H, Sato S, Ando S, Kawazoe Y, Aiba K, Nagata K, Kawase E, Chang YT, Suemori H, Eto K, Nakauchi H, Yamanaka S, Nakatsuji N, Ueda K, Uesugi M Hirata N, Nakagawa M, Fujibayashi Y, Yamauchi K, Murata A, Minami I, Tomioka M, Kondo T, Kuo TF, Endo H, Inoue H, Sato S, Ando S, Kawazoe Y, Aiba K, Nagata K, Kawase E, Chang YT, Suemori H, Eto K, Nakauchi H, Yamanaka S, Nakatsuji N, Ueda K, Uesugi M A chemical probe that labels human pluripotent stem cells A chemical probe that labels human pluripotent stem cells A chemical probe that labels human pluripotent stem cells Cell Rep., 6, 6, 1165-1174 Cell Rep., 6, 6, 1165-1174 Cell Rep., 6, 6, 1165-1174 2014 Refereed Disclose to all
Kondo T, Funayama M, Tsukita K, Hotta A, Yasuda A, Nori S, Kaneko S, Nakamura M,Takahashi R,Okano H, Yamanaka S, Inoue H Kondo T, Funayama M, Tsukita K, Hotta A, Yasuda A, Nori S, Kaneko S, Nakamura M,Takahashi R,Okano H, Yamanaka S, Inoue H Kondo T, Funayama M, Tsukita K, Hotta A, Yasuda A, Nori S, Kaneko S, Nakamura M,Takahashi R,Okano H, Yamanaka S, Inoue H Focal Transplantation of Human iPSC-Derived Glial-Rich Neural Progenitors Improves Lifespan of ALS Mice Focal Transplantation of Human iPSC-Derived Glial-Rich Neural Progenitors Improves Lifespan of ALS Mice Focal Transplantation of Human iPSC-Derived Glial-Rich Neural Progenitors Improves Lifespan of ALS Mice Stem Cell Reports., 3, 2, 242-249 Stem Cell Reports., 3, 2, 242-249 Stem Cell Reports., 3, 2, 242-249 2014 Refereed English Research paper(scientific journal) Disclose to all
Kondo T, Inoue H, Takahashi R Kondo T, Inoue H, Takahashi R Kondo T, Inoue H, Takahashi R [New and future treatments for neurological disorders--knowledge essential to daily clinics and future prospects. Topics: 15. Therapeutic application of iPS cells] [New and future treatments for neurological disorders--knowledge essential to daily clinics and future prospects. Topics: 15. Therapeutic application of iPS cells] [New and future treatments for neurological disorders--knowledge essential to daily clinics and future prospects. Topics: 15. Therapeutic application of iPS cells] Nihon Naika Gakkai Zasshi., 102, 8, 2015-2022 Nihon Naika Gakkai Zasshi., 102, 8, 2015-2022 Nihon Naika Gakkai Zasshi., 102, 8, 2015-2022 2013 Refereed Disclose to all
Inoue H Inoue H Inoue H [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 2. Diseases Originated From Stem Cell Abnormalities; 3) iPS Cell Technology for Neurodegenerative Disease] [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 2. Diseases Originated From Stem Cell Abnormalities; 3) iPS Cell Technology for Neurodegenerative Disease] [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 2. Diseases Originated From Stem Cell Abnormalities; 3) iPS Cell Technology for Neurodegenerative Disease] Nihon Naika Gakkai Zasshi., 102, 9, 2267-2272 Nihon Naika Gakkai Zasshi., 102, 9, 2267-2272 Nihon Naika Gakkai Zasshi., 102, 9, 2267-2272 2013 Refereed Disclose to all
Egawa N, Inoue H Egawa N, Inoue H Egawa N, Inoue H ALS disease modeling and drug screening using patient-specific iPS cells ALS disease modeling and drug screening using patient-specific iPS cells ALS disease modeling and drug screening using patient-specific iPS cells Rinsho Shinkeigaku., 53, 11, 1020-1022 Rinsho Shinkeigaku., 53, 11, 1020-1022 Rinsho Shinkeigaku., 53, 11, 1020-1022 2013 English Research paper(research society, symposium materials, etc.) Disclose to all
Egawa N, Kitaoka S, Tsukita K, Naitoh M, Takahashi K, Yamamoto T, Adachi F, Kondo T, Okita K, Asaka I, Aoi T, Watanabe A, Yamada Y, Morizane A, Takahashi J, Ayaki T, Ito H, Yoshikawa K, Yamawaki S, Suzuki S, Watanabe D, Hioki H, Kaneko T, Makioka K, Okamoto K, Takuma H, Tamaoka A, Hasegawa K, Nonaka T, Hasegawa M, Kawata A, Yoshida M, Nakahata T, Takahashi R, Marchetto MC, Gage FH, Yamanaka S, Inoue H Egawa N, Kitaoka S, Tsukita K, Naitoh M, Takahashi K, Yamamoto T, Adachi F, Kondo T, Okita K, Asaka I, Aoi T, Watanabe A, Yamada Y, Morizane A, Takahashi J, Ayaki T, Ito H, Yoshikawa K, Yamawaki S, Suzuki S, Watanabe D, Hioki H, Kaneko T, Makioka K, Okamoto K, Takuma H, Tamaoka A, Hasegawa K, Nonaka T, Hasegawa M, Kawata A, Yoshida M, Nakahata T, Takahashi R, Marchetto MC, Gage FH, Yamanaka S, Inoue H Egawa N, Kitaoka S, Tsukita K, Naitoh M, Takahashi K, Yamamoto T, Adachi F, Kondo T, Okita K, Asaka I, Aoi T, Watanabe A, Yamada Y, Morizane A, Takahashi J, Ayaki T, Ito H, Yoshikawa K, Yamawaki S, Suzuki S, Watanabe D, Hioki H, Kaneko T, Makioka K, Okamoto K, Takuma H, Tamaoka A, Hasegawa K, Nonaka T, Hasegawa M, Kawata A, Yoshida M, Nakahata T, Takahashi R, Marchetto MC, Gage FH, Yamanaka S, Inoue H Response to comment on "Drug screening for ALS using patient-specific induced pluripotent stem cells" Response to comment on "Drug screening for ALS using patient-specific induced pluripotent stem cells" Response to comment on "Drug screening for ALS using patient-specific induced pluripotent stem cells" Sci Transl Med., 5, 188, 188lr2 Sci Transl Med., 5, 188, 188lr2 Sci Transl Med., 5, 188, 188lr2 2013 Refereed Disclose to all
Fumuro T, Matsuhashi M, Mitsueda T, Inouchi M, Hitomi T, Nakagawa T, Matsumoto R, Kawamata J, Inoue H, Mima T, Takahashi R, Ikeda A Fumuro T, Matsuhashi M, Mitsueda T, Inouchi M, Hitomi T, Nakagawa T, Matsumoto R, Kawamata J, Inoue H, Mima T, Takahashi R, Ikeda A Fumuro T, Matsuhashi M, Mitsueda T, Inouchi M, Hitomi T, Nakagawa T, Matsumoto R, Kawamata J, Inoue H, Mima T, Takahashi R, Ikeda A Bereitschaftspotential augmentation by neuro-feedback training in Parkinson's disease Bereitschaftspotential augmentation by neuro-feedback training in Parkinson's disease Bereitschaftspotential augmentation by neuro-feedback training in Parkinson's disease Clin Neurophysiol., 124, 7, 1398-1405 Clin Neurophysiol., 124, 7, 1398-1405 Clin Neurophysiol., 124, 7, 1398-1405 2013 Refereed Disclose to all
Kondo T, Asai M, Tsukita K, Kutoku Y, Ohsawa Y, Sunada Y, Imamura K, Egawa N, Yahata N, Okita K, Takahashi K, Asaka I, Aoi T, Watanabe A, Watanabe K, Kadoya C, Nakano R, Watanabe D, Maruyama K, Hori O, Hibino S, Choshi T, Nakahata T, Hioki H, Kaneko T, Naitoh M, Yoshikawa K, Yamawaki S, Suzuki S, Hata R, Ueno S, Seki T, Kobayashi K, Toda T, Murakami K, Irie K, Klein WL, Mori H, Asada T, Takahashi R, Iwata N, Yamanaka S, Inoue H Kondo T, Asai M, Tsukita K, Kutoku Y, Ohsawa Y, Sunada Y, Imamura K, Egawa N, Yahata N, Okita K, Takahashi K, Asaka I, Aoi T, Watanabe A, Watanabe K, Kadoya C, Nakano R, Watanabe D, Maruyama K, Hori O, Hibino S, Choshi T, Nakahata T, Hioki H, Kaneko T, Naitoh M, Yoshikawa K, Yamawaki S, Suzuki S, Hata R, Ueno S, Seki T, Kobayashi K, Toda T, Murakami K, Irie K, Klein WL, Mori H, Asada T, Takahashi R, Iwata N, Yamanaka S, Inoue H Kondo T, Asai M, Tsukita K, Kutoku Y, Ohsawa Y, Sunada Y, Imamura K, Egawa N, Yahata N, Okita K, Takahashi K, Asaka I, Aoi T, Watanabe A, Watanabe K, Kadoya C, Nakano R, Watanabe D, Maruyama K, Hori O, Hibino S, Choshi T, Nakahata T, Hioki H, Kaneko T, Naitoh M, Yoshikawa K, Yamawaki S, Suzuki S, Hata R, Ueno S, Seki T, Kobayashi K, Toda T, Murakami K, Irie K, Klein WL, Mori H, Asada T, Takahashi R, Iwata N, Yamanaka S, Inoue H Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness Cell Stem Cell., 12, 4, 487-496 Cell Stem Cell., 12, 4, 487-496 Cell Stem Cell., 12, 4, 487-496 2013 Refereed English Research paper(scientific journal) Disclose to all
Imamura K, Inoue H Imamura K, Inoue H Imamura K, Inoue H Research on Neurodegenerative Diseases Using Induced Pluripotent Stem Cells Research on Neurodegenerative Diseases Using Induced Pluripotent Stem Cells Research on Neurodegenerative Diseases Using Induced Pluripotent Stem Cells Psychogeruatrics., 12, 2, 115-119 Psychogeruatrics., 12, 2, 115-119 Psychogeruatrics., 12, 2, 115-119 2012 Refereed Disclose to all
Kondo T, Takahashi R, Inoue H Kondo T, Takahashi R, Inoue H Kondo T, Takahashi R, Inoue H Cellular Replacement Therapy in Neurodegenerative Diseases Using Induced Pluripotent Stem Cells Cellular Replacement Therapy in Neurodegenerative Diseases Using Induced Pluripotent Stem Cells Cellular Replacement Therapy in Neurodegenerative Diseases Using Induced Pluripotent Stem Cells Stem Cells and Cancer Stem Cells., 2, 241-247 Stem Cells and Cancer Stem Cells., 2, 241-247 Stem Cells and Cancer Stem Cells., 2, 241-247 2012 Refereed Disclose to all
Inoue H Inoue H Inoue H [ALS Patient-Specific iPS Cells] [ALS Patient-Specific iPS Cells] [ALS Patient-Specific iPS Cells] Rinsho Shinkeigaku., 52, 11, 1137-1138 Rinsho Shinkeigaku., 52, 11, 1137-1138 Rinsho Shinkeigaku., 52, 11, 1137-1138 2012 Refereed Disclose to all
Yamakado H, Moriwaki Y, Yamasaki N, Miyakawa T, Kurisu J, Uemura K, Inoue H, Takahashi M, Takahashi R Yamakado H, Moriwaki Y, Yamasaki N, Miyakawa T, Kurisu J, Uemura K, Inoue H, Takahashi M, Takahashi R Yamakado H, Moriwaki Y, Yamasaki N, Miyakawa T, Kurisu J, Uemura K, Inoue H, Takahashi M, Takahashi R α-Synuclein BAC transgenic mice as a model for Parkinson's disease manifested decreased anxiety-like behavior and hyperlocomotion α-Synuclein BAC transgenic mice as a model for Parkinson's disease manifested decreased anxiety-like behavior and hyperlocomotion α-Synuclein BAC transgenic mice as a model for Parkinson's disease manifested decreased anxiety-like behavior and hyperlocomotion Neurosci Res., 73, 2, 173-177 Neurosci Res., 73, 2, 173-177 Neurosci Res., 73, 2, 173-177 2012 Refereed English Research paper(scientific journal) Disclose to all
Tashiro Y, Urushitani M, Inoue H, Koike M, Uchiyama Y, Komatsu M, Tanaka K, Yamazaki M, Abe M, Misawa H, Sakimura K, Ito H, Takahashi R Tashiro Y, Urushitani M, Inoue H, Koike M, Uchiyama Y, Komatsu M, Tanaka K, Yamazaki M, Abe M, Misawa H, Sakimura K, Ito H, Tkahashi R Tashiro Y, Urushitani M, Inoue H, Koike M, Uchiyama Y, Komatsu M, Tanaka K, Yamazaki M, Abe M, Misawa H, Sakimura K, Ito H, Takahashi R Motor neuron-specific disruption of proteasomes, but not autophagy, replicates amyotrophic lateral sclerosis Motor neuron-specific disruption of proteasomes, but not autophagy, replicates amyotrophic lateral sclerosis Motor neuron-specific disruption of proteasomes, but not autophagy, replicates amyotrophic lateral sclerosis J Biol Chem., 287, 51, 42984-42994 J Biol Chem., 287, 51, 42984-42994 J Biol Chem., 287, 51, 42984-42994 2012 Refereed English Research paper(scientific journal) Disclose to all
Kajiwara M, Aoi T, Okita K, Takahashi R, Inoue H, Takayama N, Endo H, Eto K, Toguchida J, Uemoto S, Yamanaka S Kajiwara M, Aoi T, Okita K, Takahashi R, Inoue H, Takayama N, Endo H, Eto K, Toguchida J, Uemoto S, Yamanaka S Kajiwara M, Aoi T, Okita K, Takahashi R, Inoue H, Takayama N, Endo H, Eto K, Toguchida J, Uemoto S, Yamanaka S Donor-dependent variations in hepatic differentiation from human-induced pluripotent stem cells Donor-dependent variations in hepatic differentiation from human-induced pluripotent stem cells Donor-dependent variations in hepatic differentiation from human-induced pluripotent stem cells Proc Natl Acad Sci U S A., 109, 31, 12538-12543 Proc Natl Acad Sci U S A., 109, 31, 12538-12543 Proc Natl Acad Sci U S A., 109, 31, 12538-12543 2012 Refereed English Research paper(scientific journal) Disclose to all
Wada T, Goparaju SK, Tooi N, Inoue H, Takahashi R, Nakatsuji N, Aiba K Wada T, Goparaju SK, Tooi N, Inoue H, Takahashi R, Nakatsuji N, Aiba K Wada T, Goparaju SK, Tooi N, Inoue H, Takahashi R, Nakatsuji N, Aiba K Amyotrophic lateral sclerosis model derived from human embryonic stem cells overexpressing mutant superoxide dismutase 1 Amyotrophic lateral sclerosis model derived from human embryonic stem cells overexpressing mutant superoxide dismutase 1 Amyotrophic lateral sclerosis model derived from human embryonic stem cells overexpressing mutant superoxide dismutase 1 Stem Cells Transl Med., 1, 5, 396-402 Stem Cells Transl Med., 1, 5, 396-402 Stem Cells Transl Med., 1, 5, 396-402 2012 Refereed English Research paper(scientific journal) Disclose to all
Egawa N, Kitaoka S, Tsukita K, Naitoh M, Takahashi K, Yamamoto T, Adachi F, Kondo T, Okita K, Asaka I, Aoi T, Watanabe A, Yamada Y, Morizane A, Takahashi J, Ayaki T, Ito H, Yoshikawa K, Yamawaki S, Suzuki S, Watanabe D, Hioki H, Kaneko T, Makioka K, Okamoto K, Takuma H, Tamaoka A, Hasegawa K, Nonaka T, Hasegawa M, Kawata A, Yoshida M, Nakahata T, Takahashi R, Marchetto MC, Gage FH, Yamanaka S, Inoue H Egawa N, Kitaoka S, Tsukita K, Naitoh M, Takahashi K, Yamamoto T, Adachi F, Kondo T, Okita K, Asaka I, Aoi T, Watanabe A, Yamada Y, Morizane A, Takahashi J, Ayaki T, Ito H, Yoshikawa K, Yamawaki S, Suzuki S, Watanabe D, Hioki H, Kaneko T, Makioka K, Okamoto K, Takuma H, Tamaoka A, Hasegawa K, Nonaka T, Hasegawa M, Kawata A, Yoshida M, Nakahata T, Takahashi R, Marchetto MC, Gage FH, Yamanaka S, Inoue H Egawa N, Kitaoka S, Tsukita K, Naitoh M, Takahashi K, Yamamoto T, Adachi F, Kondo T, Okita K, Asaka I, Aoi T, Watanabe A, Yamada Y, Morizane A, Takahashi J, Ayaki T, Ito H, Yoshikawa K, Yamawaki S, Suzuki S, Watanabe D, Hioki H, Kaneko T, Makioka K, Okamoto K, Takuma H, Tamaoka A, Hasegawa K, Nonaka T, Hasegawa M, Kawata A, Yoshida M, Nakahata T, Takahashi R, Marchetto MC, Gage FH, Yamanaka S, Inoue H Drug screening for ALS using patient-specific induced pluripotent stem cells Drug screening for ALS using patient-specific induced pluripotent stem cells Drug screening for ALS using patient-specific induced pluripotent stem cells Sci Transl Med., 4, 145, 145ra104 Sci Transl Med., 4, 145, 145ra104 Sci Transl Med., 4, 145, 145ra104 2012 Refereed English Research paper(scientific journal) Disclose to all
Kitaoka S, Kondoh H, Inoue H Kitaoka S, Kondoh H, Inoue H Kitaoka S, Kondoh H, Inoue H Induced pluripotent stem cell technology for the study of neurodegenerative diseases Induced pluripotent stem cell technology for the study of neurodegenerative diseases Induced pluripotent stem cell technology for the study of neurodegenerative diseases Induced Stem Cells., 129-142 Induced Stem Cells., 129-142 Induced Stem Cells., 129-142 2011 Refereed Disclose to all
Yahata N, Inoue H Yahata N, Inoue H Yahata N, Inoue H [Induced pluripotent stem cell] [Induced pluripotent stem cell] [Induced pluripotent stem cell] Nihon rinsho., 69, 8, 282-285 Nihon rinsho., 69, 8, 282-285 Nihon rinsho., 69, 8, 282-285 2011 Refereed Disclose to all
Egawa N, Inoue H Egawa N, Inoue H Egawa N, Inoue H iPS cells and RNA splicing in ophthalmologic disease iPS cells and RNA splicing in ophthalmologic disease iPS cells and RNA splicing in ophthalmologic disease Neuro-Ophthalmology Japan., 28, 4, 440-444 Neuro-Ophthalmology Japan., 28, 4, 440-444 Neuro-Ophthalmology Japan., 28, 4, 440-444 2011 Refereed Disclose to all
Inoue H Inoue H Inoue H [Neurodegenerative disease-specific induced pluripotent stem cell research] [Neurodegenerative disease-specific induced pluripotent stem cell research] [Neurodegenerative disease-specific induced pluripotent stem cell research] Rinsho Shinkeigaku., 51, 11, 1078 Rinsho Shinkeigaku., 51, 11, 1078 Rinsho Shinkeigaku., 51, 11, 1078 2011 Refereed Disclose to all
Inoue H, Yamanaka S Inoue H, Yamanaka S Inoue H, Yamanaka S The Use of Induced Pluripotent Stem Cells in Drug Development The Use of Induced Pluripotent Stem Cells in Drug Development The Use of Induced Pluripotent Stem Cells in Drug Development Clin Pharmacol Ther., 89, 5, 655-661 Clin Pharmacol Ther., 89, 5, 655-661 Clin Pharmacol Ther., 89, 5, 655-661 2011 Disclose to all
Kitaoka S, Kondoh H, Inoue H Kitaoka S, Kondoh H, Inoue H Kitaoka S, Kondoh H, Inoue H Induced Pluripotent Stem Cell Technology for the Study of Neurodegenerative Diseases Induced Pluripotent Stem Cell Technology for the Study of Neurodegenerative Diseases Induced Pluripotent Stem Cell Technology for the Study of Neurodegenerative Diseases Stem Cell Research Journal., 3, 3, 271-280 Stem Cell Research Journal., 3, 3, 271-280 Stem Cell Research Journal., 3, 3, 271-280 2011 Refereed English Disclose to all
Ando K, Uemura K, Kuzuya A, Maesako M, Asada-Utsugi M, Kubota M, Aoyagi N, Yoshioka K, Okawa K, Inoue H, Kawamata J, Shimohama S, Arai T, Takahashi R, Kinoshita A Ando K, Uemura K, Kuzuya A, Maesako M, Asada-Utsugi M, Kubota M, Aoyagi N, Yoshioka K, Okawa K, Inoue H, Kawamata J, Shimohama S, Arai T, Takahashi R, Kinoshita A Ando K, Uemura K, Kuzuya A, Maesako M, Asada-Utsugi M, Kubota M, Aoyagi N, Yoshioka K, Okawa K, Inoue H, Kawamata J, Shimohama S, Arai T, Takahashi R, Kinoshita A N-cadherin regulates p38MAPK signaling via association with JLP: Implications for neurodegeneration in Alzheimer’s disease N-cadherin regulates p38MAPK signaling via association with JLP: Implications for neurodegeneration in Alzheimer’s disease N-cadherin regulates p38MAPK signaling via association with JLP: Implications for neurodegeneration in Alzheimer’s disease J Biol Chem., 286, 9, 7619-7628 J Biol Chem., 286, 9, 7619-7628 J Biol Chem., 286, 9, 7619-7628 2011 Refereed Disclose to all
Yahata N, Asai M, Kitaoka S, Takahashi K, Asaka I, Hioki H, Kaneko T, Maruyama K, Saido TC, Nakahata T, Asada T, Yamanaka S, Iwata N, Inoue H Yahata N, Asai M, Kitaoka S, Takahashi K, Hioki H, Kaneko T, Maruyama K, Saido TC, Asaka I, Nakahata T, Asada T, Yamanaka S, Iwata N, Inoue H Yahata N, Asai M, Kitaoka S, Takahashi K, Asaka I, Hioki H, Kaneko T, Maruyama K, Saido TC, Nakahata T, Asada T, Yamanaka S, Iwata N, Inoue H Anti-Aβ drug screening platform using human iPS cell-derived neurons for the treatment of Alzheimer's disease Anti-Aβ drug screening platform using human iPS cell-derived neurons for the treatment of Alzheimer's disease Anti-Aβ drug screening platform using human iPS cell-derived neurons for the treatment of Alzheimer's disease PLoS One., 6, 9, e25788 PLoS One., 6, 9, e25788 PLoS One., 6, 9, e25788 2011 Refereed English Research paper(scientific journal) Disclose to all
Egawa N, Yamamoto K, Inoue H, Nishi K, Mori K, Takahashi R Egawa N, Yamamoto K, Inoue H, Hikawa R, Nishi K, Mori K, Takahashi R Egawa N, Yamamoto K, Inoue H, Nishi K, Mori K, Takahashi R The Endoplasmic Reticulum Stress Sensor, ATF6 alpha, Protects against Neurotoxin-induced Dopaminergic Neuronal Death The endoplasmic reticulum stress sensor, ATF6α, protects against neurotoxin-induced dopaminergic neuronal death The Endoplasmic Reticulum Stress Sensor, ATF6 alpha, Protects against Neurotoxin-induced Dopaminergic Neuronal Death J Biol Chem., 286, 10, 7947-7957 J Biol Chem., 286, 10, 7947-7957 J Biol Chem., 286, 10, 7947-7957 2011 Refereed English Research paper(scientific journal) Disclose to all
Murakami G, Inoue H, Tsukita K, Asai Y, Amagai Y, Aiba K, Shimogawa H, Uesugi M, Nakatsuji N, Takahashi R Murakami G, Inoue H, Tsukita K, Asai Y, Amagai Y, Aiba K, Shimogawa H, Uesugi M, Nakatsuji N, Takahashi R Murakami G, Inoue H, Tsukita K, Asai Y, Amagai Y, Aiba K, Shimogawa H, Uesugi M, Nakatsuji N, Takahashi R Chemical Library Screening Identifies a Small Molecule That Downregulates SOD1 Transcription for Drugs to Treat Amyotrophic Lateral Sclerosis Chemical Library Screening Identifies a Small Molecule That Downregulates SOD1 Transcription for Drugs to Treat Amyotrophic Lateral Sclerosis Chemical Library Screening Identifies a Small Molecule That Downregulates SOD1 Transcription for Drugs to Treat Amyotrophic Lateral Sclerosis J Biomol Screen., 16, 4, 405-414 J Biomol Screen., 16, 4, 405-414 J Biomol Screen., 16, 4, 405-414 2011 Refereed English Research paper(scientific journal) Disclose to all
Mitsumori T, Furuyashiki T, Momiyama T, Nishi A, Shuto T, Hayakawa T, Ushikubi F, Kitaoka S, Aoki T, Inoue H, Matsuoka T, Narumiya S Mitsumori T, Furuyashiki T, Momiyama T, Nishi A, Shuto T, Hayakawa T, Ushikubi F, Kitaoka S, Aoki T, Inoue H, Matsuoka T, Narumiya S Mitsumori T, Furuyashiki T, Momiyama T, Nishi A, Shuto T, Hayakawa T, Ushikubi F, Kitaoka S, Aoki T, Inoue H, Matsuoka T, Narumiya S Thromboxane receptor activation enhances striatal dopamine release, leading to suppression of GABAergic transmission and enhanced sugar intake Thromboxane receptor activation enhances striatal dopamine release, leading to suppression of GABAergic transmission and enhanced sugar intake Thromboxane receptor activation enhances striatal dopamine release, leading to suppression of GABAergic transmission and enhanced sugar intake Eur J Neurosci., 34, 4, 594-604 Eur J Neurosci., 34, 4, 594-604 Eur J Neurosci., 34, 4, 594-604 2011 Refereed English Research paper(scientific journal) Disclose to all
Takeuchi H, Iba M, Inoue H, Higuchi M, Takao K, Tsukita K, Karatsu Y, Iwamoto Y, Miyakawa T, Suhara T, Trojanowski JQ, Lee VMY, Takahashi R Takeuchi H, Iba M, Inoue H, Higuchi M, Takao K, Tsukita K, Karatsu Y, Iwamoto Y, Miyakawa T, Suhara T, Trojanowski JQ, Lee VMY, Takahashi R Takeuchi H, Iba M, Inoue H, Higuchi M, Takao K, Tsukita K, Karatsu Y, Iwamoto Y, Miyakawa T, Suhara T, Trojanowski JQ, Lee VMY, Takahashi R P301S Mutant Human Tau Transgenic Mice Manifest Early Symptoms of Human Tauopathies with Dementia and Altered Sensorimotor Gating P301S Mutant Human Tau Transgenic Mice Manifest Early Symptoms of Human Tauopathies with Dementia and Altered Sensorimotor Gating P301S Mutant Human Tau Transgenic Mice Manifest Early Symptoms of Human Tauopathies with Dementia and Altered Sensorimotor Gating PLoS One., 6, 6, e21050 PLoS One., 6, 6, e21050 PLoS One., 6, 6, e21050 2011 Refereed English Research paper(scientific journal) Disclose to all
Inoue H, Okano H Inoue H, Okano H Inoue H, Okano H [Frontline in the research of regenerative medicine] [Frontline in the research of regenerative medicine] [Frontline in the research of regenerative medicine] Rinsho Shinkeigaku., 50, 11, 886 Rinsho Shinkeigaku., 50, 11, 886 Rinsho Shinkeigaku., 50, 11, 886 2010 Refereed Disclose to all
Inoue H Inoue H Inoue H Neurodegenerative disease-specific induced pluripotent stem cells research Neurodegenerative disease-specific induced pluripotent stem cells research Neurodegenerative disease-specific induced pluripotent stem cells research Exp Cell Res., 316, 16, 2560-2564 Exp Cell Res., 316, 16, 2560-2564 Exp Cell Res., 316, 16, 2560-2564 2010 Refereed Disclose to all
Kondoh H, Inoue H, Takaori-Kondo A, Mikawa T, Minami M Kondoh H, Inoue H, Takaori-Kondo A, Mikawa T, Minami M Kondoh H, Inoue H, Takaori-Kondo A, Mikawa T, Minami M Regulational Role of Mitochondria on Ageing and Senescence Regulational Role of Mitochondria on Ageing and Senescence Regulational Role of Mitochondria on Ageing and Senescence Horizons in DNA Research, 1, 235-240 Horizons in DNA Research, 1, 235-240 Horizons in DNA Research, 1, 235-240 2010 Refereed English Disclose to all
Matsui H, Taniguchi Y, Inoue H, Kobayashi Y, Sakaki Y, Toyoda A, Uemura K, Kobayashi D, Takeda S, Takahashi R Matsui H, Taniguchi Y, Inoue H, Kobayashi Y, Sakaki Y, Toyoda A, Uemura K, Kobayashi D, Takeda S, Takahashi R Matsui H, Taniguchi Y, Inoue H, Kobayashi Y, Sakaki Y, Toyoda A, Uemura K, Kobayashi D, Takeda S, Takahashi R Loss of PINK1 in medaka fish (Oryzias latipes) causes late-onset decrease in spontaneous movement Loss of PINK1 in medaka fish (Oryzias latipes) causes late-onset decrease in spontaneous movement Loss of PINK1 in medaka fish (Oryzias latipes) causes late-onset decrease in spontaneous movement Neurosci Res., 66, 2, 151-161 Neurosci Res., 66, 2, 151-161 Neurosci Res., 66, 2, 151-161 2010 Refereed English Research paper(scientific journal) Disclose to all
Matsui H, Ito H, Taniguchi Y, Inoue H, Takeda S, Takahashi R Matsui H, Ito H, Taniguchi Y, Inoue H, Takeda S, Takahashi R Matsui H, Ito H, Taniguchi Y, Inoue H, Takeda S, Takahashi R Proteasome inhibition in medaka brain induces the features of Parkinson's disease Proteasome inhibition in medaka brain induces the features of Parkinson's disease Proteasome inhibition in medaka brain induces the features of Parkinson's disease J Neurochem, 115, 1, 178-187 J Neurochem, 115, 1, 178-187 J Neurochem, 115, 1, 178-187 2010 Refereed Disclose to all
Kobayashi K, Okamoto Y, Inoue H, Usui T, Ihara M, Kawamata J, Miki Y, Mimori T, Tomimoto, H, Takahashi R Kobayashi K, Okamoto Y, Inoue H, Usui T, Ihara M, Kawamata J, Miki Y, Mimori T, Tomimoto, H, Takahashi R Kobayashi K, Okamoto Y, Inoue H, Usui T, Ihara M, Kawamata J, Miki Y, Mimori T, Tomimoto, H, Takahashi R Leukoencephalopathy with cognitive impairment following tocilizumab for the treatment of rheumatoid arthritis (RA) Leukoencephalopathy with cognitive impairment following tocilizumab for the treatment of rheumatoid arthritis (RA) Leukoencephalopathy with cognitive impairment following tocilizumab for the treatment of rheumatoid arthritis (RA) Intern Med., 48, 15, 1307-1309 Intern Med., 48, 15, 1307-1309 Intern Med., 48, 15, 1307-1309 2009 Refereed Disclose to all
Hashida N, Ito S, Hasegawa T, Kajita T, Morifuji H, Yamazaki Y, Sakagami K, Yokotani S, Tanaka T, Endoh B, Egawa N, Inoue H, Tomimoto H, Takahashi R Hashida N, Ito S, Hasegawa T, Kajita T, Morifuji H, Yamazaki Y, Sakagami K, Yokotani S, Tanaka T, Endoh B, Egawa N, Inoue H, Tomimoto H, Takahashi R Hashida N, Ito S, Hasegawa T, Kajita T, Morifuji H, Yamazaki Y, Sakagami K, Yokotani S, Tanaka T, Endoh B, Egawa N, Inoue H, Tomimoto H, Takahashi R [Case of optic neuritis associated with cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL)] [Case of optic neuritis associated with cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL)] [Case of optic neuritis associated with cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL)] Nippon Ganka Gakkai Zasshi., 113, 4, 505-512 Nippon Ganka Gakkai Zasshi., 113, 4, 505-512 Nippon Ganka Gakkai Zasshi., 113, 4, 505-512 2009 Refereed Disclose to all
Matsui H, Taniguchi Y, Inoue H, Uemura K, Takeda S, Takahashi R Matsui H, Taniguchi Y, Inoue H, Uemura K, Takeda S, Takahashi R Matsui H, Taniguchi Y, Inoue H, Uemura K, Takeda S, Takahashi R A chemical neurotoxin, MPTP induces Parkinson's disease like phenotype, movement disorders and persistent loss of dopamine neurons in medaka fish A chemical neurotoxin, MPTP induces Parkinson's disease like phenotype, movement disorders and persistent loss of dopamine neurons in medaka fish A chemical neurotoxin, MPTP induces Parkinson's disease like phenotype, movement disorders and persistent loss of dopamine neurons in medaka fish Neurosci Res., 65, 3, 263-271 Neurosci Res., 65, 3, 263-271 Neurosci Res., 65, 3, 263-271 2009 Refereed English Research paper(scientific journal) Disclose to all
Kondo T, Inoue H, Usui T, Mimori T, Tomimoto H, Vernino S, Takahashi R Kondo T, Inoue H, Usui T, Mimori T, Tomimoto H, Vernino S, Takahashi R Kondo T, Inoue H, Usui T, Mimori T, Tomimoto H, Vernino S, Takahashi R Autoimmune autonomic ganglionopathy with Sjögren's syndrome: significance of ganglionic acetylcholine receptor antibody and therapeutic approach Autoimmune autonomic ganglionopathy with Sjögren's syndrome: significance of ganglionic acetylcholine receptor antibody and therapeutic approach Autoimmune autonomic ganglionopathy with Sjögren's syndrome: significance of ganglionic acetylcholine receptor antibody and therapeutic approach Auton Neurosci., 146, 1-2, 33-35 Auton Neurosci., 146, 1-2, 33-35 Auton Neurosci., 146, 1-2, 33-35 2009 Refereed Disclose to all
Takeuchi H, Yanagida T, Inden M, Takata K, Kitamura Y, Yamakawa K, Sawada H, Izumi Y, Yamamoto N, Kihara T, Uemura K, Inoue H, Taniguchi T, Akaike A, Takahashi R, Shimohama S Takeuchi H, Yanagida T, Inden M, Takata K, Kitamura Y, Yamakawa K, Sawada H, Izumi Y, Yamamoto N, Kihara T, Uemura K, Inoue H, Taniguchi T, Akaike A, Takahashi R, Shimohama S Takeuchi H, Yanagida T, Inden M, Takata K, Kitamura Y, Yamakawa K, Sawada H, Izumi Y, Yamamoto N, Kihara T, Uemura K, Inoue H, Taniguchi T, Akaike A, Takahashi R, Shimohama S Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone-induced Parkinson's disease models Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone-induced Parkinson's disease models Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone-induced Parkinson's disease models J Neurosci Res., 87, 2, 576-585 J Neurosci Res., 87, 2, 576-585 J Neurosci Res., 87, 2, 576-585 2009 Refereed Disclose to all
Wang HQ, Imai Y, Inoue H, Kataoka A, Iita S, Nukina N, Takahashi R Wang HQ, Imai Y, Inoue H, Kataoka A, Iita S, Nukina N, Takahashi R Wang HQ, Imai Y, Inoue H, Kataoka A, Iita S, Nukina N, Takahashi R Pael-R transgenic mice crossed with parkin deficient mice displayed progressive and selective catecholaminergic neuronal loss Pael-R transgenic mice crossed with parkin deficient mice displayed progressive and selective catecholaminergic neuronal loss Pael-R transgenic mice crossed with parkin deficient mice displayed progressive and selective catecholaminergic neuronal loss J Neurochem., 107, 1, 171-85 J Neurochem., 107, 1, 171-85 J Neurochem., 107, 1, 171-85 2008 Refereed Disclose to all
Kawamoto Y, Kobayashi Y, Suzuki Y, Inoue H, Tomimoto H, Akiguchi I, Budka H, Martins LM, Downward J, Takahashi R Kawamoto Y, Kobayashi Y, Suzuki Y, Inoue H, Tomimoto H, Akiguchi I, Budka H, Martins LM, Downward J, Takahashi R Kawamoto Y, Kobayashi Y, Suzuki Y, Inoue H, Tomimoto H, Akiguchi I, Budka H, Martins LM, Downward J, Takahashi R Accumulation of HtrA2/Omi in Neuronal and Glial Inclusions in Brains With alpha-Synucleinopathies Accumulation of HtrA2/Omi in Neuronal and Glial Inclusions in Brains With alpha-Synucleinopathies Accumulation of HtrA2/Omi in Neuronal and Glial Inclusions in Brains With alpha-Synucleinopathies J Neuropathol Exp Neurol., 67, 10, 984-993 J Neuropathol Exp Neurol., 67, 10, 984-993 J Neuropathol Exp Neurol., 67, 10, 984-993 2008 Refereed Disclose to all
Iwasato T, Katoh H, Nishimaru H, Ishikawa Y, Inoue H, Saito YM, Ando R, Iwama M, Takahashi R, Negishi M, Itohara S. Iwasato T, Katoh H, Nishimaru H, Ishikawa Y, Inoue H, Saito YM, Ando R, Iwama M, Takahashi R, Negishi M, Itohara S. Iwasato T, Katoh H, Nishimaru H, Ishikawa Y, Inoue H, Saito YM, Ando R, Iwama M, Takahashi R, Negishi M, Itohara S. Rac-GAP alpha-chimerin regulates motor-circuit formation as a key mediator of EphrinB3/EphA4 forward signaling Rac-GAP alpha-chimerin regulates motor-circuit formation as a key mediator of EphrinB3/EphA4 forward signaling Rac-GAP alpha-chimerin regulates motor-circuit formation as a key mediator of EphrinB3/EphA4 forward signaling CELL., 130, 4, 742-753 CELL., 130, 4, 742-753 CELL., 130, 4, 742-753 2007 Refereed English Research paper(scientific journal) Disclose to all
Inoue H, Lin L, Lee X, Shao Z, Mendes S, Snodgrass-Belt P, Sweigard H, Engber T, Pepinsky B, Yang L, Beal MF, Mi S, Isacson O Inoue H, Lin L, Lee X, Shao Z, Mendes S, Snodgrass-Belt P, Sweigard H, Engber T, Pepinsky B, Yang L, Beal MF, Mi S, Isacson O Inoue H, Lin L, Lee X, Shao Z, Mendes S, Snodgrass-Belt P, Sweigard H, Engber T, Pepinsky B, Yang L, Beal MF, Mi S, Isacson O Inhibition of the leucine-rich repeat protein LINGO-1 enhances survival, structure, and function of dopaminergic neurons in Parkinson’s disease models Inhibition of the leucine-rich repeat protein LINGO-1 enhances survival, structure, and function of dopaminergic neurons in Parkinson’s disease models Inhibition of the leucine-rich repeat protein LINGO-1 enhances survival, structure, and function of dopaminergic neurons in Parkinson’s disease models Proc Natl Acad Sci U S A., 104, 36, 14430-14435 Proc Natl Acad Sci U S A., 104, 36, 14430-14435 Proc Natl Acad Sci U S A., 104, 36, 14430-14435 2007 Refereed English Research paper(scientific journal) Disclose to all
Imai Y, Inoue H, Kataoka A, Wang HQ, Masuda M, Ikeda T, Tsukita K, Soda M, Kodama T, Fuwa T, Honda Y, Kaneko S, Matsumoto S, Wakamatsu K, Ito S, Miura M, Aosaki T, Itohara S, Takahashi R Imai Y, Inoue H, Kataoka A, Wang HQ, Masuda M, Ikeda T, Tsukita K, Soda M, Kodama T, Fuwa T, Honda Y, Kaneko S, Matsumoto S, Wakamatsu K, Ito S, Miura M, Aosaki T, Itohara S, Takahashi R Imai Y, Inoue H, Kataoka A, Wang HQ, Masuda M, Ikeda T, Tsukita K, Soda M, Kodama T, Fuwa T, Honda Y, Kaneko S, Matsumoto S, Wakamatsu K, Ito S, Miura M, Aosaki T, Itohara S, Takahashi R Pael receptor is involved in dopamine metabolism in the nigrostriatal system Pael receptor is involved in dopamine metabolism in the nigrostriatal system Pael receptor is involved in dopamine metabolism in the nigrostriatal system Neurosci Res., 59, 4, 413-425 Neurosci Res., 59, 4, 413-425 Neurosci Res., 59, 4, 413-425 2007 Refereed English Research paper(scientific journal) Disclose to all
Murakami T, Shoji M, Imai Y, Inoue H, Kawarabayashi T, Matsubara E, Harigaya Y, Sasaki A, Takahashi R, Abe K Murakami T, Shoji M, Imai Y, Inoue H, Kawarabayashi T, Matsubara E, Harigaya Y, Sasaki A, Takahashi R, Abe K Murakami T, Shoji M, Imai Y, Inoue H, Kawarabayashi T, Matsubara E, Harigaya Y, Sasaki A, Takahashi R, Abe K Pael-R is accumulated in Lewy bodies of Parkinson's disease Pael-R is accumulated in Lewy bodies of Parkinson's disease Pael-R is accumulated in Lewy bodies of Parkinson's disease Ann Neurol., 55, 3, 439-442 Ann Neurol., 55, 3, 439-442 Ann Neurol., 55, 3, 439-442 2004 Refereed English Disclose to all
Misawa H, Nakata K, Toda K, Matsuura J, Oda Y, Inoue H, Taneno M, Takahashi R Misawa H, Nakata K, Toda K, Matsuura J, Oda Y, Inoue H, Taneno M, Takahashi R Misawa H, Nakata K, Toda K, Matsuura J, Oda Y, Inoue H, Taneno M, Takahashi R VAChT-Cre.Fast and VAChT-Cre.Slow: Postnatal expression of Cre recombinase in somatomotor neurons with different onset VAChT-Cre.Fast and VAChT-Cre.Slow: Postnatal expression of Cre recombinase in somatomotor neurons with different onset VAChT-Cre.Fast and VAChT-Cre.Slow: Postnatal expression of Cre recombinase in somatomotor neurons with different onset Genesis., 37, 1, 44-50 Genesis., 37, 1, 44-50 Genesis., 37, 1, 44-50 2003 Refereed English Research paper(scientific journal) Disclose to all
Inoue H, Tsukita K, Iwasato T, Suzuki Y, Tomioka M, Tateno M, Nagao M, Kawata A, Saido TC, Miura M, Misawa H, Itohara S, TakahashiR Inoue H, Tsukita K, Iwasato T, Suzuki Y, Tomioka M, Tateno M, Nagap M, Kawata A, Saido TC, Miura M, Misawa H, Itohara S, Takahashi R Inoue H, Tsukita K, Iwasato T, Suzuki Y, Tomioka M, Tateno M, Nagao M, Kawata A, Saido TC, Miura M, Misawa H, Itohara S, TakahashiR The crucial role of caspase-9 in the disease progression of a transgenic ALS mouse model The crucial role of caspase-9 in the disease progression of a transgenic ALS mouse model The crucial role of caspase-9 in the disease progression of a transgenic ALS mouse model EMBO Journal., 22, 24, 6665-6674 EMBO Journal., 22, 24, 6665-6674 EMBO Journal., 22, 24, 6665-6674 2003 Refereed English Research paper(scientific journal) Disclose to all
Nakamizo T, Inoue H, Udaka F, Oda M, Kawai M, Uemura K, Takahashi M, Nishinaka K, Sawada H, Kameyama M, Koyama T Nakamizo T, Inoue H, Udaka F, Oda M, Kawai M, Uemura K, Takahashi M, Nishinaka K, Sawada H, Kameyama M, Koyama T Nakamizo T, Inoue H, Udaka F, Oda M, Kawai M, Uemura K, Takahashi M, Nishinaka K, Sawada H, Kameyama M, Koyama T Magnetic resonance imaging of primary spinal intramedullary lymphoma Magnetic resonance imaging of primary spinal intramedullary lymphoma Magnetic resonance imaging of primary spinal intramedullary lymphoma J Neuroimaging., 12, 2, 183-186 J Neuroimaging., 12, 2, 183-186 J Neuroimaging., 12, 2, 183-186 2002 Refereed English Research paper(scientific journal) Disclose to all
Imai Y, Soda M, Inoue H, Hattori N, Mizuno Y, Takahashi R Imai Y, Soda M, Inoue H, Hattori N, Mizuno Y, Takahashi R Imai Y, Soda M, Inoue H, Hattori N, Mizuno Y, Takahashi R An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin Cell., 105, 7, 891-902 Cell., 105, 7, 891-902 Cell., 105, 7, 891-902 2001 Refereed Disclose to all
Chui DH, Tanahashi H, Ozawa K, Ikeda S, Checler F, Ueda O, Suzuki H, Araki W, Inoue H, Shirotani K, Takahashi K, Gallyas F, Tabira T Chui DH, Tanahashi H, Ozawa K, Ikeda S, Checler F, Ueda O, Suzuki H, Araki W, Inoue H, Shirotani K, Takahashi K, Gallyas F, Tabira T Chui DH, Tanahashi H, Ozawa K, Ikeda S, Checler F, Ueda O, Suzuki H, Araki W, Inoue H, Shirotani K, Takahashi K, Gallyas F, Tabira T Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation Nat Med., 5, 5, 560-4 Nat Med., 5, 5, 560-4 Nat Med., 5, 5, 560-4 1999 Refereed English Research paper(scientific journal) Disclose to all
Inoue H, Sawada M, Ryo A, Tanahashi H, Wakatsuki T, Hada A, Kondoh N, Nakagaki K, Takahashi K, Suzumura A, Yamamoto M, Tabira T Inoue H, Sawada M, Ryo A, Tanahashi H, Wakatsuki T, Hada A, Kondoh N, Nakagaki K, Takahashi K, Suzumura A, Yamamoto M, Tabira T Inoue H, Sawada M, Ryo A, Tanahashi H, Wakatsuki T, Hada A, Kondoh N, Nakagaki K, Takahashi K, Suzumura A, Yamamoto M, Tabira T Serial analysis of gene expression in a microglial cell line Serial analysis of gene expression in a microglial cell line Serial analysis of gene expression in a microglial cell line Glia., 28, 3, 265-271 Glia., 28, 3, 265-271 Glia., 28, 3, 265-271 1999 Refereed English Research paper(scientific journal) Disclose to all
Inoue H, Udaka F, Takahashi M, Nishinaka K, Kameyama M Inoue H, Udaka F, Takahashi M, Nishinaka K, Kameyama M Inoue H, Udaka F, Takahashi M, Nishinaka K, Kameyama M [Secondary Parkinsonism Following Midbrain Hemorrhage] [Secondary Parkinsonism Following Midbrain Hemorrhage] [Secondary Parkinsonism Following Midbrain Hemorrhage] Rinsho Shinkeigaku., 37, 3, 266-269 Rinsho Shinkeigaku., 37, 3, 266-269 Rinsho Shinkeigaku., 37, 3, 266-269 1997 Refereed Disclose to all
Inoue H, Udaka F, Nishinaka K, Kameyama M, Amano S Inoue H, Udaka F, Nishinaka K, Kameyama M, Amano S Inoue H, Udaka F, Nishinaka K, Kameyama M, Amano S [A Case of Adult-Onset Neurenteric Cyst Presenting as Chronic Progressive Muscular Atrophy in Lower Legs] [A Case of Adult-Onset Neurenteric Cyst Presenting as Chronic Progressive Muscular Atrophy in Lower Legs] [A Case of Adult-Onset Neurenteric Cyst Presenting as Chronic Progressive Muscular Atrophy in Lower Legs] Rinsho Shinkeigaku., 37, 6, 536-539 Rinsho Shinkeigaku., 37, 6, 536-539 Rinsho Shinkeigaku., 37, 6, 536-539 1997 Refereed Disclose to all
Urushitani M, Inoue H, Udaka F, Kameyama M Urushitani M, Inoue H, Udaka F, Kameyama M Urushitani M, Inoue H, Udaka F, Kameyama M [Monocular Photopsia Preceding With Neovascular Glaucoma Due to Internal Carotid Artery Occlusion; A Case Report] [Monocular Photopsia Preceding With Neovascular Glaucoma Due to Internal Carotid Artery Occlusion; A Case Report] [Monocular Photopsia Preceding With Neovascular Glaucoma Due to Internal Carotid Artery Occlusion; A Case Report] Rinsho Shinkeigaku., 36, 3, 481-484 Rinsho Shinkeigaku., 36, 3, 481-484 Rinsho Shinkeigaku., 36, 3, 481-484 1996 Refereed Disclose to all
Inoue H, Nishinaka K, Urushitani M, Udaka F, Kameyama M Inoue H, Nishinaka K, Urushitani M, Udaka F, Kameyama M Inoue H, Nishinaka K, Urushitani M, Udaka F, Kameyama M A case of a thoracic extradural arachnoid cyst presenting with slowly progressive muscle weakness in the right upper and lower limbs A case of a thoracic extradural arachnoid cyst presenting with slowly progressive muscle weakness in the right upper and lower limbs A case of a thoracic extradural arachnoid cyst presenting with slowly progressive muscle weakness in the right upper and lower limbs Rinsho Shinkeigaku., 36, 1, 47-51 Rinsho Shinkeigaku., 36, 1, 47-51 Rinsho Shinkeigaku., 36, 1, 47-51 1996 Refereed Disclose to all
Inoue H, NIshinaka K, Urushitani M, Udaka F, Kameyama M Inoue H, NIshinaka K, Urushitani M, Udaka F, Kameyama M Inoue H, NIshinaka K, Urushitani M, Udaka F, Kameyama M [Persistent Cerebellar Ataxia Following Typhoid Fever] [Persistent Cerebellar Ataxia Following Typhoid Fever] [Persistent Cerebellar Ataxia Following Typhoid Fever] Rinsho Shinkeigaku., 35, 10, 1151-1154 Rinsho Shinkeigaku., 35, 10, 1151-1154 Rinsho Shinkeigaku., 35, 10, 1151-1154 1995 Refereed Disclose to all

  • <<
  • >>
Title language:
Misc
Author Author(Japanese) Author(English) Title Title(Japanese) Title(English) Bibliography Bibliography(Japanese) Bibliography(English) Publication date Refereed paper Language Publishing type Disclose
山本由美, 小嶋勝利, 田浦大輔, 曽根正勝, 鷲田和夫, 江川斉宏, 近藤孝之, 皆川栄子, 月田香代子, 江浪貴子, 冨本秀和, 水野敏樹, 稲垣暢也, 高橋良輔, 斯波真理子, 猪原匡史, 井上治久 山本由美, 小嶋勝利, 田浦大輔, 曽根正勝, 鷲田和夫, 江川斉宏, 近藤孝之, 皆川栄子, 月田香代子, 江浪貴子, 冨本秀和, 水野敏樹, 稲垣暢也, 高橋良輔, 斯波真理子, 猪原匡史, 井上治久 山本由美, 小嶋勝利, 田浦大輔, 曽根正勝, 鷲田和夫, 江川斉宏, 近藤孝之, 皆川栄子, 月田香代子, 江浪貴子, 冨本秀和, 水野敏樹, 稲垣暢也, 高橋良輔, 斯波真理子, 猪原匡史, 井上治久 患者由来iPS細胞を用いた遺伝性脳小血管病の病態研究 患者由来iPS細胞を用いた遺伝性脳小血管病の病態研究 患者由来iPS細胞を用いた遺伝性脳小血管病の病態研究 The 38th Annual Meeting of Japan Society for Dementia Research, Tokyo The 38th Annual Meeting of Japan Society for Dementia Research シンポジウム12(ポスター発表), 東京. The 38th Annual Meeting of Japan Society for Dementia Research, Tokyo 2019/11/08 Disclose to all
Suzuki H, Egawa N, Kondo T, Imamura K, Suga M, Shibukawa R, Okanishi Y, Goto K, Takahashi R Suzuki H, Egawa N, Kondo T, Imamura K, Suga M, Shibukawa R, Okanishi Y, Goto K, Takahashi R Suzuki H, Egawa N, Kondo T, Imamura K, Suga M, Shibukawa R, Okanishi Y, Goto K, Takahashi R Establishment of iPS cell line from Parkinson’s disease patient carrying SNCA A53T mutation(ポスター発表) Establishment of iPS cell line from Parkinson’s disease patient carrying SNCA A53T mutation(ポスター発表) Establishment of iPS cell line from Parkinson’s disease patient carrying SNCA A53T mutation(ポスター発表) 60th Annual Meeting of the Japanese Society of Neurology, Osaka. 60th Annual Meeting of the Japanese Society of Neurology, Osaka. 60th Annual Meeting of the Japanese Society of Neurology, Osaka. 2019/05/25 Disclose to all
Ohnishi H, Skerleva D, Okuyama H, Miyamoto T, Matsuura S, Kirino K, Yamamoto N, Ito J, Omori K, Saito M, Tsukita K, Inoue H, and Nakagawa T Ohnishi H, Skerleva D, Okuyama H, Miyamoto T, Matsuura S, Kirino K, Yamamoto N, Ito J, Omori K, Saito M, Tsukita K, Inoue H, and Nakagawa T Ohnishi H, Skerleva D, Okuyama H, Miyamoto T, Matsuura S, Kirino K, Yamamoto N, Ito J, Omori K, Saito M, Tsukita K, Inoue H, and Nakagawa T Trial for improvement of hair cell induction method from human iPSC Trial for improvement of hair cell induction method from human iPSC Trial for improvement of hair cell induction method from human iPSC Association for research in Otolaryngology 38th Annual MidWinter Meeting, Baltimore, USA. Association for research in Otolaryngology 38th Annual MidWinter Meeting, Baltimore, USA. Association for research in Otolaryngology 38th Annual MidWinter Meeting, Baltimore, USA. 2019/02/09 Disclose to all
Nakano-Kobayashi A, Awaya T, Kii I, Sumida Y, Okuno Y, Yoshida S, Sumida T, Inoue H, Hosoya T, Hagiwara M Nakano-Kobayashi A, Awaya T, Kii I, Sumida Y, Okuno Y, Yoshida S, Sumida T, Inoue H, Hosoya T, Hagiwara M Nakano-Kobayashi A, Awaya T, Kii I, Sumida Y, Okuno Y, Yoshida S, Sumida T, Inoue H, Hosoya T, Hagiwara M Prenatal neurogenesis induction therapy normalizes brain structure and function in Down syndrome mice(Oral Session) Prenatal neurogenesis induction therapy normalizes brain structure and function in Down syndrome mice(Oral Session) Prenatal neurogenesis induction therapy normalizes brain structure and function in Down syndrome mice(Oral Session) The 41st Annual Meeting of the Japan Neuroscience Society, Kobe. The 41st Annual Meeting of the Japan Neuroscience Society, Kobe. The 41st Annual Meeting of the Japan Neuroscience Society, Kobe. 2018/07/28 Disclose to all
Imamura K, Inoue H Imamura K, Inoue H Imamura K, Inoue H Src/c-Abl inhibitors attenuate neurodegeneration in amyotrophic lateral sclerosis(Poster Session) Src/c-Abl inhibitors attenuate neurodegeneration in amyotrophic lateral sclerosis(Poster Session) Src/c-Abl inhibitors attenuate neurodegeneration in amyotrophic lateral sclerosis(Poster Session) The 41st Annual Meeting of the Japan Neuroscience Society, Kobe. The 41st Annual Meeting of the Japan Neuroscience Society, Kobe. The 41st Annual Meeting of the Japan Neuroscience Society, Kobe. 2018/07/28 Disclose to all
Kondo T, Inoue H Kondo T, Inoue H Kondo T, Inoue H iPSC-Based Compound Screening and In Vitro Trials Identify a Synergistic Anti-amyloid β Combination for Alzheimer’s Disease(Poster Session) iPSC-Based Compound Screening and In Vitro Trials Identify a Synergistic Anti-amyloid β Combination for Alzheimer’s Disease(Poster Session) iPSC-Based Compound Screening and In Vitro Trials Identify a Synergistic Anti-amyloid β Combination for Alzheimer’s Disease(Poster Session) The 41st Annual Meeting of the Japan Neuroscience Society, Kobe. The 41st Annual Meeting of the Japan Neuroscience Society, Kobe. The 41st Annual Meeting of the Japan Neuroscience Society, Kobe. 2018/07/26 Disclose to all
菊地哲広, 森実飛鳥, 土井大輔, 孫谷弘明, 高橋良輔, 井上治久, 沖田圭介, 中川誠人, 高橋淳 菊地哲広, 森実飛鳥, 土井大輔, 孫谷弘明, 高橋良輔, 井上治久, 沖田圭介, 中川誠人, 高橋淳 菊地哲広, 森実飛鳥, 土井大輔, 孫谷弘明, 高橋良輔, 井上治久, 沖田圭介, 中川誠人, 高橋淳 霊長類モデルを用いたパーキンソン病に対する細胞移植治療の非臨床試験 霊長類モデルを用いたパーキンソン病に対する細胞移植治療の非臨床試験 霊長類モデルを用いたパーキンソン病に対する細胞移植治療の非臨床試験 The 17th Congress of the Japanese Society for Regenerative Medicine (Web)., ROMBUNNO.O‐01‐2 (WEB ONLY) The 17th Congress of the Japanese Society for Regenerative Medicine (Web)., ROMBUNNO.O‐01‐2 (WEB ONLY) The 17th Congress of the Japanese Society for Regenerative Medicine (Web)., ROMBUNNO.O‐01‐2 (WEB ONLY) 2018 Japanese Disclose to all
Kitani-Morii F, Imamura K, Kondo T, Ohara R, Yamamoto T, Sekiguchi K, Toguchida J, Mizuno T, Nakagawa M, Inoue H Kitani-Morii F, Imamura K, Kondo T, Ohara R, Yamamoto T, Sekiguchi K, Toguchida J, Mizuno T, Nakagawa M, Inoue H Kitani-Morii F, Imamura K, Kondo T, Ohara R, Yamamoto T, Sekiguchi K, Toguchida J, Mizuno T, Nakagawa M, Inoue H iPSC model for demyelinating Charcot-Marie-Tooth disease iPSC model for demyelinating Charcot-Marie-Tooth disease iPSC model for demyelinating Charcot-Marie-Tooth disease 58th Annual Meeting of the Japanese Society of Neurology, Kyoto. 58th Annual Meeting of the Japanese Society of Neurology, Kyoto. 58th Annual Meeting of the Japanese Society of Neurology, Kyoto. 2017/09/16 Disclose to all
Ohara R, Imamura K, Morii F, Egawa N, Mizuno T, Nakagawa M, Inoue H Ohara R, Imamura K, Morii F, Egawa N, Mizuno T, Nakagawa M, Inoue H Ohara R, Imamura K, Morii F, Egawa N, Mizuno T, Nakagawa M, Inoue H Modeling Charcot-Marie-Tooth disease using patient iPSCs Modeling Charcot-Marie-Tooth disease using patient iPSCs Modeling Charcot-Marie-Tooth disease using patient iPSCs 58th Annual Meeting of the Japanese Society of Neurology, Kyoto. 58th Annual Meeting of the Japanese Society of Neurology, Kyoto. 58th Annual Meeting of the Japanese Society of Neurology, Kyoto. 2017/09/16 Disclose to all
Kondo T, Funayama M, Miyake M, Tsukita K, Era T, Osaka H, Ayaki T, Takahashi R, Inoue H Kondo T, Funayama M, Miyake M, Tsukita K, Era T, Osaka H, Ayaki T, Takahashi R, Inoue H Kondo T, Funayama M, Miyake M, Tsukita K, Era T, Osaka H, Ayaki T, Takahashi R, Inoue H Modeling Alexander disease with patient iPSCs reveals cellular and molecular pathology of astrocytes Modeling Alexander disease with patient iPSCs reveals cellular and molecular pathology of astrocytes Modeling Alexander disease with patient iPSCs reveals cellular and molecular pathology of astrocytes 58th Annual Meeting of the Japanese Society of Neurology, Kyoto. 58th Annual Meeting of the Japanese Society of Neurology, Kyoto. 58th Annual Meeting of the Japanese Society of Neurology, Kyoto. 2017/09/16 Disclose to all
Imamura K, Sahara N, Inoue H Imamura K, Sahara N, Inoue H Imamura K, Sahara N, Inoue H Neuronal activity modulates oligomeric tau-mediated neurodegeneration in FTLD-Tau neurons Neuronal activity modulates oligomeric tau-mediated neurodegeneration in FTLD-Tau neurons Neuronal activity modulates oligomeric tau-mediated neurodegeneration in FTLD-Tau neurons 58th Annual Meeting of the Japanese Society of Neurology, Kyoto. 58th Annual Meeting of the Japanese Society of Neurology, Kyoto. 58th Annual Meeting of the Japanese Society of Neurology, Kyoto. 2017/09/16 Disclose to all
Mishima T, Ishikawa T, Imamura K, Kondo T, Koshiba Y, Takahashi R, Takahashi J, Watanabe A, Fujii N, Tsuboi Y, Inoue H Mishima T, Ishikawa T, Imamura K, Kondo T, Koshiba Y, Takahashi R, Takahashi J, Watanabe A, Fujii N, Tsuboi Y, Inoue H Mishima T, Ishikawa T, Imamura K, Kondo T, Koshiba Y, Takahashi R, Takahashi J, Watanabe A, Fujii N, Tsuboi Y, Inoue H Human iPSC disease modeling of Perry syndrome Human iPSC disease modeling of Perry syndrome Human iPSC disease modeling of Perry syndrome 58th Annual Meeting of the Japanese Society of Neurology, Kyoto. 58th Annual Meeting of the Japanese Society of Neurology, Kyoto. 58th Annual Meeting of the Japanese Society of Neurology, Kyoto. 2017/09/16 Disclose to all
Imamura K, Sahara N, Inoue H Imamura K, Sahara N, Inoue H Imamura K, Sahara N, Inoue H Oligomeric tau contributes to neurodegeneration in FTLD patient iPHSC-derived neurons Oligomeric tau contributes to neurodegeneration in FTLD patient iPHSC-derived neurons Oligomeric tau contributes to neurodegeneration in FTLD patient iPHSC-derived neurons The 40th Annual Meeting of the Japan Neuroscience Society, Chiba. The 40th Annual Meeting of the Japan Neuroscience Society, Chiba. The 40th Annual Meeting of the Japan Neuroscience Society, Chiba. 2017/07/20 Disclose to all
Ohara R, Imamura K, Morii F, Egawa N, Mizuno T, Nakagawa M, Inoue H Ohara R, Imamura K, Morii F, Egawa N, Mizuno T, Nakagawa M, Inoue H Ohara R, Imamura K, Morii F, Egawa N, Mizuno T, Nakagawa M, Inoue H Modeling Charcot-Marie-Tooth disease using patient iPSCs Modeling Charcot-Marie-Tooth disease using patient iPSCs Modeling Charcot-Marie-Tooth disease using patient iPSCs The 40th Annual Meeting of the Japan Neuroscience Society, Chiba. The 40th Annual Meeting of the Japan Neuroscience Society, Chiba. The 40th Annual Meeting of the Japan Neuroscience Society, Chiba. 2017/07/20 Disclose to all
Ishida Y, Kawakami H, Kitajima H, Nishiyama A, Sasai Y, Inoue H, Muguruma K Ishida Y, Kawakami H, Kitajima H, Nishiyama A, Sasai Y, Inoue H, Muguruma K Ishida Y, Kawakami H, Kitajima H, Nishiyama A, Sasai Y, Inoue H, Muguruma K Vulnerability of Purkinje Cells Generated from Spinocerebellar Ataxia Type 6 Patient-Derived iPSCs Vulnerability of Purkinje Cells Generated from Spinocerebellar Ataxia Type 6 Patient-Derived iPSCs Vulnerability of Purkinje Cells Generated from Spinocerebellar Ataxia Type 6 Patient-Derived iPSCs The 15th The ISSCR annual meeting (ISSCR2017), Boston, USA. The 15th The ISSCR annual meeting (ISSCR2017), Boston, USA. The 15th The ISSCR annual meeting (ISSCR2017), Boston, USA. 2017/06/14 Disclose to all
小林亜希子, 粟屋智就, 喜井勲, 隅田有人, 奥野友紀子, 和根崎圭子, 吉田優, 隅田ともえ, 井上治久, 細谷孝充, 萩原正敏 小林亜希子, 粟屋智就, 喜井勲, 隅田有人, 奥野友紀子, 和根崎圭子, 吉田優, 隅田ともえ, 井上治久, 細谷孝充, 萩原正敏 小林亜希子, 粟屋智就, 喜井勲, 隅田有人, 奥野友紀子, 和根崎圭子, 吉田優, 隅田ともえ, 井上治久, 細谷孝充, 萩原正敏 神経新生促進によるダウン症モデルにおける脳発達障害の是正 神経新生促進によるダウン症モデルにおける脳発達障害の是正 神経新生促進によるダウン症モデルにおける脳発達障害の是正 Annual Meeting of the JBS (Web), 90th, ROMBUNNO.2AT26‐10(2P‐1060) (WEB ONLY) Annual Meeting of the JBS (Web), 90th, ROMBUNNO.2AT26‐10(2P‐1060) (WEB ONLY) Annual Meeting of the JBS (Web), 90th, ROMBUNNO.2AT26‐10(2P‐1060) (WEB ONLY) 2017 Japanese Disclose to all
菊地哲広, 森實飛鳥, 土井大輔, 井上治久, 高橋良輔, 沖田圭介, 中川誠人, 高橋淳 菊地哲広, 森實飛鳥, 土井大輔, 井上治久, 高橋良輔, 沖田圭介, 中川誠人, 高橋淳 菊地哲広, 森實飛鳥, 土井大輔, 井上治久, 高橋良輔, 沖田圭介, 中川誠人, 高橋淳 霊長類パーキンソン病モデルへのヒトiPS細胞由来ドパミン神経前駆細胞移植 霊長類パーキンソン病モデルへのヒトiPS細胞由来ドパミン神経前駆細胞移植 霊長類パーキンソン病モデルへのヒトiPS細胞由来ドパミン神経前駆細胞移植 The 16th Congress of the Japanese Society for Regenerative Medicine, Miyagi., 16, 424 The 16th Congress of the Japanese Society for Regenerative Medicine, Miyagi., 16, 424 The 16th Congress of the Japanese Society for Regenerative Medicine, Miyagi., 16, 424 2017 Disclose to all
今村恵子, 井上治久 今村恵子, 井上治久 今村恵子, 井上治久 iPS細胞を用いた認知症モデルの可能性:iPS細胞モデルとマウスモデルについて iPS細胞を用いた認知症モデルの可能性:iPS細胞モデルとマウスモデルについて iPS細胞を用いた認知症モデルの可能性:iPS細胞モデルとマウスモデルについて The 35th Annual Meeting of Japan Society for Dementia Research, Tokyo. The 35th Annual Meeting of Japan Society for Dementia Research, Tokyo. The 35th Annual Meeting of Japan Society for Dementia Research, Tokyo. 2016/12/03 Disclose to all
Goto K, Imamura K, Mitani K, Aiba K, Nakatsuji N, Takahashi R, Inoue H Goto K, Imamura K, Mitani K, Aiba K, Nakatsuji N, Takahashi R, Inoue H Goto K, Imamura K, Mitani K, Aiba K, Nakatsuji N, Takahashi R, Inoue H Chemical library screening to identify a small compound that promotes motor neurons differentiation from iPSCs/ESCs Chemical library screening to identify a small compound that promotes motor neurons differentiation from iPSCs/ESCs Chemical library screening to identify a small compound that promotes motor neurons differentiation from iPSCs/ESCs The 39th Annual Meeting of the Japan Neuroscience Society, Yokohama. The 39th Annual Meeting of the Japan Neuroscience Society, Yokohama. The 39th Annual Meeting of the Japan Neuroscience Society, Yokohama. 2016/07/21 Disclose to all
Murakami N, Imamura K, Kondo T, Izumi Y, Kaji R, Inoue H Murakami N, Imamura K, Kondo T, Izumi Y, Kaji R, Inoue H Murakami N, Imamura K, Kondo T, Izumi Y, Kaji R, Inoue H Modeling HMSN-P motor neurons using patient iPSCs with mutant TFG Modeling HMSN-P motor neurons using patient iPSCs with mutant TFG Modeling HMSN-P motor neurons using patient iPSCs with mutant TFG 57th Annual Meeting of the Japanese Society of Neurology, Kobe. 57th Annual Meeting of the Japanese Society of Neurology, Kobe. 57th Annual Meeting of the Japanese Society of Neurology, Kobe. 2016/06/03 Disclose to all
Yamamoto Y, Kojima K, Taura D, Sone M, Washida K, Egawa N, Kondo T, Minakawa N E, Tsukita K, Enami T, Tomimoto H, Mizuno T, Takahashi R, Ihara M, Inoue H Yamamoto Y, Kojima K, Taura D, Sone M, Washida K, Egawa N, Kondo T, Minakawa N E, Tsukita K, Enami T, Tomimoto H, Mizuno T, Takahashi R, Ihara M, Inoue H Yamamoto Y, Kojima K, Taura D, Sone M, Washida K, Egawa N, Kondo T, Minakawa N E, Tsukita K, Enami T, Tomimoto H, Mizuno T, Takahashi R, Ihara M, Inoue H An iPS cell model of CADASIL: insights into the pathogenesis of a hereditary small vessel disease An iPS cell model of CADASIL: insights into the pathogenesis of a hereditary small vessel disease An iPS cell model of CADASIL: insights into the pathogenesis of a hereditary small vessel disease 57th Annual Meeting of the Japanese Society of Neurology, Kobe. 57th Annual Meeting of the Japanese Society of Neurology, Kobe. 57th Annual Meeting of the Japanese Society of Neurology, Kobe. 2016/05/18 Disclose to all
Goto K, Imamura K, Mitani K, Aiba K, Nakatsuji N, Takahashi R, Inoue H Goto K, Imamura K, Mitani K, Aiba K, Nakatsuji N, Takahashi R, Inoue H Goto K, Imamura K, Mitani K, Aiba K, Nakatsuji N, Takahashi R, Inoue H Library screening to identify compounds that promote MNs generation from iPSCs Library screening to identify compounds that promote MNs generation from iPSCs Library screening to identify compounds that promote MNs generation from iPSCs 57th Annual Meeting of the Japanese Society of Neurology, Kobe. 57th Annual Meeting of the Japanese Society of Neurology, Kobe. 57th Annual Meeting of the Japanese Society of Neurology, Kobe. 2016/05/18 Disclose to all
Mishima T, Ishikawa T, Imamura K, Kondo T, Koshiba Y, Takahashi R, Takahashi J, Watanabe A, Fujii N, Tsuboi Y, Inoue H Mishima T, Ishikawa T, Imamura K, Kondo T, Koshiba Y, Takahashi R, Takahashi J, Watanabe A, Fujii N, Tsuboi Y, Inoue H Mishima T, Ishikawa T, Imamura K, Kondo T, Koshiba Y, Takahashi R, Takahashi J, Watanabe A, Fujii N, Tsuboi Y, Inoue H A cellular model for Perry syndrome using patient iPSCs A cellular model for Perry syndrome using patient iPSCs A cellular model for Perry syndrome using patient iPSCs 57th Annual Meeting of the Japanese Society of Neurology, Kobe. 57th Annual Meeting of the Japanese Society of Neurology, Kobe. 57th Annual Meeting of the Japanese Society of Neurology, Kobe. 2016/05/18 Disclose to all
Sekine S, Kondo T, Miki K, Yoshida Y, Kurita H, Inden M, Hozumi I, Inoue H Sekine S, Kondo T, Miki K, Yoshida Y, Kurita H, Inden M, Hozumi I, Inoue H Sekine S, Kondo T, Miki K, Yoshida Y, Kurita H, Inden M, Hozumi I, Inoue H Modeling idiopathic basal ganglia calcification using patient iPSCs Modeling idiopathic basal ganglia calcification using patient iPSCs Modeling idiopathic basal ganglia calcification using patient iPSCs 57th Annual Meeting of the Japanese Society of Neurology, Kobe. 57th Annual Meeting of the Japanese Society of Neurology, Kobe. 57th Annual Meeting of the Japanese Society of Neurology, Kobe. 2016/05/18 Disclose to all
Morii F, Imamura K, Ohara R, Shibata M, Sekiguchi K, Ikeya M, Toguchida J, Mizuno T, Nakagawa M, Inoue H Morii F, Imamura K, Ohara R, Shibata M, Sekiguchi K, Ikeya M, Toguchida J, Mizuno T, Nakagawa M, Inoue H Morii F, Imamura K, Ohara R, Shibata M, Sekiguchi K, Ikeya M, Toguchida J, Mizuno T, Nakagawa M, Inoue H Modeling Charcot-Marie-Tooth disease using patient-induced pluripotent stem cells Modeling Charcot-Marie-Tooth disease using patient-induced pluripotent stem cells Modeling Charcot-Marie-Tooth disease using patient-induced pluripotent stem cells 57th Annual Meeting of the Japanese Society of Neurology, Kobe. 57th Annual Meeting of the Japanese Society of Neurology, Kobe. 57th Annual Meeting of the Japanese Society of Neurology, Kobe. 2016/05/18 Disclose to all
Matsuzono K, Murakami N, Imamura K, Kondo T, Tsukita K, Enami T, Izumi Y, Kaji R, Abe K, Inoue H Matsuzono K, Murakami N, Imamura K, Kondo T, Tsukita K, Enami T, Izumi Y, Kaji R, Abe K, Inoue H Matsuzono K, Murakami N, Imamura K, Kondo T, Tsukita K, Enami T, Izumi Y, Kaji R, Abe K, Inoue H Modeling spinocerebellar ataxia type 36 using patient induced pluripotent stem cells Modeling spinocerebellar ataxia type 36 using patient induced pluripotent stem cells Modeling spinocerebellar ataxia type 36 using patient induced pluripotent stem cells 57th Annual Meeting of the Japanese Society of Neurology, Kobe. 57th Annual Meeting of the Japanese Society of Neurology, Kobe. 57th Annual Meeting of the Japanese Society of Neurology, Kobe. 2016/05/18 Disclose to all
Shimojima K, Okamura A, Hayashi M, Kondo T, Inoue H, Yamamoto T Shimojima K, Okamura A, Hayashi M, Kondo T, Inoue H, Yamamoto T Shimojima K, Okamura A, Hayashi M, Kondo T, Inoue H, Yamamoto T CHCHD2 is down-regulated in neuronal cells differentiated from iPS cells derived from patients with lissencephaly CHCHD2 is down-regulated in neuronal cells differentiated from iPS cells derived from patients with lissencephaly CHCHD2 is down-regulated in neuronal cells differentiated from iPS cells derived from patients with lissencephaly The 13th International Congress of Human Genetics (ICHG2016), Kyoto, Japan. The 13th International Congress of Human Genetics (ICHG2016), Kyoto, Japan. The 13th International Congress of Human Genetics (ICHG2016), Kyoto, Japan. 2016/04/03 Disclose to all
菊地哲広, 森実飛鳥, 土井大輔, 井上治久, 高橋良輔, 沖田圭介, 中川誠人, 高良沙幸, 水間広, 尾上浩隆, 林拓也, 高橋淳 菊地哲広, 森実飛鳥, 土井大輔, 井上治久, 高橋良輔, 沖田圭介, 中川誠人, 高良沙幸, 水間広, 尾上浩隆, 林拓也, 高橋淳 菊地哲広, 森実飛鳥, 土井大輔, 井上治久, 高橋良輔, 沖田圭介, 中川誠人, 高良沙幸, 水間広, 尾上浩隆, 林拓也, 高橋淳 霊長類モデルへのヒトiPS細胞由来ドパミン神経前駆細胞移植 霊長類モデルへのヒトiPS細胞由来ドパミン神経前駆細胞移植 霊長類モデルへのヒトiPS細胞由来ドパミン神経前駆細胞移植 再生医療, 15, 343 再生医療, 15, 343 再生医療, 15, 343 2016 Disclose to all
岩田 修永, 松尾 和哉, 森田 知樹, 渡辺 かおり, 八田 大典, 浅井 将, 八幡 直樹, 近藤 孝之, 井上 治久, 関 恒慶, 小林 千浩, 戸田 達史, 城谷 圭朗 岩田 修永, 松尾 和哉, 森田 知樹, 渡辺 かおり, 八田 大典, 浅井 将, 八幡 直樹, 近藤 孝之, 井上 治久, 関 恒慶, 小林 千浩, 戸田 達史, 城谷 圭朗 岩田 修永, 松尾 和哉, 森田 知樹, 渡辺 かおり, 八田 大典, 浅井 将, 八幡 直樹, 近藤 孝之, 井上 治久, 関 恒慶, 小林 千浩, 戸田 達史, 城谷 圭朗 γセクレターゼによるAPP-CTFβのγ切断部位を調節する内在性分子の解析 γセクレターゼによるAPP-CTFβのγ切断部位を調節する内在性分子の解析 γセクレターゼによるAPP-CTFβのγ切断部位を調節する内在性分子の解析 日本生化学会大会プログラム・講演要旨集, 89回, [2P-355] 日本生化学会大会プログラム・講演要旨集, 89回, [2P-355] 日本生化学会大会プログラム・講演要旨集, 89回, [2P-355] 2016 Japanese Disclose to all
松尾 和哉, 吉崎 涼平, 大槻 純男, 浅井 将, 城谷 圭朗, 近藤 孝之, 井上 治久, 岩田 修永 松尾 和哉, 吉崎 涼平, 大槻 純男, 浅井 将, 城谷 圭朗, 近藤 孝之, 井上 治久, 岩田 修永 松尾 和哉, 吉崎 涼平, 大槻 純男, 浅井 将, 城谷 圭朗, 近藤 孝之, 井上 治久, 岩田 修永 アルツハイマー病サブグループのバイオマーカーの探索 アルツハイマー病サブグループのバイオマーカーの探索 アルツハイマー病サブグループのバイオマーカーの探索 日本生化学会大会プログラム・講演要旨集, 89回, [2P-354] 日本生化学会大会プログラム・講演要旨集, 89回, [2P-354] 日本生化学会大会プログラム・講演要旨集, 89回, [2P-354] 2016 Japanese Disclose to all
岩田 修永, 松尾 和哉, 大槻 純男, 浅井 将, 近藤 孝之, 井上 治久, 城谷 圭朗 岩田 修永, 松尾 和哉, 大槻 純男, 浅井 将, 近藤 孝之, 井上 治久, 城谷 圭朗 岩田 修永, 松尾 和哉, 大槻 純男, 浅井 将, 近藤 孝之, 井上 治久, 城谷 圭朗 患者由来iPS細胞を利用したアルツハイマー病のバイオマーカーの探索 患者由来iPS細胞を利用したアルツハイマー病のバイオマーカーの探索 患者由来iPS細胞を利用したアルツハイマー病のバイオマーカーの探索 Dementia Japan, 30, 4, 563-563 Dementia Japan, 30, 4, 563-563 Dementia Japan, 30, 4, 563-563 2016 Japanese Disclose to all
近藤孝之, 井上治久 近藤孝之, 井上治久 近藤孝之, 井上治久 患者由来iPS細胞を用いたアルツハイマー病研究 患者由来iPS細胞を用いたアルツハイマー病研究 患者由来iPS細胞を用いたアルツハイマー病研究 The 34th Annual Meeting of Japan Society for Dementia Research, Aomori. The 34th Annual Meeting of Japan Society for Dementia Research, Aomori. The 34th Annual Meeting of Japan Society for Dementia Research, Aomori. 2015/10/04 Disclose to all
今村恵子, 井上治久 今村恵子, 井上治久 今村恵子, 井上治久 iPS細胞由来大脳皮質神経細胞を用いた前頭側頭葉変性症の解析 iPS細胞由来大脳皮質神経細胞を用いた前頭側頭葉変性症の解析 iPS細胞由来大脳皮質神経細胞を用いた前頭側頭葉変性症の解析 The 34th Annual Meeting of Japan Society for Dementia Research, Aomori. The 34th Annual Meeting of Japan Society for Dementia Research, Aomori. The 34th Annual Meeting of Japan Society for Dementia Research, Aomori. 2015/10/04 Disclose to all
Kondo T, Inoue H Kondo T, Inoue H Kondo T, Inoue H Recapitulating neural disease by iPS-cell derived astrocytes of patients Recapitulating neural disease by iPS-cell derived astrocytes of patients Recapitulating neural disease by iPS-cell derived astrocytes of patients The 38th Annual Meeting of the Japan Neuroscience Society, Kobe. The 38th Annual Meeting of the Japan Neuroscience Society, Kobe. The 38th Annual Meeting of the Japan Neuroscience Society, Kobe. 2015/07/29 Disclose to all
Goto K, Imamura K, Mitani K, Aiba K, Nakatsuj N, Takahashi R, Inoue H Goto K, Imamura K, Mitani K, Aiba K, Nakatsuj N, Takahashi R, Inoue H Goto K, Imamura K, Mitani K, Aiba K, Nakatsuj N, Takahashi R, Inoue H Chemical library screening to identify a small compound that promotes motor neurons differentiation from iPSCs/ESCs Chemical library screening to identify a small compound that promotes motor neurons differentiation from iPSCs/ESCs Chemical library screening to identify a small compound that promotes motor neurons differentiation from iPSCs/ESCs The 38th Annual Meeting of the Japan Neuroscience Society, Kobe. The 38th Annual Meeting of the Japan Neuroscience Society, Kobe. The 38th Annual Meeting of the Japan Neuroscience Society, Kobe. 2015/07/28 Disclose to all
Morii F, Ohara R, Imamura K, Shibata M, Sekiguchi K, Ikeya M, Toguchida J, Mizuno T, Nakagawa M, Inoue H Morii F, Ohara R, Imamura K, Shibata M, Sekiguchi K, Ikeya M, Toguchida J, Mizuno T, Nakagawa M, Inoue H Morii F, Ohara R, Imamura K, Shibata M, Sekiguchi K, Ikeya M, Toguchida J, Mizuno T, Nakagawa M, Inoue H Modeling for hereditary neuropathy using patient-induced pluripotent stem cells Modeling for hereditary neuropathy using patient-induced pluripotent stem cells Modeling for hereditary neuropathy using patient-induced pluripotent stem cells 56th Annual Meeting of the Japanese Society of Neurology, Niigata. 56th Annual Meeting of the Japanese Society of Neurology, Niigata. 56th Annual Meeting of the Japanese Society of Neurology, Niigata. 2015/05/23 Disclose to all
Ohara R, Morii F, Egawa N, Okita K, Mizuno T, Nakagawa M, Yamanaka S, Inoue H Ohara R, Morii F, Egawa N, Okita K, Mizuno T, Nakagawa M, Yamanaka S, Inoue H Ohara R, Morii F, Egawa N, Okita K, Mizuno T, Nakagawa M, Yamanaka S, Inoue H Modeling Charcot-Marie-Tooth disease using patient iPSCs Modeling Charcot-Marie-Tooth disease using patient iPSCs Modeling Charcot-Marie-Tooth disease using patient iPSCs 56th Annual Meeting of the Japanese Society of Neurology, Niigata. 56th Annual Meeting of the Japanese Society of Neurology, Niigata. 56th Annual Meeting of the Japanese Society of Neurology, Niigata. 2015/05/22 Disclose to all
Tsuge I, Tsukita K, Naito M, Suzuki S, Sakuma T, Yamamoto T, Hotta A, Yamanaka S, Inoue H Tsuge I, Tsukita K, Naito M, Suzuki S, Sakuma T, Yamamoto T, Hotta A, Yamanaka S, Inoue H Tsuge I, Tsukita K, Naito M, Suzuki S, Sakuma T, Yamamoto T, Hotta A, Yamanaka S, Inoue H Genomic correction of mutant TDP-43 iPSCs Genomic correction of mutant TDP-43 iPSCs Genomic correction of mutant TDP-43 iPSCs 56th Annual Meeting of the Japanese Society of Neurology, Niigata. 56th Annual Meeting of the Japanese Society of Neurology, Niigata. 56th Annual Meeting of the Japanese Society of Neurology, Niigata. 2015/05/21 Disclose to all
引網亮太, 端祐一郎, 山門穂高, 辰己新水, 山下博史, 澤本伸克, 辻輝 之, 川本未知, 幸原伸夫, 井上治久, 漆谷真, 高橋良輔 引網亮太, 端祐一郎, 山門穂高, 辰己新水, 山下博史, 澤本伸克, 辻輝 之, 川本未知, 幸原伸夫, 井上治久, 漆谷真, 高橋良輔 引網亮太, 端祐一郎, 山門穂高, 辰己新水, 山下博史, 澤本伸克, 辻輝 之, 川本未知, 幸原伸夫, 井上治久, 漆谷真, 高橋良輔 FUS遺伝子変異を伴う筋萎縮性側索硬化症の臨床像:若年発症例を含む4症例の検討 FUS遺伝子変異を伴う筋萎縮性側索硬化症の臨床像:若年発症例を含む4症例の検討 FUS遺伝子変異を伴う筋萎縮性側索硬化症の臨床像:若年発症例を含む4症例の検討 56th Annual Meeting of the Japanese Society of Neurology, Niigata. 56th Annual Meeting of the Japanese Society of Neurology, Niigata. 56th Annual Meeting of the Japanese Society of Neurology, Niigata. 2015/05/21 Disclose to all
Murakami N, Egawa N, Ohara R, Koizumi H, Imamura K, Kondo T, Kawarai T, Izumi Y, Nakagawara M, Kaji R, Inoue H Murakami N, Egawa N, Ohara R, Koizumi H, Imamura K, Kondo T, Kawarai T, Izumi Y, Nakagawara M, Kaji R, Inoue H Murakami N, Egawa N, Ohara R, Koizumi H, Imamura K, Kondo T, Kawarai T, Izumi Y, Nakagawara M, Kaji R, Inoue H Modeling HMSNP motor neurons using patient iPSCs with mutant TFG Modeling HMSNP motor neurons using patient iPSCs with mutant TFG Modeling HMSNP motor neurons using patient iPSCs with mutant TFG 56th Annual Meeting of the Japanese Society of Neurology, Niigata. 56th Annual Meeting of the Japanese Society of Neurology, Niigata. 56th Annual Meeting of the Japanese Society of Neurology, Niigata. 2015/05/21 Disclose to all
Goto K, Imamura K, Mitani K, Aiba K, Nakatsuji N, Takahashi R, Inoue H Goto K, Imamura K, Mitani K, Aiba K, Nakatsuji N, Takahashi R, Inoue H Goto K, Imamura K, Mitani K, Aiba K, Nakatsuji N, Takahashi R, Inoue H Chemical library screening to identify a small compound that promotes motor neurons differentiation from human iPSCs/ESCs Chemical library screening to identify a small compound that promotes motor neurons differentiation from human iPSCs/ESCs Chemical library screening to identify a small compound that promotes motor neurons differentiation from human iPSCs/ESCs 56th Annual Meeting of the Japanese Society of Neurology, Niigata. 56th Annual Meeting of the Japanese Society of Neurology, Niigata. 56th Annual Meeting of the Japanese Society of Neurology, Niigata. 2015/05/21 Disclose to all
Egawa N, Goto K, Yoshida M, Enami T, Tsukita K, Imamura K, Nakahara T, Takahashi R, Saito M, Inoue H Egawa N, Goto K, Yoshida M, Enami T, Tsukita K, Imamura K, Nakahara T, Takahashi R, Saito M, Inoue H Egawa N, Goto K, Yoshida M, Enami T, Tsukita K, Imamura K, Nakahara T, Takahashi R, Saito M, Inoue H Specific phenotypes of motor neurons derived from spinal muscular atrophy Specific phenotypes of motor neurons derived from spinal muscular atrophy Specific phenotypes of motor neurons derived from spinal muscular atrophy 56th Annual Meeting of the Japanese Society of Neurology, Niigata. 56th Annual Meeting of the Japanese Society of Neurology, Niigata. 56th Annual Meeting of the Japanese Society of Neurology, Niigata. 2015/05/21 Disclose to all
村上永尚, 和泉唯信, 梶龍兒, 井上治久 村上永尚, 和泉唯信, 梶龍兒, 井上治久 村上永尚, 和泉唯信, 梶龍兒, 井上治久 病理医を誘うiPS細胞を使った疾患研究 疾患特異的iPS細胞を用いた神経疾患解析と創薬研究 病理医を誘うiPS細胞を使った疾患研究 疾患特異的iPS細胞を用いた神経疾患解析と創薬研究 病理医を誘うiPS細胞を使った疾患研究 疾患特異的iPS細胞を用いた神経疾患解析と創薬研究 病理と臨床, 33, 6, 615-621 病理と臨床, 33, 6, 615-621 病理と臨床, 33, 6, 615-621 2015 Japanese Disclose to all
菊地哲広, 森実飛鳥, 土井大輔, 井上治久, 高橋良輔, 沖田圭介, 中川誠人, 高橋淳 菊地哲広, 森実飛鳥, 土井大輔, 井上治久, 高橋良輔, 沖田圭介, 中川誠人, 高橋淳 菊地哲広, 森実飛鳥, 土井大輔, 井上治久, 高橋良輔, 沖田圭介, 中川誠人, 高橋淳 パーキンソン病患者由来iPSCからのドパミン神経誘導 パーキンソン病患者由来iPSCからのドパミン神経誘導 パーキンソン病患者由来iPSCからのドパミン神経誘導 再生医療, 14, 323 再生医療, 14, 323 再生医療, 14, 323 2015 Disclose to all
森田 知樹, 小出 恵理子, 八田 大典, 渡辺 かおり, 近藤 孝之, 浅井 将, 城谷 圭朗, 井上 治久, 岩田 修永 森田 知樹, 小出 恵理子, 八田 大典, 渡辺 かおり, 近藤 孝之, 浅井 将, 城谷 圭朗, 井上 治久, 岩田 修永 森田 知樹, 小出 恵理子, 八田 大典, 渡辺 かおり, 近藤 孝之, 浅井 将, 城谷 圭朗, 井上 治久, 岩田 修永 アルツハイマー病患者iPS細胞由来神経細胞におけるオートファジーの機能破綻 アルツハイマー病患者iPS細胞由来神経細胞におけるオートファジーの機能破綻 アルツハイマー病患者iPS細胞由来神経細胞におけるオートファジーの機能破綻 Dementia Japan, 29, 3, 372-372 Dementia Japan, 29, 3, 372-372 Dementia Japan, 29, 3, 372-372 2015 Japanese Disclose to all
津下 到, 鈴木 茂彦, 内藤 素子, 堀田 秋津, 井上 治久 津下 到, 鈴木 茂彦, 内藤 素子, 堀田 秋津, 井上 治久 津下 到, 鈴木 茂彦, 内藤 素子, 堀田 秋津, 井上 治久 iPS細胞研究最前線 疾患モデルから臓器再生まで(Vol.14) 患者由来iPS細胞を用いた神経疾患研究 iPS細胞研究最前線 疾患モデルから臓器再生まで(Vol.14) 患者由来iPS細胞を用いた神経疾患研究 iPS細胞研究最前線 疾患モデルから臓器再生まで(Vol.14) 患者由来iPS細胞を用いた神経疾患研究 医学のあゆみ, 252, 7, 824-828 医学のあゆみ, 252, 7, 824-828 医学のあゆみ, 252, 7, 824-828 2015 Japanese Disclose to all
大原亮, 今村恵子, 森井芙貴子, 江川斉宏, 沖田圭介, 水野敏樹, 中川正法, 山中伸弥, 井上治久 大原亮, 今村恵子, 森井芙貴子, 江川斉宏, 沖田圭介, 水野敏樹, 中川正法, 山中伸弥, 井上治久 大原亮, 今村恵子, 森井芙貴子, 江川斉宏, 沖田圭介, 水野敏樹, 中川正法, 山中伸弥, 井上治久 患者iPS細胞を用いたCharcot‐Marie‐Tooth病モデルの確立 患者iPS細胞を用いたCharcot‐Marie‐Tooth病モデルの確立 患者iPS細胞を用いたCharcot‐Marie‐Tooth病モデルの確立 日本末梢神経学会学術集会プログラム・抄録, 26th, 100 日本末梢神経学会学術集会プログラム・抄録, 26th, 100 日本末梢神経学会学術集会プログラム・抄録, 26th, 100 2015 Japanese Disclose to all
大原亮, 森井芙貴子, 江川斉宏, 沖田圭介, 水野敏樹, 中川正法, 山中伸弥, 井上治久 大原亮, 森井芙貴子, 江川斉宏, 沖田圭介, 水野敏樹, 中川正法, 山中伸弥, 井上治久 大原亮, 森井芙貴子, 江川斉宏, 沖田圭介, 水野敏樹, 中川正法, 山中伸弥, 井上治久 患者iPS細胞を用いたCharcot‐Marie‐Tooth病モデルの確立 患者iPS細胞を用いたCharcot‐Marie‐Tooth病モデルの確立 患者iPS細胞を用いたCharcot‐Marie‐Tooth病モデルの確立 末梢神経, 26, 2, 289 末梢神経, 26, 2, 289 末梢神経, 26, 2, 289 2015 Japanese Disclose to all
Okita K, Kikuchi T, Morizane A, Doi D, Nakagawa M, Inoue H, Takahashi R, Takahashi J Okita K, Kikuchi T, Morizane A, Doi D, Nakagawa M, Inoue H, Takahashi R, Takahashi J Okita K, Kikuchi T, Morizane A, Doi D, Nakagawa M, Inoue H, Takahashi R, Takahashi J Induced pluripotent stem cells derived from idiopathic parkinson’s disease patients differentiate into midbrain dopaminergic neurons and improve motor function of parkinson’s disease model rats Induced pluripotent stem cells derived from idiopathic parkinson’s disease patients differentiate into midbrain dopaminergic neurons and improve motor function of parkinson’s disease model rats Induced pluripotent stem cells derived from idiopathic parkinson’s disease patients differentiate into midbrain dopaminergic neurons and improve motor function of parkinson’s disease model rats ISSCR Annual Meeting 2015 ISSCR Annual Meeting 2015 ISSCR Annual Meeting 2015 2015 English Disclose to all
Goto K, Imamura K, Mitani K, Aiba K, Nakatsuji N, Takahashi R, Inoue H Goto K, Imamura K, Mitani K, Aiba K, Nakatsuji N, Takahashi R, Inoue H Goto K, Imamura K, Mitani K, Aiba K, Nakatsuji N, Takahashi R, Inoue H Chemical library screening to identify a small compound that promotes motor neurons differentiation from human iPSCs/ESCs Chemical library screening to identify a small compound that promotes motor neurons differentiation from human iPSCs/ESCs Chemical library screening to identify a small compound that promotes motor neurons differentiation from human iPSCs/ESCs The 37th Annual Meeting of the Japan Neuroscience Society, Yokohama, Japan. The 37th Annual Meeting of the Japan Neuroscience Society, Yokohama, Japan. The 37th Annual Meeting of the Japan Neuroscience Society, Yokohama, Japan. 2014/09/11 Disclose to all
Egawa N, Yoshida M, Enami T, Tsukita K, Imamura K, Nakahata T, Takahashi R, Saito M, Inoue H Egawa N, Yoshida M, Enami T, Tsukita K, Imamura K, Nakahata T, Takahashi R, Saito M, Inoue H Egawa N, Yoshida M, Enami T, Tsukita K, Imamura K, Nakahata T, Takahashi R, Saito M, Inoue H Specific phenotypes of motor neurons derived from spinal muscular disease Specific phenotypes of motor neurons derived from spinal muscular disease Specific phenotypes of motor neurons derived from spinal muscular disease The 37th Annual Meeting of the Japan Neuroscience Society, Yokohama, Japan. The 37th Annual Meeting of the Japan Neuroscience Society, Yokohama, Japan. The 37th Annual Meeting of the Japan Neuroscience Society, Yokohama, Japan. 2014/09/11 Disclose to all
小芝泰, 森實飛鳥, 菊地哲広, 山門穂高, 陣上直人, 土井大輔, 西村周泰, 皆川栄子, 江川斉宏, 井上治久, 高橋淳, 高橋良輔 小芝泰, 森實飛鳥, 菊地哲広, 山門穂高, 陣上直人, 土井大輔, 西村周泰, 皆川栄子, 江川斉宏, 井上治久, 高橋淳, 高橋良輔 小芝泰, 森實飛鳥, 菊地哲広, 山門穂高, 陣上直人, 土井大輔, 西村周泰, 皆川栄子, 江川斉宏, 井上治久, 高橋淳, 高橋良輔 iPS 細胞モデルによるLRRK2 I2020T 変異パーキンソン病の研究 iPS 細胞モデルによるLRRK2 I2020T 変異パーキンソン病の研究 iPS 細胞モデルによるLRRK2 I2020T 変異パーキンソン病の研究 55th Annual Meeting of the Japanese Society of Neurology, Fukuoka. 55th Annual Meeting of the Japanese Society of Neurology, Fukuoka. 55th Annual Meeting of the Japanese Society of Neurology, Fukuoka. 2014/05/23 Disclose to all
関恒慶, 小林千浩, 八幡直樹, 浅井将, 岩田修永, 井上治久, 戸田達史 関恒慶, 小林千浩, 八幡直樹, 浅井将, 岩田修永, 井上治久, 戸田達史 関恒慶, 小林千浩, 八幡直樹, 浅井将, 岩田修永, 井上治久, 戸田達史 神経系細胞分化過程の遺伝子解析によるアルツハイマー病病態制御遺伝子の検索 神経系細胞分化過程の遺伝子解析によるアルツハイマー病病態制御遺伝子の検索 神経系細胞分化過程の遺伝子解析によるアルツハイマー病病態制御遺伝子の検索 55th Annual Meeting of the Japanese Society of Neurology, Fukuoka. 55th Annual Meeting of the Japanese Society of Neurology, Fukuoka. 55th Annual Meeting of the Japanese Society of Neurology, Fukuoka. 2014/05/23 Disclose to all
近藤孝之, 舟山美里, 月田香代子, 堀田秋津, 安田明正, 海苔聡, 金子慎二郎, 中村雅也, 高橋良輔, 岡野栄之, 山中伸弥, 井上治久 近藤孝之, 舟山美里, 月田香代子, 堀田秋津, 安田明正, 海苔聡, 金子慎二郎, 中村雅也, 高橋良輔, 岡野栄之, 山中伸弥, 井上治久 近藤孝之, 舟山美里, 月田香代子, 堀田秋津, 安田明正, 海苔聡, 金子慎二郎, 中村雅也, 高橋良輔, 岡野栄之, 山中伸弥, 井上治久 ヒトiPS細胞由来のアストロサイトを用いたALSモデルマウスの脊髄移植治療 ヒトiPS細胞由来のアストロサイトを用いたALSモデルマウスの脊髄移植治療 ヒトiPS細胞由来のアストロサイトを用いたALSモデルマウスの脊髄移植治療 55th Annual Meeting of the Japanese Society of Neurology, Fukuoka. 55th Annual Meeting of the Japanese Society of Neurology, Fukuoka. 55th Annual Meeting of the Japanese Society of Neurology, Fukuoka. 2014/05/22 Disclose to all
今村恵子, 和泉唯信, 月田香代子, 古谷博和, 江良択実, 中畑龍俊, 梶龍兒山中伸弥, 井上治久 今村恵子, 和泉唯信, 月田香代子, 古谷博和, 江良択実, 中畑龍俊, 梶龍兒山中伸弥, 井上治久 今村恵子, 和泉唯信, 月田香代子, 古谷博和, 江良択実, 中畑龍俊, 梶龍兒山中伸弥, 井上治久 家族性筋萎縮性側索硬化症患者由来iPS細胞を用いた疾患モデルの作製 家族性筋萎縮性側索硬化症患者由来iPS細胞を用いた疾患モデルの作製 家族性筋萎縮性側索硬化症患者由来iPS細胞を用いた疾患モデルの作製 55th Annual Meeting of the Japanese Society of Neurology, Fukuoka. 55th Annual Meeting of the Japanese Society of Neurology, Fukuoka. 55th Annual Meeting of the Japanese Society of Neurology, Fukuoka. 2014/05/22 Disclose to all
城谷 圭朗, 能登 雄太, 高橋 茜, 森田 知樹, 小出 恵理子, 浅井 将, 近藤 孝之, 井上 治久, 岩田 修永 城谷 圭朗, 能登 雄太, 高橋 茜, 森田 知樹, 小出 恵理子, 浅井 将, 近藤 孝之, 井上 治久, 岩田 修永 城谷 圭朗, 能登 雄太, 高橋 茜, 森田 知樹, 小出 恵理子, 浅井 将, 近藤 孝之, 井上 治久, 岩田 修永 認知症研究におけるCell Biology I リソソーム・オートファジー アルツハイマー病iPS細胞由来神経細胞のオートファジー関連分子の解析 認知症研究におけるCell Biology I リソソーム・オートファジー アルツハイマー病iPS細胞由来神経細胞のオートファジー関連分子の解析 認知症研究におけるCell Biology I リソソーム・オートファジー アルツハイマー病iPS細胞由来神経細胞のオートファジー関連分子の解析 Dementia Japan, 28, 4, 424-424 Dementia Japan, 28, 4, 424-424 Dementia Japan, 28, 4, 424-424 2014 Japanese Disclose to all
浅井将, 城谷圭朗, 近藤孝之, 井上治久, 岩田修永 浅井将, 城谷圭朗, 近藤孝之, 井上治久, 岩田修永 孤発性および家族性アルツハイマー病患者由来iPS細胞を用いたアルツハイマー病の病態解析 孤発性および家族性アルツハイマー病患者由来iPS細胞を用いたアルツハイマー病の病態解析 日本薬理学雑誌, 143, 1, 23-26 日本薬理学雑誌, 143, 1, 23-26 , 143, 1, 23-26 2014 Japanese Introduction and explanation (scientific journal) Disclose to all
今村恵子, 和泉唯信, 月田香代子, 古谷博和, 江良択実, 中畑龍俊, 梶龍兒, 山中伸弥, 井上治久 今村恵子, 和泉唯信, 月田香代子, 古谷博和, 江良択実, 中畑龍俊, 梶龍兒, 山中伸弥, 井上治久 今村恵子, 和泉唯信, 月田香代子, 古谷博和, 江良択実, 中畑龍俊, 梶龍兒, 山中伸弥, 井上治久 家族性筋萎縮性側索硬化症患者由来iPS細胞を用いた疾患モデルの作製 家族性筋萎縮性側索硬化症患者由来iPS細胞を用いた疾患モデルの作製 家族性筋萎縮性側索硬化症患者由来iPS細胞を用いた疾患モデルの作製 日本神経学会学術大会プログラム・抄録集, 55th, Suppl., 653-S172 日本神経学会学術大会プログラム・抄録集, 55th, Suppl., 653-S172 日本神経学会学術大会プログラム・抄録集, 55th, Suppl., 653-S172 2014 Japanese Disclose to all
近藤孝之, 舟山美里, 月田香代子, 中畑龍俊, 山中伸弥, 井上治久 近藤孝之, 舟山美里, 月田香代子, 中畑龍俊, 山中伸弥, 井上治久 近藤孝之, 舟山美里, 月田香代子, 中畑龍俊, 山中伸弥, 井上治久 アルツハイマー病患者由来iPS細胞を用いた細胞内Aβ関連ストレスと薬剤応答性の解明 アルツハイマー病患者由来iPS細胞を用いた細胞内Aβ関連ストレスと薬剤応答性の解明 アルツハイマー病患者由来iPS細胞を用いた細胞内Aβ関連ストレスと薬剤応答性の解明 再生医療, 13, 198 再生医療, 13, 198 再生医療, 13, 198 2014 Japanese Disclose to all
今村恵子, 月田香代子, 古谷博和, 江良択実, 中畑龍俊, 山中伸弥, 井上治久 今村恵子, 月田香代子, 古谷博和, 江良択実, 中畑龍俊, 山中伸弥, 井上治久 今村恵子, 月田香代子, 古谷博和, 江良択実, 中畑龍俊, 山中伸弥, 井上治久 家族性筋萎縮性側索硬化症患者由来iPS細胞を用いた疾患モデルの作製 家族性筋萎縮性側索硬化症患者由来iPS細胞を用いた疾患モデルの作製 家族性筋萎縮性側索硬化症患者由来iPS細胞を用いた疾患モデルの作製 再生医療, 13, 280 再生医療, 13, 280 再生医療, 13, 280 2014 Japanese Disclose to all
中村 英二郎, 室伏 善照, 今村 恵子, 丹羽 明, 杉山 愛子, 木下 和生, 新垣 隆一郎, 柴崎 昇, 山崎 俊成, 神波 大己, 斎藤 潤, 井上 治久, 小川 修 中村 英二郎, 室伏 善照, 今村 恵子, 丹羽 明, 杉山 愛子, 木下 和生, 新垣 隆一郎, 柴崎 昇, 山崎 俊成, 神波 大己, 斎藤 潤, 井上 治久, 小川 修 中村 英二郎, 室伏 善照, 今村 恵子, 丹羽 明, 杉山 愛子, 木下 和生, 新垣 隆一郎, 柴崎 昇, 山崎 俊成, 神波 大己, 斎藤 潤, 井上 治久, 小川 修 遺伝性腫瘍 基礎と臨床の架け橋 患者由来iPS細胞を用いた家族性腫瘍疾患VHL病に対する新規治療法創出の試み(Hereditary cancer: bridges between bench and bedside Development of new therapeutic strategy for VHL hereditary cancer disease by using patient-derived iPS cells) 遺伝性腫瘍 基礎と臨床の架け橋 患者由来iPS細胞を用いた家族性腫瘍疾患VHL病に対する新規治療法創出の試み(Hereditary cancer: bridges between bench and bedside Development of new therapeutic strategy for VHL hereditary cancer disease by using patient-derived iPS cells) 遺伝性腫瘍 基礎と臨床の架け橋 患者由来iPS細胞を用いた家族性腫瘍疾患VHL病に対する新規治療法創出の試み(Hereditary cancer: bridges between bench and bedside Development of new therapeutic strategy for VHL hereditary cancer disease by using patient-derived iPS cells) 日本癌学会総会記事, 73回, S20-6 日本癌学会総会記事, 73回, S20-6 日本癌学会総会記事, 73回, S20-6 2014 English Disclose to all
菊地哲広, 森実飛鳥, 土井大輔, 井上治久, 高橋良輔, 沖田圭介, 中川誠人, 高橋淳 菊地哲広, 森実飛鳥, 土井大輔, 井上治久, 高橋良輔, 沖田圭介, 中川誠人, 高橋淳 菊地哲広, 森実飛鳥, 土井大輔, 井上治久, 高橋良輔, 沖田圭介, 中川誠人, 高橋淳 パーキンソン病患者由来iPSCからのドパミン神経誘導 パーキンソン病患者由来iPSCからのドパミン神経誘導 パーキンソン病患者由来iPSCからのドパミン神経誘導 再生医療, 13, 257 再生医療, 13, 257 再生医療, 13, 257 2014 Japanese Disclose to all
小芝 泰, 森實 飛鳥, 菊地 哲弘, 山門 穂高, 陣上 直人, 土井 大輔, 西村 周泰, 皆川 栄子, 江川 斉宏, 井上 治久, 高橋 淳, 高橋 良輔 小芝 泰, 森實 飛鳥, 菊地 哲弘, 山門 穂高, 陣上 直人, 土井 大輔, 西村 周泰, 皆川 栄子, 江川 斉宏, 井上 治久, 高橋 淳, 高橋 良輔 小芝 泰, 森實 飛鳥, 菊地 哲弘, 山門 穂高, 陣上 直人, 土井 大輔, 西村 周泰, 皆川 栄子, 江川 斉宏, 井上 治久, 高橋 淳, 高橋 良輔 iPS細胞モデルによるLRRK2 12020T変異パーキンソン病の研究 iPS細胞モデルによるLRRK2 12020T変異パーキンソン病の研究 iPS細胞モデルによるLRRK2 12020T変異パーキンソン病の研究 臨床神経学, 54, 172 臨床神経学, 54, 172 臨床神経学, 54, 172 2014 Japanese Disclose to all
中野梨絵, 浅井 将, 近藤孝之, 月田香代子, 渡邊かおり, 門谷千恵, 村上一馬, 入江一浩, Klein L. William, 森 啓, 丸山 敬, 朝田 隆, 城谷圭朗, 井上治久, 岩田修永 中野梨絵, 浅井 将, 近藤孝之, 月田香代子, 渡邊かおり, 門谷千恵, 村上一馬, 入江一浩, Klein L. William, 森 啓, 丸山 敬, 朝田 隆, 城谷圭朗, 井上治久, 岩田修永 中野梨絵, 浅井 将, 近藤孝之, 月田香代子, 渡邊かおり, 門谷千恵, 村上一馬, 入江一浩, Klein L. William, 森 啓, 丸山 敬, 朝田 隆, 城谷圭朗, 井上治久, 岩田修永 アルツハイマー病患者iPS細胞由来神経系細胞におけるAβオリゴマーの細胞毒性 アルツハイマー病患者iPS細胞由来神経系細胞におけるAβオリゴマーの細胞毒性 アルツハイマー病患者iPS細胞由来神経系細胞におけるAβオリゴマーの細胞毒性 The 32nd Annual Meeting of Japan Society for Dementia Research, Matsumoto. The 32nd Annual Meeting of Japan Society for Dementia Research, Matsumoto. The 32nd Annual Meeting of Japan Society for Dementia Research, Matsumoto. 2013/11/08 Disclose to all
Shirotani K, Kondo T, Asai M, Tsukita K, Watanabe K, Maruyama K, Murakami K, Irie K, Klein WL, Mori H, Asadam T, Inoue H, Iwata N Shirotani K, Kondo T, Asai M, Tsukita K, Watanabe K, Maruyama K, Murakami K, Irie K, Klein WL, Mori H, Asadam T, Inoue H, Iwata N Shirotani K, Kondo T, Asai M, Tsukita K, Watanabe K, Maruyama K, Murakami K, Irie K, Klein WL, Mori H, Asadam T, Inoue H, Iwata N Modeling Alzheimer’s disease using induced pluripotent stem cells from familial and sporadic Alzheimer's disease patients Modeling Alzheimer’s disease using induced pluripotent stem cells from familial and sporadic Alzheimer's disease patients Modeling Alzheimer’s disease using induced pluripotent stem cells from familial and sporadic Alzheimer's disease patients Alzheimer's Association International Conference (AAIC 2013), Boston, USA. Alzheimer's Association International Conference (AAIC 2013), Boston, USA. Alzheimer's Association International Conference (AAIC 2013), Boston, USA. 2013/07/14 Disclose to all
Egawa N, Takahashi R, Inoue H Egawa N, Takahashi R, Inoue H Egawa N, Takahashi R, Inoue H Generation of motor neurons through patient-specific iPSCs with mutant TDP-43 Generation of motor neurons through patient-specific iPSCs with mutant TDP-43 Generation of motor neurons through patient-specific iPSCs with mutant TDP-43 The 36th Annual Meeting of the Japan Neuroscience Society, Kyoto, Japan. The 36th Annual Meeting of the Japan Neuroscience Society, Kyoto, Japan. The 36th Annual Meeting of the Japan Neuroscience Society, Kyoto, Japan. 2013/06/21 Disclose to all
Kondo T, Takahashi R, Inoue H Kondo T, Takahashi R, Inoue H Kondo T, Takahashi R, Inoue H Efficient derivation of functional astrocytes from human induced pluripotent stem cells Efficient derivation of functional astrocytes from human induced pluripotent stem cells Efficient derivation of functional astrocytes from human induced pluripotent stem cells The 36th Annual Meeting of the Japan Neuroscience Society, Kyoto, Japan. The 36th Annual Meeting of the Japan Neuroscience Society, Kyoto, Japan. The 36th Annual Meeting of the Japan Neuroscience Society, Kyoto, Japan. 2013/06/20 Disclose to all
Koshiba Y, Morizane A, Yamakado H, Kikuchi T, Doi D, Nishimura K, Minakawa E, Egawa N, Kondo T, Inoue H, Takahashi J, Takahashi R Koshiba Y, Morizane A, Yamakado H, Kikuchi T, Doi D, Nishimura K, Minakawa E, Egawa N, Kondo T, Inoue H, Takahashi J, Takahashi R Koshiba Y, Morizane A, Yamakado H, Kikuchi T, Doi D, Nishimura K, Minakawa E, Egawa N, Kondo T, Inoue H, Takahashi J, Takahashi R iPS Cell Modeling of Genetic Parkinson's Disease iPS Cell Modeling of Genetic Parkinson's Disease iPS Cell Modeling of Genetic Parkinson's Disease The 36th Annual Meeting of the Japan Neuroscience Society, Kyoto, Japan. The 36th Annual Meeting of the Japan Neuroscience Society, Kyoto, Japan. The 36th Annual Meeting of the Japan Neuroscience Society, Kyoto, Japan. 2013/06/20 Disclose to all
Yoshida M, Kitaoka S, Yamane M, Tsukita K, Inoue H, Saito M, Nakahata T Yoshida M, Kitaoka S, Yamane M, Tsukita K, Inoue H, Saito M, Nakahata T Yoshida M, Kitaoka S, Yamane M, Tsukita K, Inoue H, Saito M, Nakahata T Spinal Motor Neurons Generated from Induced Pluripotent Stem Cells Derived from Spinal Muscular Atrophy Patients Failed to Cluster Acetylcholine Receptors at The Neuromuscular Junctions Spinal Motor Neurons Generated from Induced Pluripotent Stem Cells Derived from Spinal Muscular Atrophy Patients Failed to Cluster Acetylcholine Receptors at The Neuromuscular Junctions Spinal Motor Neurons Generated from Induced Pluripotent Stem Cells Derived from Spinal Muscular Atrophy Patients Failed to Cluster Acetylcholine Receptors at The Neuromuscular Junctions ISSCR 11th Annual Meeting Boston, MA, USA. ISSCR 11th Annual Meeting Boston, MA, USA. ISSCR 11th Annual Meeting Boston, MA, USA. 2013/06/13 Disclose to all
Kikuchi T, Morizane A, Doi D, Okita K, Inoue H, Takahashi J Kikuchi T, Morizane A, Doi D, Okita K, Inoue H, Takahashi J Kikuchi T, Morizane A, Doi D, Okita K, Inoue H, Takahashi J Induced Pluripotent Stem Cells Derived From Idiopathic Parkinson's Disease Patients Differentiate into Midbrain Dopaminergic Neurons Induced Pluripotent Stem Cells Derived From Idiopathic Parkinson's Disease Patients Differentiate into Midbrain Dopaminergic Neurons Induced Pluripotent Stem Cells Derived From Idiopathic Parkinson's Disease Patients Differentiate into Midbrain Dopaminergic Neurons ISSCR 11th Annual Meeting Boston, MA, USA. ISSCR 11th Annual Meeting Boston, MA, USA. ISSCR 11th Annual Meeting Boston, MA, USA. 2013/06/13 Disclose to all
今村恵子, 月田香代子, 江川斉宏, 近藤孝之, 井上治久 今村恵子, 月田香代子, 江川斉宏, 近藤孝之, 井上治久 今村恵子, 月田香代子, 江川斉宏, 近藤孝之, 井上治久 上位運動ニューロン解析に向けたヒトiPS細胞由来投射ニューロンの作製 上位運動ニューロン解析に向けたヒトiPS細胞由来投射ニューロンの作製 上位運動ニューロン解析に向けたヒトiPS細胞由来投射ニューロンの作製 54th Annual Meeting of the Japanese Society of Neurology, Tokyo. 54th Annual Meeting of the Japanese Society of Neurology, Tokyo. 54th Annual Meeting of the Japanese Society of Neurology, Tokyo. 2013/06/01 Disclose to all
村上学, 井上治久, 月田香代子, 淺井康行, 饗庭一博, 天貝祐地, 山下博史, 植村健吾, 伊東秀文, 下川浩輝, 上杉志成, 中辻憲夫, 高橋良輔 村上学, 井上治久, 月田香代子, 淺井康行, 饗庭一博, 天貝祐地, 山下博史, 植村健吾, 伊東秀文, 下川浩輝, 上杉志成, 中辻憲夫, 高橋良輔 村上学, 井上治久, 月田香代子, 淺井康行, 饗庭一博, 天貝祐地, 山下博史, 植村健吾, 伊東秀文, 下川浩輝, 上杉志成, 中辻憲夫, 高橋良輔 既存薬によるSOD1転写を標的とした筋萎縮性側索硬化症の開発 既存薬によるSOD1転写を標的とした筋萎縮性側索硬化症の開発 既存薬によるSOD1転写を標的とした筋萎縮性側索硬化症の開発 54th Annual Meeting of the Japanese Society of Neurology, Tokyo. 54th Annual Meeting of the Japanese Society of Neurology, Tokyo. 54th Annual Meeting of the Japanese Society of Neurology, Tokyo. 2013/06/01 Disclose to all
小芝 泰, 森實飛鳥, 山門穂高, 菊地哲宏, 皆川栄子, 土井大輔, 西村周泰, 江川斉宏, 井上治久, 高橋 淳, 高橋良輔 小芝 泰, 森實飛鳥, 山門穂高, 菊地哲宏, 皆川栄子, 土井大輔, 西村周泰, 江川斉宏, 井上治久, 高橋 淳, 高橋良輔 小芝 泰, 森實飛鳥, 山門穂高, 菊地哲宏, 皆川栄子, 土井大輔, 西村周泰, 江川斉宏, 井上治久, 高橋 淳, 高橋良輔 疾患特異的iPS細胞モデルによる遺伝性パーキンソン病の研究 疾患特異的iPS細胞モデルによる遺伝性パーキンソン病の研究 疾患特異的iPS細胞モデルによる遺伝性パーキンソン病の研究 54th Annual Meeting of the Japanese Society of Neurology, Tokyo. 54th Annual Meeting of the Japanese Society of Neurology, Tokyo. 54th Annual Meeting of the Japanese Society of Neurology, Tokyo. 2013/06/01 Disclose to all
小松研一, 井上治久, 山下博史, 近藤孝之, 植村健吾, 高橋良輔 小松研一, 井上治久, 山下博史, 近藤孝之, 植村健吾, 高橋良輔 小松研一, 井上治久, 山下博史, 近藤孝之, 植村健吾, 高橋良輔 筋萎縮性側索硬化症モデルマウス由来iPS細胞は、運動ニューロン死を再現する 筋萎縮性側索硬化症モデルマウス由来iPS細胞は、運動ニューロン死を再現する 筋萎縮性側索硬化症モデルマウス由来iPS細胞は、運動ニューロン死を再現する 54th Annual Meeting of the Japanese Society of Neurology, Tokyo. 54th Annual Meeting of the Japanese Society of Neurology, Tokyo. 54th Annual Meeting of the Japanese Society of Neurology, Tokyo. 2013/06/01 Disclose to all
近藤孝之, 八幡直樹, 舟山美里, 月田香代子, 浅井 将, 岩田修永, 川勝 忍, 和泉唯信, 梶 龍兒, 朝田 隆, 高橋良輔, 井上治久 近藤孝之, 八幡直樹, 舟山美里, 月田香代子, 浅井 将, 岩田修永, 川勝 忍, 和泉唯信, 梶 龍兒, 朝田 隆, 高橋良輔, 井上治久 近藤孝之, 八幡直樹, 舟山美里, 月田香代子, 浅井 将, 岩田修永, 川勝 忍, 和泉唯信, 梶 龍兒, 朝田 隆, 高橋良輔, 井上治久 家族性アルツハイマー病患者由来iPS細胞の樹立と解析 家族性アルツハイマー病患者由来iPS細胞の樹立と解析 家族性アルツハイマー病患者由来iPS細胞の樹立と解析 54th Annual Meeting of the Japanese Society of Neurology, Tokyo. 54th Annual Meeting of the Japanese Society of Neurology, Tokyo. 54th Annual Meeting of the Japanese Society of Neurology, Tokyo. 2013/05/30 Disclose to all
江川斉宏, 井上治久 江川斉宏, 井上治久 江川斉宏, 井上治久 iPS細胞を用いたALSの病態解析 iPS細胞を用いたALSの病態解析 iPS細胞を用いたALSの病態解析 54th Annual Meeting of the Japanese Society of Neurology, Symposium, Tokyo. 54th Annual Meeting of the Japanese Society of Neurology, Symposium「iPS細胞研究の現状と展望」, Tokyo. 54th Annual Meeting of the Japanese Society of Neurology, Symposium, Tokyo. 2013/05/29 Disclose to all
Yoshida M, Kitaoka S, Yamane M, Tsukita K, Nakahata T, Inoue H, Saito M Yoshida M, Kitaoka S, Yamane M, Tsukita K, Nakahata T, Inoue H, Saito M Yoshida M, Kitaoka S, Yamane M, Tsukita K, Nakahata T, Inoue H, Saito M Spinal Motor Neurons Generated from Induced Pluripotent Stem Cells Derived from Spinal Muscular Atrophy Patients Failed To Cluster Acetylcholine Receptors at the Neuromuscular Junction Spinal Motor Neurons Generated from Induced Pluripotent Stem Cells Derived from Spinal Muscular Atrophy Patients Failed To Cluster Acetylcholine Receptors at the Neuromuscular Junction Spinal Motor Neurons Generated from Induced Pluripotent Stem Cells Derived from Spinal Muscular Atrophy Patients Failed To Cluster Acetylcholine Receptors at the Neuromuscular Junction The American Academy of Neurology 65th Annual Meeting, San Diego, CA, USA. The American Academy of Neurology 65th Annual Meeting, San Diego, CA, USA. The American Academy of Neurology 65th Annual Meeting, San Diego, CA, USA. 2013/03/19 Disclose to all
Egawa N, Tsukita K, Takahashi K, Okita K, Nakahata T, Yamanaka S, Inoue H Egawa N, Tsukita K, Takahashi K, Okita K, Nakahata T, Yamanaka S, Inoue H Egawa N, Tsukita K, Takahashi K, Okita K, Nakahata T, Yamanaka S, Inoue H Generation of Motor Neurons through Patient-Specific iPSCs with Mutant TDP-43 Generation of Motor Neurons through Patient-Specific iPSCs with Mutant TDP-43 Generation of Motor Neurons through Patient-Specific iPSCs with Mutant TDP-43 CiRA International Symposium 2013 , Kyoto, Japan. CiRA International Symposium 2013 , Kyoto, Japan. CiRA International Symposium 2013 , Kyoto, Japan. 2013/03/11 Disclose to all
Hirata N, Nakagawa M, Fujibayashi Y, Yamauchi K, Murata A, Minami I, Tomioka M, Kondo T, Kuo TF, Endo H, Inoue H, Sato S, Ando S, Kawazoe Y, Aiba K, Nagata K, Kawase K, Chang YT, Suemori H, Eto K, Nakauchi H, Yamanaka S, Nakatsuji N, Ueda K, Uesugi K Hirata N, Nakagawa M, Fujibayashi Y, Yamauchi K, Murata A, Minami I, Tomioka M, Kondo T, Kuo TF, Endo H, Inoue H, Sato S, Ando S, Kawazoe Y, Aiba K, Nagata K, Kawase K, Chang YT, Suemori H, Eto K, Nakauchi H, Yamanaka S, Nakatsuji N, Ueda K, Uesugi K Hirata N, Nakagawa M, Fujibayashi Y, Yamauchi K, Murata A, Minami I, Tomioka M, Kondo T, Kuo TF, Endo H, Inoue H, Sato S, Ando S, Kawazoe Y, Aiba K, Nagata K, Kawase K, Chang YT, Suemori H, Eto K, Nakauchi H, Yamanaka S, Nakatsuji N, Ueda K, Uesugi K Fluorescent Chemical Probes for Human Stem Cells Fluorescent Chemical Probes for Human Stem Cells Fluorescent Chemical Probes for Human Stem Cells CiRA International Symposium 2013 , Kyoto, Japan. CiRA International Symposium 2013 , Kyoto, Japan. CiRA International Symposium 2013 , Kyoto, Japan. 2013/03/11 Disclose to all
Asai M, Yahata N, Iwata N, Inoue H Asai M, Yahata N, Iwata N, Inoue H Asai M, Yahata N, Iwata N, Inoue H Anti-Aβ drug validation using human iPS cell-derived neurons for the treatment of Alzheimer's disease Anti-Aβ drug validation using human iPS cell-derived neurons for the treatment of Alzheimer's disease Anti-Aβ drug validation using human iPS cell-derived neurons for the treatment of Alzheimer's disease The 11th International Conference on Alzheimer's & Parkinson's Diseases (AD/PD 2013), Florence, Italy. The 11th International Conference on Alzheimer's & Parkinson's Diseases (AD/PD 2013), Florence, Italy. The 11th International Conference on Alzheimer's & Parkinson's Diseases (AD/PD 2013), Florence, Italy. 2013/03/07 Disclose to all
中野 梨絵, 浅井 将, 近藤 孝之, 月田 香代子, 渡邊 かおり, 門谷 千恵, 村上 一馬, 入江 一浩, Klein William L, 森 啓, 丸山 啓, 朝田 隆, 城谷 圭朗, 井上 治久, 岩田 修永 中野 梨絵, 浅井 将, 近藤 孝之, 月田 香代子, 渡邊 かおり, 門谷 千恵, 村上 一馬, 入江 一浩, Klein William L, 森 啓, 丸山 啓, 朝田 隆, 城谷 圭朗, 井上 治久, 岩田 修永 中野 梨絵, 浅井 将, 近藤 孝之, 月田 香代子, 渡邊 かおり, 門谷 千恵, 村上 一馬, 入江 一浩, Klein William L, 森 啓, 丸山 啓, 朝田 隆, 城谷 圭朗, 井上 治久, 岩田 修永 アルツハイマー病患者iPS細胞由来神経系細胞におけるAβオリゴマーの細胞毒性 アルツハイマー病患者iPS細胞由来神経系細胞におけるAβオリゴマーの細胞毒性 アルツハイマー病患者iPS細胞由来神経系細胞におけるAβオリゴマーの細胞毒性 Dementia Japan, 27, 4, 477-477 Dementia Japan, 27, 4, 477-477 Dementia Japan, 27, 4, 477-477 2013 Japanese Disclose to all
浅井 将, 中野 梨絵, 荒木 希, 渡邊 かおり, 八幡 直樹, 関 恒慶, 小林 千浩, 戸田 達史, 城谷 圭朗, 井上 治久, 岩田 修永 浅井 将, 中野 梨絵, 荒木 希, 渡邊 かおり, 八幡 直樹, 関 恒慶, 小林 千浩, 戸田 達史, 城谷 圭朗, 井上 治久, 岩田 修永 浅井 将, 中野 梨絵, 荒木 希, 渡邊 かおり, 八幡 直樹, 関 恒慶, 小林 千浩, 戸田 達史, 城谷 圭朗, 井上 治久, 岩田 修永 iPS細胞技術を用いた神経疾患研究の進歩と今後の展望 神経分化過程におけるAβ40とAβ42の産生比の変化とその責任遺伝子の解析 iPS細胞技術を用いた神経疾患研究の進歩と今後の展望 神経分化過程におけるAβ40とAβ42の産生比の変化とその責任遺伝子の解析 iPS細胞技術を用いた神経疾患研究の進歩と今後の展望 神経分化過程におけるAβ40とAβ42の産生比の変化とその責任遺伝子の解析 The 86th Annual Meeting of the Japanese Biochemical Society, Yokohama., 3S15a-3 The 86th Annual Meeting of the Japanese Biochemical Society, Yokohama., 3S15a-3 The 86th Annual Meeting of the Japanese Biochemical Society, Yokohama., 3S15a-3 2013 Japanese Disclose to all
近藤孝之, 八幡直樹, 舟山美里, 月田香代子, 浅井将, 岩田修永, 川勝忍, 和泉唯信, 梶龍兒, 朝田隆, 高橋良輔, 井上治久 近藤孝之, 八幡直樹, 舟山美里, 月田香代子, 浅井将, 岩田修永, 川勝忍, 和泉唯信, 梶龍兒, 朝田隆, 高橋良輔, 井上治久 近藤孝之, 八幡直樹, 舟山美里, 月田香代子, 浅井将, 岩田修永, 川勝忍, 和泉唯信, 梶龍兒, 朝田隆, 高橋良輔, 井上治久 家族性アルツハイマー病患者由来iPS細胞の樹立と解析 家族性アルツハイマー病患者由来iPS細胞の樹立と解析 家族性アルツハイマー病患者由来iPS細胞の樹立と解析 54th Annual Meeting of the Japanese Society of Neurology, Tokyo. Program・Abstract., 345 54th Annual Meeting of the Japanese Society of Neurology, Tokyo. Program・Abstract., 345 54th Annual Meeting of the Japanese Society of Neurology, Tokyo. Program・Abstract., 345 2013 Japanese Disclose to all
菊地哲広, 森実飛鳥, 土井大輔, 井上治久, 沖田圭介, 高橋淳 菊地哲広, 森実飛鳥, 土井大輔, 井上治久, 沖田圭介, 高橋淳 菊地哲広, 森実飛鳥, 土井大輔, 井上治久, 沖田圭介, 高橋淳 パーキンソン病患者由来iPSCからのドパミン神経誘導 パーキンソン病患者由来iPSCからのドパミン神経誘導 パーキンソン病患者由来iPSCからのドパミン神経誘導 再生医療, 12, 298 再生医療, 12, 298 再生医療, 12, 298 2013 Japanese Disclose to all
村上 学, 井上 治久, 月田 香代子, 淺井 康行, 饗庭 一博, 天貝 裕地, 山下 博史, 植村 健吾, 伊東 秀文, 下川 浩輝, 上杉 志成, 中辻 憲夫, 高橋 良輔 村上 学, 井上 治久, 月田 香代子, 淺井 康行, 饗庭 一博, 天貝 裕地, 山下 博史, 植村 健吾, 伊東 秀文, 下川 浩輝, 上杉 志成, 中辻 憲夫, 高橋 良輔 村上 学, 井上 治久, 月田 香代子, 淺井 康行, 饗庭 一博, 天貝 裕地, 山下 博史, 植村 健吾, 伊東 秀文, 下川 浩輝, 上杉 志成, 中辻 憲夫, 高橋 良輔 既存薬によるSOD1転写を標的とした筋萎縮性側索硬化症新規治療法の開発 既存薬によるSOD1転写を標的とした筋萎縮性側索硬化症新規治療法の開発 既存薬によるSOD1転写を標的とした筋萎縮性側索硬化症新規治療法の開発 臨床神経学, 53, 12, 1592 臨床神経学, 53, 12, 1592 臨床神経学, 53, 12, 1592 2013 Japanese Disclose to all
小芝 泰, 森實 飛鳥, 山門 穂高, 菊地 哲宏, 皆川 栄子, 土井 大輔, 西村 周泰, 江川 斉宏, 井上 治久, 高橋 淳, 高橋 良輔 小芝 泰, 森實 飛鳥, 山門 穂高, 菊地 哲宏, 皆川 栄子, 土井 大輔, 西村 周泰, 江川 斉宏, 井上 治久, 高橋 淳, 高橋 良輔 小芝 泰, 森實 飛鳥, 山門 穂高, 菊地 哲宏, 皆川 栄子, 土井 大輔, 西村 周泰, 江川 斉宏, 井上 治久, 高橋 淳, 高橋 良輔 疾患特異的iPS細胞モデルによる遺伝性パーキンソン病の研究 疾患特異的iPS細胞モデルによる遺伝性パーキンソン病の研究 疾患特異的iPS細胞モデルによる遺伝性パーキンソン病の研究 臨床神経学, 53, 12, 1592 臨床神経学, 53, 12, 1592 臨床神経学, 53, 12, 1592 2013 Japanese Disclose to all
Egawa N, Tsukita K, Takahashi K, Okita K, Yoshikawa K, Yamawaki S, Naitoh M, Suzuki S, Okamoto K, Takuma H, Tamaoka A, Nakahata T, Takahashi R, Yamanaka S, Inoue H Egawa N, Tsukita K, Takahashi K, Okita K, Yoshikawa K, Yamawaki S, Naitoh M, Suzuki S, Okamoto K, Takuma H, Tamaoka A, Nakahata T, Takahashi R, Yamanaka S, Inoue H Egawa N, Tsukita K, Takahashi K, Okita K, Yoshikawa K, Yamawaki S, Naitoh M, Suzuki S, Okamoto K, Takuma H, Tamaoka A, Nakahata T, Takahashi R, Yamanaka S, Inoue H Generation Motor Neurons Through Patient-specific Ipscs With Mutant Tdp-43 Generation Motor Neurons Through Patient-specific Ipscs With Mutant Tdp-43 Generation Motor Neurons Through Patient-specific Ipscs With Mutant Tdp-43 The 23rd International Symposium on ALS/MND, Chicago, USA. The 23rd International Symposium on ALS/MND, Chicago, USA. The 23rd International Symposium on ALS/MND, Chicago, USA. 2012/12/05 Disclose to all
近藤 孝之, 池田 昭夫, 松本 理器, 池田 仁, 井上 有史, 高橋 良輔, 井上 治久 近藤 孝之, 池田 昭夫, 松本 理器, 池田 仁, 井上 有史, 高橋 良輔, 井上 治久 近藤 孝之, 池田 昭夫, 松本 理器, 池田 仁, 井上 有史, 高橋 良輔, 井上 治久 ウンフェルリヒト・ルントボルグ病患者由来iPS細胞の樹立 ウンフェルリヒト・ルントボルグ病患者由来iPS細胞の樹立 ウンフェルリヒト・ルントボルグ病患者由来iPS細胞の樹立 臨床神経学, 52, 12, 1536-1536 臨床神経学, 52, 12, 1536-1536 臨床神経学, 52, 12, 1536-1536 2012/12 Japanese Disclose to all
Egawa N, Inoue H Egawa N, Inoue H Egawa N, Inoue H Generation motor neurons through patient-specific iPSCs with mutant TDP-43 Generation motor neurons through patient-specific iPSCs with mutant TDP-43 Generation motor neurons through patient-specific iPSCs with mutant TDP-43 Cold Spring Harbor Laboratory: Neurodegenerative Diseases, New York, USA. Cold Spring Harbor Laboratory: Neurodegenerative Diseases, New York, USA. Cold Spring Harbor Laboratory: Neurodegenerative Diseases, New York, USA. 2012/11/28 Disclose to all
Yahata N, Asai M, Iwata N, Inoue H Yahata N, Asai M, Iwata N, Inoue H Yahata N, Asai M, Iwata N, Inoue H Anti-Amyloid β drug validation using human iPS cell-derived neurons for the treatment of Alzheimer's disease Anti-Amyloid β drug validation using human iPS cell-derived neurons for the treatment of Alzheimer's disease Anti-Amyloid β drug validation using human iPS cell-derived neurons for the treatment of Alzheimer's disease The 42nd Annual Meeting of the Society for Neuroscience, New Orleans, USA. The 42nd Annual Meeting of the Society for Neuroscience, New Orleans, USA. The 42nd Annual Meeting of the Society for Neuroscience, New Orleans, USA. 2012/10/17 Disclose to all
Egawa N, Tsukita K, Takahashi K, Okita K, Yoshikawa K, Yamawaki S, Naitoh M, Suzuki S, Okamoto K, Takuma H, Tamaoka A, Nakahata T, Takahashi R, Yamanaka S, Inoue H Egawa N, Tsukita K, Takahashi K, Okita K, Yoshikawa K, Yamawaki S, Naitoh M, Suzuki S, Okamoto K, Takuma H, Tamaoka A, Nakahata T, Takahashi R, Yamanaka S, Inoue H Egawa N, Tsukita K, Takahashi K, Okita K, Yoshikawa K, Yamawaki S, Naitoh M, Suzuki S, Okamoto K, Takuma H, Tamaoka A, Nakahata T, Takahashi R, Yamanaka S, Inoue H Generation motor neurons through patient-specific iPSCs with mutant TDP-43 Generation motor neurons through patient-specific iPSCs with mutant TDP-43 Generation motor neurons through patient-specific iPSCs with mutant TDP-43 The 42nd Annual Meeting of the Society for Neuroscience, New Orleans, USA. The 42nd Annual Meeting of the Society for Neuroscience, New Orleans, USA. The 42nd Annual Meeting of the Society for Neuroscience, New Orleans, USA. 2012/10/15 Disclose to all
Murakami G, Inoue H, Tsukita K, Asai Y, Aiba K, Amagai Y, Shimogawa H, Uesugi M, Nakatsuji N, Takahashi R Murakami G, Inoue H, Tsukita K, Asai Y, Aiba K, Amagai Y, Shimogawa H, Uesugi M, Nakatsuji N, Takahashi R Murakami G, Inoue H, Tsukita K, Asai Y, Aiba K, Amagai Y, Shimogawa H, Uesugi M, Nakatsuji N, Takahashi R Chemical library screening identifies a small molecule that downregulates SOD1 transcription for drugs to treat amyotrophic lateral sclerosis Chemical library screening identifies a small molecule that downregulates SOD1 transcription for drugs to treat amyotrophic lateral sclerosis Chemical library screening identifies a small molecule that downregulates SOD1 transcription for drugs to treat amyotrophic lateral sclerosis The 35th Annual Meeting of the Japan Neuroscience Society, Nagoya, Japan. The 35th Annual Meeting of the Japan Neuroscience Society, Nagoya, Japan. The 35th Annual Meeting of the Japan Neuroscience Society, Nagoya, Japan. 2012/09/19 Disclose to all
Tashiro Y, Ito H, Inoue H, Yamazaki M, Abe M, Misawa H, Sakimura K, Takahashi R Tashiro Y, Ito H, Inoue H, Yamazaki M, Abe M, Misawa H, Sakimura K, Takahashi R Tashiro Y, Ito H, Inoue H, Yamazaki M, Abe M, Misawa H, Sakimura K, Takahashi R The analysis of 26S proteasome conditional knockout mice for the mechanisms of neurodegenerative diseases The analysis of 26S proteasome conditional knockout mice for the mechanisms of neurodegenerative diseases The analysis of 26S proteasome conditional knockout mice for the mechanisms of neurodegenerative diseases The 35th Annual Meeting of the Japan Neuroscience Society, Nagoya, Japan. The 35th Annual Meeting of the Japan Neuroscience Society, Nagoya, Japan. The 35th Annual Meeting of the Japan Neuroscience Society, Nagoya, Japan. 2012/09/19 Disclose to all
Kondo T, Kitaoka S, Tsukita K, Takahashi K, Okita K, Yoshikawa K, Yamawaki S, Naitoh Motoko, Suzuki S, Izumi Y, Kaji R, Takuma Hiroshi, Tamaoka Akira, Morita M, Nakano I, Kawata A, Nakahata T, Takahashi R, Yamanaka S, Inoue H Kondo T, Kitaoka S, Tsukita K, Takahashi K, Okita K, Yoshikawa K, Yamawaki S, Naitoh Motoko, Suzuki S, Izumi Y, Kaji R, Takuma Hiroshi, Tamaoka Akira, Morita M, Nakano I, Kawata A, Nakahata T, Takahashi R, Yamanaka S, Inoue H Kondo T, Kitaoka S, Tsukita K, Takahashi K, Okita K, Yoshikawa K, Yamawaki S, Naitoh Motoko, Suzuki S, Izumi Y, Kaji R, Takuma Hiroshi, Tamaoka Akira, Morita M, Nakano I, Kawata A, Nakahata T, Takahashi R, Yamanaka S, Inoue H Generation of disease-specific induced pluripotent stem cells from familial amyotrophic lateral sclerosis Generation of disease-specific induced pluripotent stem cells from familial amyotrophic lateral sclerosis Generation of disease-specific induced pluripotent stem cells from familial amyotrophic lateral sclerosis The 35th Annual Meeting of the Japan Neuroscience Society, Nagoya, Japan. The 35th Annual Meeting of the Japan Neuroscience Society, Nagoya, Japan. The 35th Annual Meeting of the Japan Neuroscience Society, Nagoya, Japan. 2012/09/19 Disclose to all
Yahata N, Asai M, Iwata N, Inoue H Yahata N, Asai M, Iwata N, Inoue H Yahata N, Asai M, Iwata N, Inoue H Anti-Aβ drug screening platform using human iPS cell-derived neurons for the treatment of Alzheimer's disease Anti-Aβ drug screening platform using human iPS cell-derived neurons for the treatment of Alzheimer's disease Anti-Aβ drug screening platform using human iPS cell-derived neurons for the treatment of Alzheimer's disease The 35th Annual Meeting of the Japan Neuroscience Society, Nagoya, Japan. The 35th Annual Meeting of the Japan Neuroscience Society, Nagoya, Japan. The 35th Annual Meeting of the Japan Neuroscience Society, Nagoya, Japan. 2012/09/18 Disclose to all
Kikuchi T, Morizane A, Doi D, Okita K, Inoue H, Takahashi J Kikuchi T, Morizane A, Doi D, Okita K, Inoue H, Takahashi J Kikuchi T, Morizane A, Doi D, Okita K, Inoue H, Takahashi J induced pluripotent stem cells derived from idiopathic parkinson's disease patients differentiate into midbrain dopaminergic neurons induced pluripotent stem cells derived from idiopathic parkinson's disease patients differentiate into midbrain dopaminergic neurons induced pluripotent stem cells derived from idiopathic parkinson's disease patients differentiate into midbrain dopaminergic neurons ISSCR 10th Annual Meeting, Yokohama, Japan. ISSCR 10th Annual Meeting, Yokohama, Japan. ISSCR 10th Annual Meeting, Yokohama, Japan. 2012/06/14 Disclose to all
Kitaoka S, Tsukita K, Takahashi K, Okita K, Yamada Y, Izumi Y, Kaji R, Nakahata T, Takahashi R, Yamanaka S, Inoue H Kitaoka S, Tsukita K, Takahashi K, Okita K, Yamada Y, Izumi Y, Kaji R, Nakahata T, Takahashi R, Yamanaka S, Inoue H Kitaoka S, Tsukita K, Takahashi K, Okita K, Yamada Y, Izumi Y, Kaji R, Nakahata T, Takahashi R, Yamanaka S, Inoue H Generation of patient-specific induced pluripotent stem cells carrying mutation in sod1 Generation of patient-specific induced pluripotent stem cells carrying mutation in sod1 Generation of patient-specific induced pluripotent stem cells carrying mutation in sod1 ISSCR 10th Annual Meeting, Yokohama, Japan. ISSCR 10th Annual Meeting, Yokohama, Japan. ISSCR 10th Annual Meeting, Yokohama, Japan. 2012/06/14 Disclose to all
Komatsu K, Inoue H, Yamashita H, Kondo T, Kitaoka S, Takahashi R Komatsu K, Inoue H, Yamashita H, Kondo T, Kitaoka S, Takahashi R Komatsu K, Inoue H, Yamashita H, Kondo T, Kitaoka S, Takahashi R Establishment of iPS cells from amyotrophic lateral sclerosis model mice and motor neuronal differentiation Establishment of iPS cells from amyotrophic lateral sclerosis model mice and motor neuronal differentiation Establishment of iPS cells from amyotrophic lateral sclerosis model mice and motor neuronal differentiation ISSCR 10th Annual Meeting, Yokohama, Japan. ISSCR 10th Annual Meeting, Yokohama, Japan. ISSCR 10th Annual Meeting, Yokohama, Japan. 2012/06/14 Disclose to all
Murakami G, Inoue H, Asai Y, Aiba K, Itoh H, Uesugi M, Nakatsuji N, Takahashi R Murakami G, Inoue H, Asai Y, Aiba K, Itoh H, Uesugi M, Nakatsuji N, Takahashi R Murakami G, Inoue H, Asai Y, Aiba K, Itoh H, Uesugi M, Nakatsuji N, Takahashi R Chemical library screening identifies a small molecule that downregulates SOD1 transcription for drugs to treat amyotrophic lateral sclerosis Chemical library screening identifies a small molecule that downregulates SOD1 transcription for drugs to treat amyotrophic lateral sclerosis Chemical library screening identifies a small molecule that downregulates SOD1 transcription for drugs to treat amyotrophic lateral sclerosis 13th Asian Oceanian Congress of Neurology, Melbourne, Australia. 13th Asian Oceanian Congress of Neurology, Melbourne, Australia. 13th Asian Oceanian Congress of Neurology, Melbourne, Australia. 2012/06/04 Disclose to all
村上学, 井上治久, 月田香代子, 伊藤秀文, 淺井康行, 天貝裕地, 饗庭一博, 下川浩輝, 上杉志成, 中辻憲夫, 高橋良輔 村上学, 井上治久, 月田香代子, 伊藤秀文, 淺井康行, 天貝裕地, 饗庭一博, 下川浩輝, 上杉志成, 中辻憲夫, 高橋良輔 村上学, 井上治久, 月田香代子, 伊藤秀文, 淺井康行, 天貝裕地, 饗庭一博, 下川浩輝, 上杉志成, 中辻憲夫, 高橋良輔 既存薬によるSOD1転写を標的とした筋萎縮性側索硬化症新規治療法の開発 既存薬によるSOD1転写を標的とした筋萎縮性側索硬化症新規治療法の開発 既存薬によるSOD1転写を標的とした筋萎縮性側索硬化症新規治療法の開発 53rd Annual Meeting of the Japanese Society of Neurology, Tokyo. 53rd Annual Meeting of the Japanese Society of Neurology, Tokyo. 53rd Annual Meeting of the Japanese Society of Neurology, Tokyo. 2012/05/25 Disclose to all
竹内啓喜, 井上治久, 樋口真人, 高雄啓三, 月田香代子, 唐津歓子, 岩本由美子, 宮川剛, 須原哲也, 高橋良輔 竹内啓喜, 井上治久, 樋口真人, 高雄啓三, 月田香代子, 唐津歓子, 岩本由美子, 宮川剛, 須原哲也, 高橋良輔 竹内啓喜, 井上治久, 樋口真人, 高雄啓三, 月田香代子, 唐津歓子, 岩本由美子, 宮川剛, 須原哲也, 高橋良輔 ヒトP301S変異タウトランスジェニックマウスの病初期におけるプレスパルス抑制 ヒトP301S変異タウトランスジェニックマウスの病初期におけるプレスパルス抑制 ヒトP301S変異タウトランスジェニックマウスの病初期におけるプレスパルス抑制 53rd Annual Meeting of the Japanese Society of Neurology, Tokyo. 53rd Annual Meeting of the Japanese Society of Neurology, Tokyo. 53rd Annual Meeting of the Japanese Society of Neurology, Tokyo. 2012/05/25 Disclose to all
小松研一, 井上治久, 山下博史, 近藤孝之, 高橋良輔 小松研一, 井上治久, 山下博史, 近藤孝之, 高橋良輔 小松研一, 井上治久, 山下博史, 近藤孝之, 高橋良輔 筋萎縮性側索硬化症モデルマウスiPS細胞の樹立および運動ニューロンへの分化 筋萎縮性側索硬化症モデルマウスiPS細胞の樹立および運動ニューロンへの分化 筋萎縮性側索硬化症モデルマウスiPS細胞の樹立および運動ニューロンへの分化 53rd Annual Meeting of the Japanese Society of Neurology, Tokyo. 53rd Annual Meeting of the Japanese Society of Neurology, Tokyo. 53rd Annual Meeting of the Japanese Society of Neurology, Tokyo. 2012/05/25 Disclose to all
近藤孝之, 池田昭夫, 松本理器, 池田仁, 井上有史, 高橋良輔, 井上治久 近藤孝之, 池田昭夫, 松本理器, 池田仁, 井上有史, 高橋良輔, 井上治久 近藤孝之, 池田昭夫, 松本理器, 池田仁, 井上有史, 高橋良輔, 井上治久 ウンフェルリヒト・ルントボルグ病患者由来iPS細胞の樹立 ウンフェルリヒト・ルントボルグ病患者由来iPS細胞の樹立 ウンフェルリヒト・ルントボルグ病患者由来iPS細胞の樹立 53rd Annual Meeting of the Japanese Society of Neurology, Tokyo. 53rd Annual Meeting of the Japanese Society of Neurology, Tokyo. 53rd Annual Meeting of the Japanese Society of Neurology, Tokyo. 2012/05/24 Disclose to all
田代善崇, 伊東秀文, 井上治久, 山崎真弥, 阿部学, 三澤日出巳, 崎村建司, 高橋良輔 田代善崇, 伊東秀文, 井上治久, 山崎真弥, 阿部学, 三澤日出巳, 崎村建司, 高橋良輔 田代善崇, 伊東秀文, 井上治久, 山崎真弥, 阿部学, 三澤日出巳, 崎村建司, 高橋良輔 脊髄運動神経特異的26Sプロテアソームサブユニット欠損マウスはALS的病理所見を伴う運動神経細胞死を呈する 脊髄運動神経特異的26Sプロテアソームサブユニット欠損マウスはALS的病理所見を伴う運動神経細胞死を呈する 脊髄運動神経特異的26Sプロテアソームサブユニット欠損マウスはALS的病理所見を伴う運動神経細胞死を呈する 53rd Annual Meeting of the Japanese Society of Neurology, Tokyo. 53rd Annual Meeting of the Japanese Society of Neurology, Tokyo. 53rd Annual Meeting of the Japanese Society of Neurology, Tokyo. 2012/05/23 Disclose to all
竹内啓喜, 井上治久, 樋口真人, 高雄啓三, 月田香代子, 唐津歓子, 岩本由美子, 宮川剛, 須原哲也, 高橋良輔 竹内啓喜, 井上治久, 樋口真人, 高雄啓三, 月田香代子, 唐津歓子, 岩本由美子, 宮川剛, 須原哲也, 高橋良輔 竹内啓喜, 井上治久, 樋口真人, 高雄啓三, 月田香代子, 唐津歓子, 岩本由美子, 宮川剛, 須原哲也, 高橋良輔 ヒトP301S変異タウトランスジェニックマウスの病初期におけるプレパルス抑制 ヒトP301S変異タウトランスジェニックマウスの病初期におけるプレパルス抑制 ヒトP301S変異タウトランスジェニックマウスの病初期におけるプレパルス抑制 53rd Annual Meeting of the Japanese Society of Neurology, Tokyo. Program・Abstract., 423 53rd Annual Meeting of the Japanese Society of Neurology, Tokyo. Program・Abstract., 423 53rd Annual Meeting of the Japanese Society of Neurology, Tokyo. Program・Abstract., 423 2012 Japanese Disclose to all
菊地哲広, 森実飛鳥, 土井大輔, 井上治久, 沖田圭介, 高橋淳 菊地哲広, 森実飛鳥, 土井大輔, 井上治久, 沖田圭介, 高橋淳 菊地哲広, 森実飛鳥, 土井大輔, 井上治久, 沖田圭介, 高橋淳 パーキンソン病患者由来iPSCからのドーパミン神経誘導 パーキンソン病患者由来iPSCからのドーパミン神経誘導 パーキンソン病患者由来iPSCからのドーパミン神経誘導 再生医療, 11, 255 再生医療, 11, 255 再生医療, 11, 255 2012 Japanese Disclose to all
Komatsu K, Inoue H, Kondo T, Kitaoka S, Takahashi R Komatsu K, Inoue H, Kondo T, Kitaoka S, Takahashi R Komatsu K, Inoue H, Kondo T, Kitaoka S, Takahashi R Establishment of iPS cells from amyotrophic lateral sclerosis model mice and motor neuronal differentiation Establishment of iPS cells from amyotrophic lateral sclerosis model mice and motor neuronal differentiation Establishment of iPS cells from amyotrophic lateral sclerosis model mice and motor neuronal differentiation The XXth World Congress of Neurology. Marrakesh, Morocco. The XXth World Congress of Neurology. Marrakesh, Morocco. The XXth World Congress of Neurology. Marrakesh, Morocco. 2011/11/16 Disclose to all
Tashiro Y, Ito H, Inoue H, Yamazaki M, Abe M, Misawa H, Sakimura K, Takahashi R Tashiro Y, Ito H, Inoue H, Yamazaki M, Abe M, Misawa H, Sakimura K, Takahashi R Tashiro Y, Ito H, Inoue H, Yamazaki M, Abe M, Misawa H, Sakimura K, Takahashi R The analysis of 26S proteasome conditional knockout mice for the mechanisms of neurodegenerative diseases The analysis of 26S proteasome conditional knockout mice for the mechanisms of neurodegenerative diseases The analysis of 26S proteasome conditional knockout mice for the mechanisms of neurodegenerative diseases The 34th Annual Meeting of the Japan Neuroscience Society, Yokohama, Japan. The 34th Annual Meeting of the Japan Neuroscience Society, Yokohama, Japan. The 34th Annual Meeting of the Japan Neuroscience Society, Yokohama, Japan. 2011/09/17 Disclose to all
Kitaoka S, Tsukita K, Takahashi K, Okita K, Kondo T, Yoshikawa K, Yamawaki S, Naitoh M, Suzuki S, Izumi Y, Kaji R, Takuma H, Tamaoka A, Morita M, Nakano I, Kawata A, Nakahata T, Takahashi R, Yamanaka S, Inoue H Kitaoka S, Tsukita K, Takahashi K, Okita K, Kondo T, Yoshikawa K, Yamawaki S, Naitoh M, Suzuki S, Izumi Y, Kaji R, Takuma H, Tamaoka A, Morita M, Nakano I, Kawata A, Nakahata T, Takahashi R, Yamanaka S, Inoue H Kitaoka S, Tsukita K, Takahashi K, Okita K, Kondo T, Yoshikawa K, Yamawaki S, Naitoh M, Suzuki S, Izumi Y, Kaji R, Takuma H, Tamaoka A, Morita M, Nakano I, Kawata A, Nakahata T, Takahashi R, Yamanaka S, Inoue H Induction of astrocyte differentiation from human induced pluripotent stem cells carrying mutant SOD1 Induction of astrocyte differentiation from human induced pluripotent stem cells carrying mutant SOD1 Induction of astrocyte differentiation from human induced pluripotent stem cells carrying mutant SOD1 The 34th Annual Meeting of the Japan Neuroscience Society, Yokohama, Japan. The 34th Annual Meeting of the Japan Neuroscience Society, Yokohama, Japan. The 34th Annual Meeting of the Japan Neuroscience Society, Yokohama, Japan. 2011/09/16 Disclose to all
Murakami G, Inoue H, Tsukita K, Asai Y, Amagai Y, Aiba K, Shimogawa H, Uesugi M, Nakatsuji N, Takahashi R Murakami G, Inoue H, Tsukita K, Asai Y, Amagai Y, Aiba K, Shimogawa H, Uesugi M, Nakatsuji N, Takahashi R Murakami G, Inoue H, Tsukita K, Asai Y, Amagai Y, Aiba K, Shimogawa H, Uesugi M, Nakatsuji N, Takahashi R Chemical library screening identifies a small molecule that downregulates SOD1 transcription for drugs to treat amyotrophic lateral sclerosis Chemical library screening identifies a small molecule that downregulates SOD1 transcription for drugs to treat amyotrophic lateral sclerosis Chemical library screening identifies a small molecule that downregulates SOD1 transcription for drugs to treat amyotrophic lateral sclerosis The 34th Annual Meeting of the Japan Neuroscience Society, Yokohama, Japan. The 34th Annual Meeting of the Japan Neuroscience Society, Yokohama, Japan. The 34th Annual Meeting of the Japan Neuroscience Society, Yokohama, Japan. 2011/09/15 Disclose to all
Yahata N, Tsukita K, Karatsu Y, Adachi F, Asaka I, Okita K, Izumi Y, Kaji R, Kawakatsu S, Asada T, Yamanaka S, Inoue H Yahata N, Tsukita K, Karatsu Y, Adachi F, Asaka I, Okita K, Izumi Y, Kaji R, Kawakatsu S, Asada T, Yamanaka S, Inoue H Yahata N, Tsukita K, Karatsu Y, Adachi F, Asaka I, Okita K, Izumi Y, Kaji R, Kawakatsu S, Asada T, Yamanaka S, Inoue H Generation of induced pluripotent stem cells from a familial Alzheimer's disease patient Generation of induced pluripotent stem cells from a familial Alzheimer's disease patient Generation of induced pluripotent stem cells from a familial Alzheimer's disease patient The 34th Annual Meeting of the Japan Neuroscience Society, Yokohama, Japan. The 34th Annual Meeting of the Japan Neuroscience Society, Yokohama, Japan. The 34th Annual Meeting of the Japan Neuroscience Society, Yokohama, Japan. 2011/09/15 Disclose to all
Komatsu K, Inoue H, Kondo T, Kitaoka S, Takahashi K, Yamanaka S, Takahashi R Komatsu K, Inoue H, Kondo T, Kitaoka S, Takahashi K, Yamanaka S, Takahashi R Komatsu K, Inoue H, Kondo T, Kitaoka S, Takahashi K, Yamanaka S, Takahashi R Establishment of iPS cells from amyotrophic lateral sclerosis model mice and motor neuronal differentiation Establishment of iPS cells from amyotrophic lateral sclerosis model mice and motor neuronal differentiation Establishment of iPS cells from amyotrophic lateral sclerosis model mice and motor neuronal differentiation The 34th Annual Meeting of the Japan Neuroscience Society, Yokohama, Japan. The 34th Annual Meeting of the Japan Neuroscience Society, Yokohama, Japan. The 34th Annual Meeting of the Japan Neuroscience Society, Yokohama, Japan. 2011/09/15 Disclose to all
Kondo T, Inoue H, Minakawa E, Koshiba Y, Washida K, Egawa N, Takahashi K, Nakahata T, Yamanaka S, Takahashi R Kondo T, Inoue H, Minakawa E, Koshiba Y, Washida K, Egawa N, Takahashi K, Nakahata T, Yamanaka S, Takahashi R Kondo T, Inoue H, Minakawa E, Koshiba Y, Washida K, Egawa N, Takahashi K, Nakahata T, Yamanaka S, Takahashi R Generation of disease-specific induced pluripotent stem cells from sporadic Parkinson's disease patients Generation of disease-specific induced pluripotent stem cells from sporadic Parkinson's disease patients Generation of disease-specific induced pluripotent stem cells from sporadic Parkinson's disease patients The 34th Annual Meeting of the Japan Neuroscience Society, Yokohama, Japan. The 34th Annual Meeting of the Japan Neuroscience Society, Yokohama, Japan. The 34th Annual Meeting of the Japan Neuroscience Society, Yokohama, Japan. 2011/09/15 Disclose to all
Yamakado H, Moriwaki Y, Yamasaki N, Kurisu J, Miyakawa T, Uemura K, Inoue H, Takahashi T Yamakado H, Moriwaki Y, Yamasaki N, Kurisu J, Miyakawa T, Uemura K, Inoue H, Takahashi T Yamakado H, Moriwaki Y, Yamasaki N, Kurisu J, Miyakawa T, Uemura K, Inoue H, Takahashi T Decreased anxiety-like behavior in alpha-synuclein BAC transgenic mice recapitulates early non-motor symptoms in Parkinson disease Decreased anxiety-like behavior in alpha-synuclein BAC transgenic mice recapitulates early non-motor symptoms in Parkinson disease Decreased anxiety-like behavior in alpha-synuclein BAC transgenic mice recapitulates early non-motor symptoms in Parkinson disease The 34th Annual Meeting of the Japan Neuroscience Society, Yokohama, Japan. The 34th Annual Meeting of the Japan Neuroscience Society, Yokohama, Japan. The 34th Annual Meeting of the Japan Neuroscience Society, Yokohama, Japan. 2011/09/15 Disclose to all
小松研一, 井上治久, 近藤孝之, 北岡志保, 一阪朋子, 高橋和利, 山中伸弥, 高橋良輔 小松研一, 井上治久, 近藤孝之, 北岡志保, 一阪朋子, 高橋和利, 山中伸弥, 高橋良輔 小松研一, 井上治久, 近藤孝之, 北岡志保, 一阪朋子, 高橋和利, 山中伸弥, 高橋良輔 筋萎縮性側索硬化症モデルマウスiPS細胞の樹立および運動ニューロンへの分化 筋萎縮性側索硬化症モデルマウスiPS細胞の樹立および運動ニューロンへの分化 筋萎縮性側索硬化症モデルマウスiPS細胞の樹立および運動ニューロンへの分化 52nd Annual Meeting of the Japanese Society of Neurology, Nagoya. 52nd Annual Meeting of the Japanese Society of Neurology, Nagoya. 52nd Annual Meeting of the Japanese Society of Neurology, Nagoya. 2011/05/19 Disclose to all
竹内啓喜, 井上治久, 赤池昭紀, 澤田秀幸, 下濱俊, 高橋良輔 竹内啓喜, 井上治久, 赤池昭紀, 澤田秀幸, 下濱俊, 高橋良輔 竹内啓喜, 井上治久, 赤池昭紀, 澤田秀幸, 下濱俊, 高橋良輔 小胞体ストレスに対するニコチンのドーパミン(DA)神経保護 小胞体ストレスに対するニコチンのドーパミン(DA)神経保護 小胞体ストレスに対するニコチンのドーパミン(DA)神経保護 52nd Annual Meeting of the Japanese Society of Neurology, Nagoya. 52nd Annual Meeting of the Japanese Society of Neurology, Nagoya. 52nd Annual Meeting of the Japanese Society of Neurology, Nagoya. 2011/05/19 Disclose to all
田代善崇, 伊東秀文, 井上治久, 山崎真弥, 阿部学, 三澤日出巳, 崎村建司, 高橋良輔 田代善崇, 伊東秀文, 井上治久, 山崎真弥, 阿部学, 三澤日出巳, 崎村建司, 高橋良輔 田代善崇, 伊東秀文, 井上治久, 山崎真弥, 阿部学, 三澤日出巳, 崎村建司, 高橋良輔 神経変性疾患モデル作製のための26Sプロテアソームコンディショナルノックアウト マウスの確立と解析 神経変性疾患モデル作製のための26Sプロテアソームコンディショナルノックアウト マウスの確立と解析 神経変性疾患モデル作製のための26Sプロテアソームコンディショナルノックアウト マウスの確立と解析 52nd Annual Meeting of the Japanese Society of Neurology, Nagoya. 52nd Annual Meeting of the Japanese Society of Neurology, Nagoya. 52nd Annual Meeting of the Japanese Society of Neurology, Nagoya. 2011/05/19 Disclose to all
村上学, 井上治久, 月田香代子, 淺井康行, 饗庭一博, 天貝裕地, 下川浩輝, 上杉志成, 中辻憲夫, 高橋良輔 村上学, 井上治久, 月田香代子, 淺井康行, 饗庭一博, 天貝裕地, 下川浩輝, 上杉志成, 中辻憲夫, 高橋良輔 村上学, 井上治久, 月田香代子, 淺井康行, 饗庭一博, 天貝裕地, 下川浩輝, 上杉志成, 中辻憲夫, 高橋良輔 転写を標的とした家族性筋萎縮性側索硬化症新規治療法の開発 転写を標的とした家族性筋萎縮性側索硬化症新規治療法の開発 転写を標的とした家族性筋萎縮性側索硬化症新規治療法の開発 52nd Annual Meeting of the Japanese Society of Neurology, Nagoya. 52nd Annual Meeting of the Japanese Society of Neurology, Nagoya. 52nd Annual Meeting of the Japanese Society of Neurology, Nagoya. 2011/05/19 Disclose to all
北岡志保, 井上治久, 月田香代子, 高橋和利, 近藤孝之, 吉川勝宇, 山脇聖子, 内藤素子, 鈴木茂彦, 伊東秀文, 和泉唯信, 梶 龍兒, 宅間浩, 玉岡晃, 森田光哉, 中野今治, 川田明広, 中畑龍俊, 高橋良輔, 山中伸弥 北岡志保, 井上治久, 月田香代子, 高橋和利, 近藤孝之, 吉川勝宇, 山脇聖子, 内藤素子, 鈴木茂彦, 伊東秀文, 和泉唯信, 梶 龍兒, 宅間浩, 玉岡晃, 森田光哉, 中野今治, 川田明広, 中畑龍俊, 高橋良輔, 山中伸弥 北岡志保, 井上治久, 月田香代子, 高橋和利, 近藤孝之, 吉川勝宇, 山脇聖子, 内藤素子, 鈴木茂彦, 伊東秀文, 和泉唯信, 梶 龍兒, 宅間浩, 玉岡晃, 森田光哉, 中野今治, 川田明広, 中畑龍俊, 高橋良輔, 山中伸弥 変異SOD1を有するALS患者由来iPS細胞の樹立とアストロサイトへの分化 変異SOD1を有するALS患者由来iPS細胞の樹立とアストロサイトへの分化 変異SOD1を有するALS患者由来iPS細胞の樹立とアストロサイトへの分化 52nd Annual Meeting of the Japanese Society of Neurology, Nagoya. 52nd Annual Meeting of the Japanese Society of Neurology, Nagoya. 52nd Annual Meeting of the Japanese Society of Neurology, Nagoya. 2011/05/19 Disclose to all
Komatsu K, Inoue H, Kondo T, Kitaoka S, Takahashi K, Yamanaka S, Takahashi R Komatsu K, Inoue H, Kondo T, Kitaoka S, Takahashi K, Yamanaka S, Takahashi R Komatsu K, Inoue H, Kondo T, Kitaoka S, Takahashi K, Yamanaka S, Takahashi R Establishment of iPS cells from amyotrophic lateral sclerosis model mice and motor neuronal differentiation Establishment of iPS cells from amyotrophic lateral sclerosis model mice and motor neuronal differentiation Establishment of iPS cells from amyotrophic lateral sclerosis model mice and motor neuronal differentiation Neuroscience Research, Volume 71, Supplement, e195-E197 Neuroscience Research, Volume 71, Supplement, e195-E197 Neuroscience Research, Volume 71, Supplement, e195-E197 2011 English Summary of the papers read (international conference) Disclose to all
Yahata N, Tsukita K, Karatsu Y, Adachi F, Asaka I, Okita K, Izumi Y, Kaji R, Kawakatsu S, Asada T, Yamanaka S, Inoue H Yahata N, Tsukita K, Karatsu Y, Adachi F, Asaka I, Okita K, Izumi Y, Kaji R, Kawakatsu S, Asada T, Yamanaka S, Inoue H Yahata N, Tsukita K, Karatsu Y, Adachi F, Asaka I, Okita K, Izumi Y, Kaji R, Kawakatsu S, Asada T, Yamanaka S, Inoue H Generation of induced pluripotent stem cells from a familial Alzheimer's disease patient Generation of induced pluripotent stem cells from a familial Alzheimer's disease patient Generation of induced pluripotent stem cells from a familial Alzheimer's disease patient Neuroscience Research, Volume 71, Supplement, e191 Neuroscience Research, Volume 71, Supplement, e191 Neuroscience Research, Volume 71, Supplement, e191 2011 Disclose to all
Yamakado H, Moriwaki Y, Yamasaki N, Kurisu J, Miyakawa T, Uemura K, Inoue H, Takahashi R Yamakado H, Moriwaki Y, Yamasaki N, Kurisu J, Miyakawa T, Uemura K, Inoue H, Takahashi R Yamakado H, Moriwaki Y, Yamasaki N, Kurisu J, Miyakawa T, Uemura K, Inoue H, Takahashi R Decreased anxiety-like behavior in alpha-synuclein BAC transgenic mice recapitulates early non-motor symptoms in Parkinson disease Decreased anxiety-like behavior in alpha-synuclein BAC transgenic mice recapitulates early non-motor symptoms in Parkinson disease Decreased anxiety-like behavior in alpha-synuclein BAC transgenic mice recapitulates early non-motor symptoms in Parkinson disease Neuroscience Research, Volume 71, Supplement, e189 Neuroscience Research, Volume 71, Supplement, e189 Neuroscience Research, Volume 71, Supplement, e189 2011 Disclose to all
Kondo T, Inoue H, Minakawa E, Koshiba Y, Washida K, Egawa N, Takahashi K, Nakahata T, Yamanaka S, Takahashi R Kondo T, Inoue H, Minakawa E, Koshiba Y, Washida K, Egawa N, Takahashi K, Nakahata T, Yamanaka S, Takahashi R Kondo T, Inoue H, Minakawa E, Koshiba Y, Washida K, Egawa N, Takahashi K, Nakahata T, Yamanaka S, Takahashi R Generation of disease-specific induced pluripotent stem cells from sporadic Parkinson's disease patients Generation of disease-specific induced pluripotent stem cells from sporadic Parkinson's disease patients Generation of disease-specific induced pluripotent stem cells from sporadic Parkinson's disease patients Neuroscience Research, Volume 71, Supplement, e186 Neuroscience Research, Volume 71, Supplement, e186 Neuroscience Research, Volume 71, Supplement, e186 2011 Disclose to all
Murakami G, Inoue H, Tsukita K, Amagai Y, Aiba K, Shimogawa H, Uesugi M, Nakatsuji N, Takahashi R Murakami G, Inoue H, Tsukita K, Amagai Y, Aiba K, Shimogawa H, Uesugi M, Nakatsuji N, Takahashi R Murakami G, Inoue H, Tsukita K, Amagai Y, Aiba K, Shimogawa H, Uesugi M, Nakatsuji N, Takahashi R Chemical Library Screening Identifies a Small Molecule That Downregulates SOD1 Transcription for Drugs to Treat Amyotrophic Lateral Sclerosis Chemical Library Screening Identifies a Small Molecule That Downregulates SOD1 Transcription for Drugs to Treat Amyotrophic Lateral Sclerosis Chemical Library Screening Identifies a Small Molecule That Downregulates SOD1 Transcription for Drugs to Treat Amyotrophic Lateral Sclerosis Neuroscience Research, Volume 71, Supplement, e55 Neuroscience Research, Volume 71, Supplement, e55 Neuroscience Research, Volume 71, Supplement, e55 2011 Disclose to all
Inoue H Inoue H Inoue H Neurodegenerative disease-specific induced pluripotent stem cell research Neurodegenerative disease-specific induced pluripotent stem cell research Neurodegenerative disease-specific induced pluripotent stem cell research Journal of Pharmacological Sciences, Volume 115, Supplement Journal of Pharmacological Sciences, Volume 115, Supplement Journal of Pharmacological Sciences, Volume 115, Supplement 2011 Disclose to all
田代 善崇, 伊東 秀文, 井上 治久, 山崎 真弥, 阿部 学, 三澤 日出巳, 崎村 建司, 高橋 良輔 田代 善崇, 伊東 秀文, 井上 治久, 山崎 真弥, 阿部 学, 三澤 日出巳, 崎村 建司, 高橋 良輔 田代 善崇, 伊東 秀文, 井上 治久, 山崎 真弥, 阿部 学, 三澤 日出巳, 崎村 建司, 高橋 良輔 神経変性疾患モデル作製のための26Sプロテアソームコンディショナルノックアウトマウスの確立と解析 神経変性疾患モデル作製のための26Sプロテアソームコンディショナルノックアウトマウスの確立と解析 神経変性疾患モデル作製のための26Sプロテアソームコンディショナルノックアウトマウスの確立と解析 , 51, 12, 1317 , 51, 12, 1317 , 51, 12, 1317 2011 Disclose to all
Kikuchi T, Morizane A, Okita K, Inoue H, Takahashi J Kikuchi T, Morizane A, Okita K, Inoue H, Takahashi J Kikuchi T, Morizane A, Okita K, Inoue H, Takahashi J Induced pluripotent stem cells derived from Parkinson's disease patient differentiated into midbrain dopaminergic neurons Induced pluripotent stem cells derived from Parkinson's disease patient differentiated into midbrain dopaminergic neurons Induced pluripotent stem cells derived from Parkinson's disease patient differentiated into midbrain dopaminergic neurons ISSCR 9th annual meeting ISSCR 9th annual meeting ISSCR 9th annual meeting 2011 English Disclose to all
Kitaoka S, Tsukita K, Takahashi K, Okita K, Kondo T, Yoshikawa K, Yamawaki S, Naitoh M, Suzuki S, Izumi Y, Kaji R, Takuma H, Tamaoka A, Morita M, Nakano I, Kawata A, Nakahata T, Takahashi R, Yamanaka S, Inoue H Kitaoka S, Tsukita K, Takahashi K, Okita K, Kondo T, Yoshikawa K, Yamawaki S, Naitoh M, Suzuki S, Izumi Y, Kaji R, Takuma H, Tamaoka A, Morita M, Nakano I, Kawata A, Nakahata T, Takahashi R, Yamanaka S, Inoue H Kitaoka S, Tsukita K, Takahashi K, Okita K, Kondo T, Yoshikawa K, Yamawaki S, Naitoh M, Suzuki S, Izumi Y, Kaji R, Takuma H, Tamaoka A, Morita M, Nakano I, Kawata A, Nakahata T, Takahashi R, Yamanaka S, Inoue H Induction of astrocyte differentiation from human induced pluripotent stem cells carrying mutant SOD1 Induction of astrocyte differentiation from human induced pluripotent stem cells carrying mutant SOD1 Induction of astrocyte differentiation from human induced pluripotent stem cells carrying mutant SOD1 Neuroscience Research, 71, E294-E294 Neuroscience Research, 71, E294-E294 Neuroscience Research, 71, E294-E294 2011 Disclose to all
Kondo T, Inoue H, Minakwa E, Koshiba Y, Washida K, Egawa N, Takahashi K, Nakahata T, Yamanaka S, Takahashi R Kondo T, Inoue H, Minakwa E, Koshiba Y, Washida K, Egawa N, Takahashi K, Nakahata T, Yamanaka S, Takahashi R Kondo T, Inoue H, Minakwa E, Koshiba Y, Washida K, Egawa N, Takahashi K, Nakahata T, Yamanaka S, Takahashi R Generation of disease-specific induced pluripotent stem cells from sporadic Parkinson's disease patients Generation of disease-specific induced pluripotent stem cells from sporadic Parkinson's disease patients Generation of disease-specific induced pluripotent stem cells from sporadic Parkinson's disease patients Neuroscience Research, 71, E191-E191 Neuroscience Research, 71, E191-E191 Neuroscience Research, 71, E191-E191 2011 Disclose to all
浅井 将, 八幡 直樹, 北岡 志保, 高橋 和利, 浅香 勲, 日置 寛之, 金子 武嗣, 丸山 敬, 西道 隆臣, 中畑 龍俊, 朝田 隆, 山中 伸弥, 岩田 修永, 井上 治久 浅井 将, 八幡 直樹, 北岡 志保, 高橋 和利, 浅香 勲, 日置 寛之, 金子 武嗣, 丸山 敬, 西道 隆臣, 中畑 龍俊, 朝田 隆, 山中 伸弥, 岩田 修永, 井上 治久 浅井 将, 八幡 直樹, 北岡 志保, 高橋 和利, 浅香 勲, 日置 寛之, 金子 武嗣, 丸山 敬, 西道 隆臣, 中畑 龍俊, 朝田 隆, 山中 伸弥, 岩田 修永, 井上 治久 iPS細胞由来神経細胞におけるAβ産生とセクレターゼ阻害剤に対する応答 iPS細胞由来神経細胞におけるAβ産生とセクレターゼ阻害剤に対する応答 iPS細胞由来神経細胞におけるAβ産生とセクレターゼ阻害剤に対する応答 Dementia Japan, 25, 3, 402-402 Dementia Japan, 25, 3, 402-402 Dementia Japan, 25, 3, 402-402 2011 Japanese Disclose to all
浅井 将, 八幡 直樹, 北岡 志保, 高橋 和利, 浅香 勲, 日置 寛之, 金子 武嗣, 丸山 敬, 西道 隆臣, 中畑 龍俊, 朝田 隆, 山中 伸弥, 岩田 修永, 井上 治久 浅井 将, 八幡 直樹, 北岡 志保, 高橋 和利, 浅香 勲, 日置 寛之, 金子 武嗣, 丸山 敬, 西道 隆臣, 中畑 龍俊, 朝田 隆, 山中 伸弥, 岩田 修永, 井上 治久 浅井 将, 八幡 直樹, 北岡 志保, 高橋 和利, 浅香 勲, 日置 寛之, 金子 武嗣, 丸山 敬, 西道 隆臣, 中畑 龍俊, 朝田 隆, 山中 伸弥, 岩田 修永, 井上 治久 iPS細胞由来神経細胞におけるAβ産生とセクレターゼ阻害剤に対する応答 iPS細胞由来神経細胞におけるAβ産生とセクレターゼ阻害剤に対する応答 iPS細胞由来神経細胞におけるAβ産生とセクレターゼ阻害剤に対する応答 The 84th Annual Meeting of the Japanese Biochemical Society., 2P-0602 The 84th Annual Meeting of the Japanese Biochemical Society., 2P-0602 The 84th Annual Meeting of the Japanese Biochemical Society., 2P-0602 2011 Japanese Disclose to all
北岡志保, 井上治久, 月田香代子, 高橋和利, 近藤孝之, 吉川勝宇, 山脇聖子, 内藤素子, 鈴木茂彦, 伊東秀文, 和泉唯信, 梶龍兒, 宅間浩, 玉岡晃, 森田光哉, 中野今治, 川田明広, 中畑龍俊, 高橋良輔, 山中伸弥 北岡志保, 井上治久, 月田香代子, 高橋和利, 近藤孝之, 吉川勝宇, 山脇聖子, 内藤素子, 鈴木茂彦, 伊東秀文, 和泉唯信, 梶龍兒, 宅間浩, 玉岡晃, 森田光哉, 中野今治, 川田明広, 中畑龍俊, 高橋良輔, 山中伸弥 北岡志保, 井上治久, 月田香代子, 高橋和利, 近藤孝之, 吉川勝宇, 山脇聖子, 内藤素子, 鈴木茂彦, 伊東秀文, 和泉唯信, 梶龍兒, 宅間浩, 玉岡晃, 森田光哉, 中野今治, 川田明広, 中畑龍俊, 高橋良輔, 山中伸弥 変異SOD1を有するALS患者由来iPS細胞の樹立とアストロサイトへの分化 変異SOD1を有するALS患者由来iPS細胞の樹立とアストロサイトへの分化 変異SOD1を有するALS患者由来iPS細胞の樹立とアストロサイトへの分化 52nd Annual Meeting of the Japanese Society of Neurology, Nagoya. Program・Abstract., 381 52nd Annual Meeting of the Japanese Society of Neurology, Nagoya. Program・Abstract., 381 52nd Annual Meeting of the Japanese Society of Neurology, Nagoya. Program・Abstract., 381 2011 Japanese Disclose to all
北岡 志保, 井上 治久, 月田 香代子, 高橋 和利, 近藤 孝之, 吉川 勝宇, 山脇 聖子, 内藤 素子, 鈴木 茂彦, 伊東 秀文, 和泉 唯信, 梶 龍兒, 宅間 浩, 玉岡 晃, 森田 光哉, 中野 今治, 川田 明広, 中畑 龍俊, 高橋 良輔, 山中 伸弥 北岡 志保, 井上 治久, 月田 香代子, 高橋 和利, 近藤 孝之, 吉川 勝宇, 山脇 聖子, 内藤 素子, 鈴木 茂彦, 伊東 秀文, 和泉 唯信, 梶 龍兒, 宅間 浩, 玉岡 晃, 森田 光哉, 中野 今治, 川田 明広, 中畑 龍俊, 高橋 良輔, 山中 伸弥 北岡 志保, 井上 治久, 月田 香代子, 高橋 和利, 近藤 孝之, 吉川 勝宇, 山脇 聖子, 内藤 素子, 鈴木 茂彦, 伊東 秀文, 和泉 唯信, 梶 龍兒, 宅間 浩, 玉岡 晃, 森田 光哉, 中野 今治, 川田 明広, 中畑 龍俊, 高橋 良輔, 山中 伸弥 変異SOD1を有するALS患者由来iPS細胞の樹立とアストロサイトへの分化 変異SOD1を有するALS患者由来iPS細胞の樹立とアストロサイトへの分化 変異SOD1を有するALS患者由来iPS細胞の樹立とアストロサイトへの分化 臨床神経学, 51, 12, 1316-1316 臨床神経学, 51, 12, 1316-1316 臨床神経学, 51, 12, 1316-1316 2011 Japanese Disclose to all
小松 研一, 井上 治久, 近藤 孝之, 北岡 志保, 一阪 朋子, 高橋 和利, 山中 伸弥, 高橋 良輔 小松 研一, 井上 治久, 近藤 孝之, 北岡 志保, 一阪 朋子, 高橋 和利, 山中 伸弥, 高橋 良輔 小松 研一, 井上 治久, 近藤 孝之, 北岡 志保, 一阪 朋子, 高橋 和利, 山中 伸弥, 高橋 良輔 筋萎縮性側索硬化症モデルマウスiPS細胞の樹立および運動ニューロンへの分化 筋萎縮性側索硬化症モデルマウスiPS細胞の樹立および運動ニューロンへの分化 筋萎縮性側索硬化症モデルマウスiPS細胞の樹立および運動ニューロンへの分化 臨床神経学, 51, 12 臨床神経学, 51, 12 臨床神経学, 51, 12 2011 Disclose to all
村上 学, 井上 治久, 月田 香代子, 淺井 康行, 饗庭 一博, 天貝 裕地, 下川 浩輝, 上杉 志成, 中辻 憲夫, 高橋 良輔 村上 学, 井上 治久, 月田 香代子, 淺井 康行, 饗庭 一博, 天貝 裕地, 下川 浩輝, 上杉 志成, 中辻 憲夫, 高橋 良輔 村上 学, 井上 治久, 月田 香代子, 淺井 康行, 饗庭 一博, 天貝 裕地, 下川 浩輝, 上杉 志成, 中辻 憲夫, 高橋 良輔 転写を標的とした家族性筋萎縮性側索硬化症新規治療法の開発 転写を標的とした家族性筋萎縮性側索硬化症新規治療法の開発 転写を標的とした家族性筋萎縮性側索硬化症新規治療法の開発 臨床神経学, 51, 12, 1317 臨床神経学, 51, 12, 1317 臨床神経学, 51, 12, 1317 2011 Disclose to all
近藤孝之, 高橋良輔, 井上治久 近藤孝之, 高橋良輔, 井上治久 近藤孝之, 高橋良輔, 井上治久 ALSの治療とケア〜再生医療とiPS細胞〜 ALSの治療とケア〜再生医療とiPS細胞〜 ALSの治療とケア〜再生医療とiPS細胞〜 Clinical Neuroscience, 29, 9, 1055-1057 Clinical Neuroscience, 29, 9, 1055-1057 Clinical Neuroscience, 29, 9, 1055-1057 2011 Japanese Disclose to all
Murakami G, Inoue H, Tsukita K, Asai Y, Amagai Y, Aiba K, Uesugi M, Nakatsuji N, Takahashi R Murakami G, Inoue H, Tsukita K, Asai Y, Amagai Y, Aiba K, Uesugi M, Nakatsuji N, Takahashi R Murakami G, Inoue H, Tsukita K, Asai Y, Amagai Y, Aiba K, Uesugi M, Nakatsuji N, Takahashi R Transcription-targeted drug discovery for SOD1-mediated ALS using high-throughput screening technique Transcription-targeted drug discovery for SOD1-mediated ALS using high-throughput screening technique Transcription-targeted drug discovery for SOD1-mediated ALS using high-throughput screening technique The 40th Annual Meeting of the Society for Neuroscience, San Diego, USA. The 40th Annual Meeting of the Society for Neuroscience, San Diego, USA. The 40th Annual Meeting of the Society for Neuroscience, San Diego, USA. 2010/11/17 Disclose to all
Kitaoka S, Inoue H, Tsukita K, Kawada M, Naitoh M, Takahashi K, Yoshikawa K, Kondo T, Yamawaki S, Watanabe D, Suzuki S, Takahashi R, Yamanaka S Kitaoka S, Inoue H, Tsukita K, Kawada M, Naitoh M, Takahashi K, Yoshikawa K, Kondo T, Yamawaki S, Watanabe D, Suzuki S, Takahashi R, Yamanaka S Kitaoka S, Inoue H, Tsukita K, Kawada M, Naitoh M, Takahashi K, Yoshikawa K, Kondo T, Yamawaki S, Watanabe D, Suzuki S, Takahashi R, Yamanaka S Analysis of motor neurons derived from induced pluripotent stem cells from ALS patients Analysis of motor neurons derived from induced pluripotent stem cells from ALS patients Analysis of motor neurons derived from induced pluripotent stem cells from ALS patients The 40th Annual Meeting of the Society for Neuroscience, San Diego, USA. The 40th Annual Meeting of the Society for Neuroscience, San Diego, USA. The 40th Annual Meeting of the Society for Neuroscience, San Diego, USA. 2010/11/17 Disclose to all
Yahata N, Inoue H, Kitaoka S, Tsukita K, Kondo T, Egawa N, Asaka I, Takahashi K, Nakahata T, Kawakatsu S, Takahashi R, Asada T, Yamanaka S Yahata N, Inoue H, Kitaoka S, Tsukita K, Kondo T, Egawa N, Asaka I, Takahashi K, Nakahata T, Kawakatsu S, Takahashi R, Asada T, Yamanaka S Yahata N, Inoue H, Kitaoka S, Tsukita K, Kondo T, Egawa N, Asaka I, Takahashi K, Nakahata T, Kawakatsu S, Takahashi R, Asada T, Yamanaka S Generation of disease-specific induced pluripotent stem cells from Alzheimer’s disease patients Generation of disease-specific induced pluripotent stem cells from Alzheimer’s disease patients Generation of disease-specific induced pluripotent stem cells from Alzheimer’s disease patients The 40th Annual Meeting of the Society for Neuroscience, San Diego, USA. The 40th Annual Meeting of the Society for Neuroscience, San Diego, USA. The 40th Annual Meeting of the Society for Neuroscience, San Diego, USA. 2010/11/14 Disclose to all
Mitsumori T, Furuyashiki T, Kitaoka S, Inoue H, Matsuoka T, Narumiya S Mitsumori T, Furuyashiki T, Kitaoka S, Inoue H, Matsuoka T, Narumiya S Mitsumori T, Furuyashiki T, Kitaoka S, Inoue H, Matsuoka T, Narumiya S Roles of thromboxane receptor in dopaminergic signaling in the striatum Roles of thromboxane receptor in dopaminergic signaling in the striatum Roles of thromboxane receptor in dopaminergic signaling in the striatum The 33rd Annual Meeting of the Japan Neuroscience Society, Kobe, Japan. The 33rd Annual Meeting of the Japan Neuroscience Society, Kobe, Japan. The 33rd Annual Meeting of the Japan Neuroscience Society, Kobe, Japan. 2010/09/03 Disclose to all
Kondo T, Inoue H, Egawa N, Yoshikawa K, Yamawaki S, Naitoh M, Suzuki S, Takahashi K, Hasegawa K, Nakahata T, Yamanaka S, Takahashi R Kondo T, Inoue H, Egawa N, Yoshikawa K, Yamawaki S, Naitoh M, Suzuki S, Takahashi K, Hasegawa K, Nakahata T, Yamanaka S, Takahashi R Kondo T, Inoue H, Egawa N, Yoshikawa K, Yamawaki S, Naitoh M, Suzuki S, Takahashi K, Hasegawa K, Nakahata T, Yamanaka S, Takahashi R Generation of disease-specific induced pluripotent stem cells from hereditary Parkinson’s disease Generation of disease-specific induced pluripotent stem cells from hereditary Parkinson’s disease Generation of disease-specific induced pluripotent stem cells from hereditary Parkinson’s disease The 33rd Annual Meeting of the Japan Neuroscience Society, Kobe, Japan. The 33rd Annual Meeting of the Japan Neuroscience Society, Kobe, Japan. The 33rd Annual Meeting of the Japan Neuroscience Society, Kobe, Japan. 2010/09/03 Disclose to all
Yahata N, Inoue H, Kitaoka S, Tsukita K, Kondo T, Naohiro E, Asaka I, Takahashi K, Nakahata T, Kawakatsu S, Takahashi R, Asada T, Yamanaka S Yahata N, Inoue H, Kitaoka S, Tsukita K, Kondo T, Naohiro E, Asaka I, Takahashi K, Nakahata T, Kawakatsu S, Takahashi R, Asada T, Yamanaka S Yahata N, Inoue H, Kitaoka S, Tsukita K, Kondo T, Naohiro E, Asaka I, Takahashi K, Nakahata T, Kawakatsu S, Takahashi R, Asada T, Yamanaka S Generation of disease-specific induced pluripotent stem cells from Alzheimer’s disease patients Generation of disease-specific induced pluripotent stem cells from Alzheimer’s disease patients Generation of disease-specific induced pluripotent stem cells from Alzheimer’s disease patients The 33rd Annual Meeting of the Japan Neuroscience Society, Kobe, Japan. The 33rd Annual Meeting of the Japan Neuroscience Society, Kobe, Japan. The 33rd Annual Meeting of the Japan Neuroscience Society, Kobe, Japan. 2010/09/03 Disclose to all
Takeuchi H, Inoue H, Higuchi M, Tsukita K, Trojanowski J, Lee V, Ji B, Takahashi R, Suhara T Takeuchi H, Inoue H, Higuchi M, Tsukita K, Trojanowski J, Lee V, Ji B, Takahashi R, Suhara T Takeuchi H, Inoue H, Higuchi M, Tsukita K, Trojanowski J, Lee V, Ji B, Takahashi R, Suhara T Development of therapies and monitoring against tauopathies with dementia Development of therapies and monitoring against tauopathies with dementia Development of therapies and monitoring against tauopathies with dementia The 33rd Annual Meeting of the Japan Neuroscience Society, Kobe, Japan. The 33rd Annual Meeting of the Japan Neuroscience Society, Kobe, Japan. The 33rd Annual Meeting of the Japan Neuroscience Society, Kobe, Japan. 2010/09/02 Disclose to all
Komatsu K, Inoue H, Kondo T, Kitaoka S, Ichisaka T, Takahashi K, Yamanaka S, Takahashi R Komatsu K, Inoue H, Kondo T, Kitaoka S, Ichisaka T, Takahashi K, Yamanaka S, Takahashi R Komatsu K, Inoue H, Kondo T, Kitaoka S, Ichisaka T, Takahashi K, Yamanaka S, Takahashi R Establishment of iPS cells from amyotrophic lateral sclerosis model mice Establishment of iPS cells from amyotrophic lateral sclerosis model mice Establishment of iPS cells from amyotrophic lateral sclerosis model mice The 33rd Annual Meeting of the Japan Neuroscience Society, Kobe, Japan. The 33rd Annual Meeting of the Japan Neuroscience Society, Kobe, Japan. The 33rd Annual Meeting of the Japan Neuroscience Society, Kobe, Japan. 2010/09/02 Disclose to all
Kitaoka S, Inoue H, Tsukita K, Kawada M, Naitoh M, Takahashi K, Yoshikawa K, Kondo T, Yamawaki S, Watanabe D, Suzuki S, Nakahata T, Takahashi R, Yamanaka S Kitaoka S, Inoue H, Tsukita K, Kawada M, Naitoh M, Takahashi K, Yoshikawa K, Kondo T, Yamawaki S, Watanabe D, Suzuki S, Nakahata T, Takahashi R, Yamanaka S Kitaoka S, Inoue H, Tsukita K, Kawada M, Naitoh M, Takahashi K, Yoshikawa K, Kondo T, Yamawaki S, Watanabe D, Suzuki S, Nakahata T, Takahashi R, Yamanaka S Differentiation of induced pluripotent stem cells from ALS patients generates motor neurons Differentiation of induced pluripotent stem cells from ALS patients generates motor neurons Differentiation of induced pluripotent stem cells from ALS patients generates motor neurons The 33rd Annual Meeting of the Japan Neuroscience Society, Kobe, Japan. The 33rd Annual Meeting of the Japan Neuroscience Society, Kobe, Japan. The 33rd Annual Meeting of the Japan Neuroscience Society, Kobe, Japan. 2010/09/02 Disclose to all
Baba S, Hua E, Nakamura K, Sears M, Inoue H, Conklin BR Baba S, Hua E, Nakamura K, Sears M, Inoue H, Conklin BR Baba S, Hua E, Nakamura K, Sears M, Inoue H, Conklin BR Functional Neuro Muscular Culture Derived From Human iPS Cells Functional Neuro Muscular Culture Derived From Human iPS Cells Functional Neuro Muscular Culture Derived From Human iPS Cells ISSCR 8th Annual Meeting, San Francisco, USA. ISSCR 8th Annual Meeting, San Francisco, USA. ISSCR 8th Annual Meeting, San Francisco, USA. 2010/06/16 Disclose to all
八幡直樹, 井上治久, 北岡志保, 月田香代子, 近藤孝之, 江川斉宏, 浅香勲, 高橋和利, 中畑龍俊, 川勝忍, 高橋良輔, 朝田隆, 山中伸弥 八幡直樹, 井上治久, 北岡志保, 月田香代子, 近藤孝之, 江川斉宏, 浅香勲, 高橋和利, 中畑龍俊, 川勝忍, 高橋良輔, 朝田隆, 山中伸弥 八幡直樹, 井上治久, 北岡志保, 月田香代子, 近藤孝之, 江川斉宏, 浅香勲, 高橋和利, 中畑龍俊, 川勝忍, 高橋良輔, 朝田隆, 山中伸弥 若年性アルツハイマー病患者由来iPS細胞の樹立・解析 若年性アルツハイマー病患者由来iPS細胞の樹立・解析 若年性アルツハイマー病患者由来iPS細胞の樹立・解析 51st Annual Meeting of the Japanese Society of Neurology, Tokyo. 51st Annual Meeting of the Japanese Society of Neurology, Tokyo. 51st Annual Meeting of the Japanese Society of Neurology, Tokyo. 2010/05/22 Disclose to all
北岡志保, 井上治久, 月田香代子, 川田三代, 高橋和利, 近藤孝之, 吉川勝宇, 山脇聖子, 内藤素子, 鈴木茂彦, 伊東秀文, 和泉唯信, 森田光哉, 中野今治, 川田明広, 中畑龍俊, 高橋良輔, 山中伸弥 北岡志保, 井上治久, 月田香代子, 川田三代, 高橋和利, 近藤孝之, 吉川勝宇, 山脇聖子, 内藤素子, 鈴木茂彦, 伊東秀文, 和泉唯信, 森田光哉, 中野今治, 川田明広, 中畑龍俊, 高橋良輔, 山中伸弥 北岡志保, 井上治久, 月田香代子, 川田三代, 高橋和利, 近藤孝之, 吉川勝宇, 山脇聖子, 内藤素子, 鈴木茂彦, 伊東秀文, 和泉唯信, 森田光哉, 中野今治, 川田明広, 中畑龍俊, 高橋良輔, 山中伸弥 変異SOD1を有するALS患者由来iPS細胞の樹立と脊髄運動ニューロンへの分化 変異SOD1を有するALS患者由来iPS細胞の樹立と脊髄運動ニューロンへの分化 変異SOD1を有するALS患者由来iPS細胞の樹立と脊髄運動ニューロンへの分化 51st Annual Meeting of the Japanese Society of Neurology, Tokyo. 51st Annual Meeting of the Japanese Society of Neurology, Tokyo. 51st Annual Meeting of the Japanese Society of Neurology, Tokyo. 2010/05/21 Disclose to all
江川斉宏, 井上治久, 近藤孝之, 吉川勝宇, 山脇聖子, 内藤素子, 鈴木茂彦, 高橋和利, 長谷川一子, 中畑龍俊, 山中伸弥, 高橋良輔 江川斉宏, 井上治久, 近藤孝之, 吉川勝宇, 山脇聖子, 内藤素子, 鈴木茂彦, 高橋和利, 長谷川一子, 中畑龍俊, 山中伸弥, 高橋良輔 江川斉宏, 井上治久, 近藤孝之, 吉川勝宇, 山脇聖子, 内藤素子, 鈴木茂彦, 高橋和利, 長谷川一子, 中畑龍俊, 山中伸弥, 高橋良輔 遺伝性パーキンソン病患者由来iPS細胞の樹立・解析 遺伝性パーキンソン病患者由来iPS細胞の樹立・解析 遺伝性パーキンソン病患者由来iPS細胞の樹立・解析 51st Annual Meeting of the Japanese Society of Neurology, Tokyo. 51st Annual Meeting of the Japanese Society of Neurology, Tokyo. 51st Annual Meeting of the Japanese Society of Neurology, Tokyo. 2010/05/20 Disclose to all
Mitsumori T, Furuyashiki T, Kitaoka S, Inoue H, Matsuoka T, Narumiya S Mitsumori T, Furuyashiki T, Kitaoka S, Inoue H, Matsuoka T, Narumiya S Mitsumori T, Furuyashiki T, Kitaoka S, Inoue H, Matsuoka T, Narumiya S Roles of thromboxane receptor in dopaminergic signaling in the striatum Roles of thromboxane receptor in dopaminergic signaling in the striatum Roles of thromboxane receptor in dopaminergic signaling in the striatum Neuroscience Research, Volume 68, Supplement 1, e235-190P Neuroscience Research, Volume 68, Supplement 1, e235-190P Neuroscience Research, Volume 68, Supplement 1, e235-190P 2010 English Summary of the papers read (international conference) Disclose to all
Egawa N, Yamamoto K, Inoue H, Nishi K, Mori K Egawa N, Yamamoto K, Inoue H, Nishi K, Mori K Egawa N, Yamamoto K, Inoue H, Nishi K, Mori K The endoplasmic reticulum stress sensor, ATF6α, protects against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced dopaminergic neuronal death in a p38 Mitogen-Activated Protein Kinase dependent manner The endoplasmic reticulum stress sensor, ATF6α, protects against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced dopaminergic neuronal death in a p38 Mitogen-Activated Protein Kinase dependent manner The endoplasmic reticulum stress sensor, ATF6α, protects against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced dopaminergic neuronal death in a p38 Mitogen-Activated Protein Kinase dependent manner Neuroscience Research, Volume 68, Supplement 1, e193-E193 Neuroscience Research, Volume 68, Supplement 1, e193-E193 Neuroscience Research, Volume 68, Supplement 1, e193-E193 2010 English Summary of the papers read (international conference) Disclose to all
Kondo T, Inoue H, Egawa N, Yoshikawa K, Yamawaki S, Naitoh M, Suzuki S, Takahashi K, Hasegawa K, Nakahata T, Yamanaka S, Takahashi R Kondo T, Inoue H, Egawa N, Yoshikawa K, Yamawaki S, Naitoh M, Suzuki S, Takahashi K, Hasegawa K, Nakahata T, Yamanaka S, Takahashi R Kondo T, Inoue H, Egawa N, Yoshikawa K, Yamawaki S, Naitoh M, Suzuki S, Takahashi K, Hasegawa K, Nakahata T, Yamanaka S, Takahashi R Generation of disease-specific induced pluripotent stem cells from hereditary Parkinson’s disease Generation of disease-specific induced pluripotent stem cells from hereditary Parkinson’s disease Generation of disease-specific induced pluripotent stem cells from hereditary Parkinson’s disease Neuroscience Research, Volume 68, Supplement 1, e306-E306 Neuroscience Research, Volume 68, Supplement 1, e306-E306 Neuroscience Research, Volume 68, Supplement 1, e306-E306 2010 English Summary of the papers read (international conference) Disclose to all
Kitaoka S, Inoue H, Tsukita T, Kawada M, Naitoh M, Takahashi K, Yoshikawa K, Kondo T, Yamawaki S, Watanabe D, Suzuki S, Nakahata T, Takahashi R, Yamanaka S Kitaoka S, Inoue H, Tsukita T, Kawada M, Naitoh M, Takahashi K, Yoshikawa K, Kondo T, Yamawaki S, Watanabe D, Suzuki S, Nakahata T, Takahashi R, Yamanaka S Kitaoka S, Inoue H, Tsukita T, Kawada M, Naitoh M, Takahashi K, Yoshikawa K, Kondo T, Yamawaki S, Watanabe D, Suzuki S, Nakahata T, Takahashi R, Yamanaka S Differentiation of induced pluripotent stem cells from ALS patients generates motor neurons Differentiation of induced pluripotent stem cells from ALS patients generates motor neurons Differentiation of induced pluripotent stem cells from ALS patients generates motor neurons Neuroscience Research, Volume 68, Supplement 1, e197 Neuroscience Research, Volume 68, Supplement 1, e197 Neuroscience Research, Volume 68, Supplement 1, e197 2010 Disclose to all
Murakami G, Inoue H, Tsukita K, Asai Y, Aiba K, Amagai Y, Uesugi M, Nakatsuji N, Takahashi R Murakami G, Inoue H, Tsukita K, Asai Y, Aiba K, Amagai Y, Uesugi M, Nakatsuji N, Takahashi R Murakami G, Inoue H, Tsukita K, Asai Y, Aiba K, Amagai Y, Uesugi M, Nakatsuji N, Takahashi R A high-throughput screening assay for drug discovery in SOD1-mediated ALS targeting the transcription of SOD1 A high-throughput screening assay for drug discovery in SOD1-mediated ALS targeting the transcription of SOD1 A high-throughput screening assay for drug discovery in SOD1-mediated ALS targeting the transcription of SOD1 Neuroscience Research, Volume 68, Supplement 1, e311-E311 Neuroscience Research, Volume 68, Supplement 1, e311-E311 Neuroscience Research, Volume 68, Supplement 1, e311-E311 2010 English Summary of the papers read (international conference) Disclose to all
Takeuchi H, Inoue H, Higuchi M, Tsukita K, John T, Virginia L, Ji B, Takahashi R, Suhara T Takeuchi H, Inoue H, Higuchi M, Tsukita K, John T, Virginia L, Ji B, Takahashi R, Suhara T Takeuchi H, Inoue H, Higuchi M, Tsukita K, John T, Virginia L, Ji B, Takahashi R, Suhara T Development of therapies and monitoring against tauopathies with dementia Development of therapies and monitoring against tauopathies with dementia Development of therapies and monitoring against tauopathies with dementia Neuroscience Research, Volume 68, Supplement 1, e67-E67 Neuroscience Research, Volume 68, Supplement 1, e67-E67 Neuroscience Research, Volume 68, Supplement 1, e67-E67 2010 English Summary of the papers read (international conference) Disclose to all
Tashiro Y, Inoue H, Yamazaki M, Abe M, Ito H, Misawa H, Sakimura K, Takahashi R Tashiro Y, Inoue H, Yamazaki M, Abe M, Ito H, Misawa H, Sakimura K, Takahashi R Tashiro Y, Inoue H, Yamazaki M, Abe M, Ito H, Misawa H, Sakimura K, Takahashi R The analysis of 26S proteasome conditional knockout mice for the mechanisms of neurodegenerative diseases The analysis of 26S proteasome conditional knockout mice for the mechanisms of neurodegenerative diseases The analysis of 26S proteasome conditional knockout mice for the mechanisms of neurodegenerative diseases Neuroscience Research, Volume 68, Supplement 1, e96-E96 Neuroscience Research, Volume 68, Supplement 1, e96-E96 Neuroscience Research, Volume 68, Supplement 1, e96-E96 2010 English Summary of the papers read (international conference) Disclose to all
Komatsu K, Inoue H, Kondo T, Kitaoka S, Ichisaka T, Takahashi K, Yamanaka S, Takahashi R Komatsu K, Inoue H, Kondo T, Kitaoka S, Ichisaka T, Takahashi K, Yamanaka S, Takahashi R Komatsu K, Inoue H, Kondo T, Kitaoka S, Ichisaka T, Takahashi K, Yamanaka S, Takahashi R Establishment of iPS cells from amyotrophic lateral sclerosis model mice Establishment of iPS cells from amyotrophic lateral sclerosis model mice Establishment of iPS cells from amyotrophic lateral sclerosis model mice Neuroscience Research, Volume 68, Supplement 1, e197-E197 Neuroscience Research, Volume 68, Supplement 1, e197-E197 Neuroscience Research, Volume 68, Supplement 1, e197-E197 2010 English Summary of the papers read (international conference) Disclose to all
YAHATA NAOKI, INOUE HARUHISA 八幡直樹, 井上治久 YAHATA NAOKI, INOUE HARUHISA 認知症最前線 2.疾患特異的iPS細胞を用いた神経変性疾患の研究 認知症最前線 2.疾患特異的iPS細胞を用いた神経変性疾患の研究 認知症最前線 2.疾患特異的iPS細胞を用いた神経変性疾患の研究 日本生物学的精神医学会誌, 21, 4, 257-260 日本生物学的精神医学会誌, 21, 4, 257-260 日本生物学的精神医学会誌, 21, 4, 257-260 2010 Japanese Disclose to all
T.Kondo, H.Inoue, N.Egawa, K.Yoshikawa, S.Yamawaki, M.Naitoh, S.Suzuki, K.Tkahashi, K.Hasegawa, T.Nakahata, S.Yamanaka, R.Takahashi T.Kondo, H.Inoue, N.Egawa, K.Yoshikawa, S.Yamawaki, M.Naitoh, S.Suzuki, K.Tkahashi, K.Hasegawa, T.Nakahata, S.Yamanaka, R.Takahashi T.Kondo, H.Inoue, N.Egawa, K.Yoshikawa, S.Yamawaki, M.Naitoh, S.Suzuki, K.Tkahashi, K.Hasegawa, T.Nakahata, S.Yamanaka, R.Takahashi Generation of disease-specific induced pluripotent stem cells from hereditary Parkinson's disease Generation of disease-specific induced pluripotent stem cells from hereditary Parkinson's disease Generation of disease-specific induced pluripotent stem cells from hereditary Parkinson's disease Neuroscience Research, 68, E306 Neuroscience Research, 68, E306 Neuroscience Research, 68, E306 2010 Disclose to all
S.Kitaoka, H.Inoue, K.Tsukita, M.Kawada, M.Naitoh, K.Takahashi, K.Yoshikawa, T.Kondo, S.Yamawaki, D.Watanabe, S.Suzuki, T.Nakahata, R.Takahashi, S.Yamanaka S.Kitaoka, H.Inoue, K.Tsukita, M.Kawada, M.Naitoh, K.Takahashi, K.Yoshikawa, T.Kondo, S.Yamawaki, D.Watanabe, S.Suzuki, T.Nakahata, R.Takahashi, S.Yamanaka S.Kitaoka, H.Inoue, K.Tsukita, M.Kawada, M.Naitoh, K.Takahashi, K.Yoshikawa, T.Kondo, S.Yamawaki, D.Watanabe, S.Suzuki, T.Nakahata, R.Takahashi, S.Yamanaka Differentiation of induced pluripotent stem cells from ALS patients generates motor neurons Differentiation of induced pluripotent stem cells from ALS patients generates motor neurons Differentiation of induced pluripotent stem cells from ALS patients generates motor neurons Neuroscience Research, 68, E197 Neuroscience Research, 68, E197 Neuroscience Research, 68, E197 2010 Disclose to all
八幡直樹, 井上治久, 北岡志保, 月田香代子, 近藤孝之, 江川斉宏, 浅香勲, 高橋和利, 中畑龍俊, 川勝忍, 高橋良輔, 朝日隆, 朝日隆, 山中伸弥 八幡直樹, 井上治久, 北岡志保, 月田香代子, 近藤孝之, 江川斉宏, 浅香勲, 高橋和利, 中畑龍俊, 川勝忍, 高橋良輔, 朝日隆, 朝日隆, 山中伸弥 八幡直樹, 井上治久, 北岡志保, 月田香代子, 近藤孝之, 江川斉宏, 浅香勲, 高橋和利, 中畑龍俊, 川勝忍, 高橋良輔, 朝日隆, 朝日隆, 山中伸弥 若年性アルツハイマー病患者由来iPS細胞の樹立・解析 若年性アルツハイマー病患者由来iPS細胞の樹立・解析 若年性アルツハイマー病患者由来iPS細胞の樹立・解析 51st Annual Meeting of the Japanese Society of Neurology, Tokyo. Program・Abstract., 330 51st Annual Meeting of the Japanese Society of Neurology, Tokyo. Program・Abstract., 330 51st Annual Meeting of the Japanese Society of Neurology, Tokyo. Program・Abstract., 330 2010 Japanese Disclose to all
江川斉宏, 井上治久, 近藤孝之, 吉川勝宇, 山脇聖子, 内藤素子, 鈴木茂彦, 高橋和利, 長谷川一子, 中畑龍俊, 山中伸弥, 高橋良輔 江川斉宏, 井上治久, 近藤孝之, 吉川勝宇, 山脇聖子, 内藤素子, 鈴木茂彦, 高橋和利, 長谷川一子, 中畑龍俊, 山中伸弥, 高橋良輔 江川斉宏, 井上治久, 近藤孝之, 吉川勝宇, 山脇聖子, 内藤素子, 鈴木茂彦, 高橋和利, 長谷川一子, 中畑龍俊, 山中伸弥, 高橋良輔 遺伝性パーキンソン病患者由来iPS細胞の樹立・解析 遺伝性パーキンソン病患者由来iPS細胞の樹立・解析 遺伝性パーキンソン病患者由来iPS細胞の樹立・解析 51st Annual Meeting of the Japanese Society of Neurology, Tokyo. Program・Abstract., 239 51st Annual Meeting of the Japanese Society of Neurology, Tokyo. Program・Abstract., 239 51st Annual Meeting of the Japanese Society of Neurology, Tokyo. Program・Abstract., 239 2010 Japanese Disclose to all
北岡志保, 井上治久, 月田香代子, 川田三代, 高橋和利, 近藤孝之, 吉川勝宇, 山脇聖子, 内藤素子, 鈴木茂彦, 伊東秀文, 和泉唯信, 森田光哉, 中野今治, 川田明広, 中畑龍俊, 高橋良輔, 山中伸弥 北岡志保, 井上治久, 月田香代子, 川田三代, 高橋和利, 近藤孝之, 吉川勝宇, 山脇聖子, 内藤素子, 鈴木茂彦, 伊東秀文, 和泉唯信, 森田光哉, 中野今治, 川田明広, 中畑龍俊, 高橋良輔, 山中伸弥 北岡志保, 井上治久, 月田香代子, 川田三代, 高橋和利, 近藤孝之, 吉川勝宇, 山脇聖子, 内藤素子, 鈴木茂彦, 伊東秀文, 和泉唯信, 森田光哉, 中野今治, 川田明広, 中畑龍俊, 高橋良輔, 山中伸弥 変異SOD1を有するALS患者由来iPS細胞の樹立と脊髄運動ニューロンへの分化 変異SOD1を有するALS患者由来iPS細胞の樹立と脊髄運動ニューロンへの分化 変異SOD1を有するALS患者由来iPS細胞の樹立と脊髄運動ニューロンへの分化 51st Annual Meeting of the Japanese Society of Neurology, Tokyo. Program・Abstract., 262 51st Annual Meeting of the Japanese Society of Neurology, Tokyo. Program・Abstract., 262 51st Annual Meeting of the Japanese Society of Neurology, Tokyo. Program・Abstract., 262 2010 Japanese Disclose to all
北岡 志保, 井上 治久, 月田 香代子, 川田 三代, 内藤 素子, 高橋 和利, 吉川 勝宇, 近藤 孝之, 山脇 聖子, 渡辺 大, 鈴木 茂彦, 中畑 龍俊, 高橋 良輔, 山中 伸弥 北岡 志保, 井上 治久, 月田 香代子, 川田 三代, 内藤 素子, 高橋 和利, 吉川 勝宇, 近藤 孝之, 山脇 聖子, 渡辺 大, 鈴木 茂彦, 中畑 龍俊, 高橋 良輔, 山中 伸弥 北岡 志保, 井上 治久, 月田 香代子, 川田 三代, 内藤 素子, 高橋 和利, 吉川 勝宇, 近藤 孝之, 山脇 聖子, 渡辺 大, 鈴木 茂彦, 中畑 龍俊, 高橋 良輔, 山中 伸弥 ALS患者由来iPS細胞から運動ニューロンへの分化(Differentiation of induced pluripotent stem cells from ALS patients generates motor neurons) ALS患者由来iPS細胞から運動ニューロンへの分化(Differentiation of induced pluripotent stem cells from ALS patients generates motor neurons) ALS患者由来iPS細胞から運動ニューロンへの分化(Differentiation of induced pluripotent stem cells from ALS patients generates motor neurons) 神経化学, 49, 2-3, 585-585 神経化学, 49, 2-3, 585-585 神経化学, 49, 2-3, 585-585 2010 English Disclose to all
八幡 直樹, 井上 治久, 北岡 志保, 月田 香代子, 近藤 孝之, 江川 斉宏, 浅香 勲, 高橋 和利, 中畑 龍俊, 川勝 忍, 高橋 良輔, 朝田 隆, 山中 伸弥 八幡 直樹, 井上 治久, 北岡 志保, 月田 香代子, 近藤 孝之, 江川 斉宏, 浅香 勲, 高橋 和利, 中畑 龍俊, 川勝 忍, 高橋 良輔, 朝田 隆, 山中 伸弥 八幡 直樹, 井上 治久, 北岡 志保, 月田 香代子, 近藤 孝之, 江川 斉宏, 浅香 勲, 高橋 和利, 中畑 龍俊, 川勝 忍, 高橋 良輔, 朝田 隆, 山中 伸弥 アルツハイマー病患者由来iPS細胞の樹立(Generation of disease-specific induced pluripotent stem cells from Alzheimer's disease patients) アルツハイマー病患者由来iPS細胞の樹立(Generation of disease-specific induced pluripotent stem cells from Alzheimer's disease patients) アルツハイマー病患者由来iPS細胞の樹立(Generation of disease-specific induced pluripotent stem cells from Alzheimer's disease patients) 神経化学, 49, 2-3, 667-667 神経化学, 49, 2-3, 667-667 神経化学, 49, 2-3, 667-667 2010 English Disclose to all
近藤 孝之, 井上 治久, 江川 斉宏, 吉川 勝宇, 山脇 聖子, 内藤 素子, 鈴木 茂彦, 高橋 和利, 長谷川 一子, 中畑 龍俊, 山中 伸弥, 高橋 良輔 近藤 孝之, 井上 治久, 江川 斉宏, 吉川 勝宇, 山脇 聖子, 内藤 素子, 鈴木 茂彦, 高橋 和利, 長谷川 一子, 中畑 龍俊, 山中 伸弥, 高橋 良輔 近藤 孝之, 井上 治久, 江川 斉宏, 吉川 勝宇, 山脇 聖子, 内藤 素子, 鈴木 茂彦, 高橋 和利, 長谷川 一子, 中畑 龍俊, 山中 伸弥, 高橋 良輔 遺伝性パーキンソン病患者由来iPS細胞の樹立(Generation of disease-specific induced pluripotent stem cells from hereditary Parkinson's disease) 遺伝性パーキンソン病患者由来iPS細胞の樹立(Generation of disease-specific induced pluripotent stem cells from hereditary Parkinson's disease) 遺伝性パーキンソン病患者由来iPS細胞の樹立(Generation of disease-specific induced pluripotent stem cells from hereditary Parkinson's disease) 神経化学, 49, 2-3, 668-668 神経化学, 49, 2-3, 668-668 神経化学, 49, 2-3, 668-668 2010 English Disclose to all
江川 斉宏, 井上 治久, 近藤 孝之, 吉川 勝宇, 山脇 聖子, 内藤 素子, 鈴木 茂彦, 高橋 和利, 長谷川 一子, 中畑 龍俊, 山中 伸弥, 高橋 良輔 江川 斉宏, 井上 治久, 近藤 孝之, 吉川 勝宇, 山脇 聖子, 内藤 素子, 鈴木 茂彦, 高橋 和利, 長谷川 一子, 中畑 龍俊, 山中 伸弥, 高橋 良輔 江川 斉宏, 井上 治久, 近藤 孝之, 吉川 勝宇, 山脇 聖子, 内藤 素子, 鈴木 茂彦, 高橋 和利, 長谷川 一子, 中畑 龍俊, 山中 伸弥, 高橋 良輔 遺伝性パーキンソン病患者由来iPS細胞の樹立・解析 遺伝性パーキンソン病患者由来iPS細胞の樹立・解析 遺伝性パーキンソン病患者由来iPS細胞の樹立・解析 臨床神経学, 50, 12, 1142-1142 臨床神経学, 50, 12, 1142-1142 臨床神経学, 50, 12, 1142-1142 2010 Japanese Disclose to all
北岡 志保, 井上 治久, 月田 香代子, 川田 三代, 高橋 和利, 近藤 孝之, 吉川 勝宇, 山脇 聖子, 内藤 素子, 鈴木 茂彦, 伊東 秀文, 和泉 唯信, 森田 光哉, 中野 今治, 川田 明広, 中畑 龍俊, 高橋 良輔, 山中 伸弥 北岡 志保, 井上 治久, 月田 香代子, 川田 三代, 高橋 和利, 近藤 孝之, 吉川 勝宇, 山脇 聖子, 内藤 素子, 鈴木 茂彦, 伊東 秀文, 和泉 唯信, 森田 光哉, 中野 今治, 川田 明広, 中畑 龍俊, 高橋 良輔, 山中 伸弥 北岡 志保, 井上 治久, 月田 香代子, 川田 三代, 高橋 和利, 近藤 孝之, 吉川 勝宇, 山脇 聖子, 内藤 素子, 鈴木 茂彦, 伊東 秀文, 和泉 唯信, 森田 光哉, 中野 今治, 川田 明広, 中畑 龍俊, 高橋 良輔, 山中 伸弥 変異SOD1を有するALS患者由来iPS細胞の樹立と脊髄運動ニューロンへの分化 変異SOD1を有するALS患者由来iPS細胞の樹立と脊髄運動ニューロンへの分化 変異SOD1を有するALS患者由来iPS細胞の樹立と脊髄運動ニューロンへの分化 臨床神経学, 50, 12, 1163-1163 臨床神経学, 50, 12, 1163-1163 臨床神経学, 50, 12, 1163-1163 2010 Japanese Disclose to all
八幡 直樹, 井上 治久, 北岡 志保, 月田 香代子, 近藤 孝之, 江川 斉宏, 浅香 勲, 高橋 和利, 中畑 龍俊, 川勝 忍, 高橋 良輔, 朝日 隆, 山中 伸弥 八幡 直樹, 井上 治久, 北岡 志保, 月田 香代子, 近藤 孝之, 江川 斉宏, 浅香 勲, 高橋 和利, 中畑 龍俊, 川勝 忍, 高橋 良輔, 朝日 隆, 山中 伸弥 八幡 直樹, 井上 治久, 北岡 志保, 月田 香代子, 近藤 孝之, 江川 斉宏, 浅香 勲, 高橋 和利, 中畑 龍俊, 川勝 忍, 高橋 良輔, 朝日 隆, 山中 伸弥 若年性アルツハイマー病患者由来iPS細胞の樹立・解析 若年性アルツハイマー病患者由来iPS細胞の樹立・解析 若年性アルツハイマー病患者由来iPS細胞の樹立・解析 臨床神経学, 50, 12, 1226-1226 臨床神経学, 50, 12, 1226-1226 臨床神経学, 50, 12, 1226-1226 2010 Japanese Disclose to all
山門 穂高, 森脇 康博, 山崎 信幸, 宮川 剛, 植村 健吾, 井上 治久, 高橋 良輔 山門 穂高, 森脇 康博, 山崎 信幸, 宮川 剛, 植村 健吾, 井上 治久, 高橋 良輔 山門 穂高, 森脇 康博, 山崎 信幸, 宮川 剛, 植村 健吾, 井上 治久, 高橋 良輔 PARK4マウスモデル PARK4マウスモデル PARK4マウスモデル 臨床神経学, 50, 12, 1185 臨床神経学, 50, 12, 1185 臨床神経学, 50, 12, 1185 2010 Disclose to all
Wada T, Aiba K, Tooi N, Inoue H, Takahashi R, Nakatsuji N Wada T, Aiba K, Tooi N, Inoue H, Takahashi R, Nakatsuji N Wada T, Aiba K, Tooi N, Inoue H, Takahashi R, Nakatsuji N Establishment of A Human Embryonic Stem Cell-Derived Familial ALS Model Establishment of A Human Embryonic Stem Cell-Derived Familial ALS Model Establishment of A Human Embryonic Stem Cell-Derived Familial ALS Model 20th International Symposium on ALS/MND, Berlin, Germany. 20th International Symposium on ALS/MND, Berlin, Germany. 20th International Symposium on ALS/MND, Berlin, Germany. 2009/12/09 Disclose to all
Takeuchi H, Inoue H, Higuchi M, Tsukita K, Ji B, Trojanowski JQ, Lee Virginia MY, Takahashi R, Suhara T Takeuchi H, Inoue H, Higuchi M, Tsukita K, Ji B, Trojanowski JQ, Lee Virginia MY, Takahashi R, Suhara T Takeuchi H, Inoue H, Higuchi M, Tsukita K, Ji B, Trojanowski JQ, Lee Virginia MY, Takahashi R, Suhara T Molecular neuroimaging diagnosis and immunization therapies against tauopathies. Molecular neuroimaging diagnosis and immunization therapies against tauopathies. Molecular neuroimaging diagnosis and immunization therapies against tauopathies. 7th Annual Congress of IDDST Shanghai, China. 7th Annual Congress of IDDST Shanghai, China. 7th Annual Congress of IDDST Shanghai, China. 2009/10/25 Disclose to all
Egawa N, Yamamoto K, Inoue H, Nishi K, Mori K, Takahashi R Egawa N, Yamamoto K, Inoue H, Nishi K, Mori K, Takahashi R Egawa N, Yamamoto K, Inoue H, Nishi K, Mori K, Takahashi R Endoplasimic reticulum stress sensor ATF6α plays a critical role in the protection from 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced dopaminergic neuronal death Endoplasimic reticulum stress sensor ATF6α plays a critical role in the protection from 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced dopaminergic neuronal death Endoplasimic reticulum stress sensor ATF6α plays a critical role in the protection from 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced dopaminergic neuronal death Neuroscience 2009, Chicago, USA. Neuroscience 2009, Chicago, USA. Neuroscience 2009, Chicago, USA. 2009/10/20 Disclose to all
Takeuchi H, Inoue H, Higuchi M, Tsukita K, Trojanowski JQ, Lee VM Y, Ji B, Takahashi1 R, Suhara T Takeuchi H, Inoue H, Higuchi M, Tsukita K, Trojanowski JQ, Lee VM Y, Ji B, Takahashi1 R, Suhara T Takeuchi H, Inoue H, Higuchi M, Tsukita K, Trojanowski JQ, Lee VM Y, Ji B, Takahashi1 R, Suhara T Development of therapies and monitoring for tauopathies with dementia Development of therapies and monitoring for tauopathies with dementia Development of therapies and monitoring for tauopathies with dementia Neuroscience 2009, Chicago, USA. Neuroscience 2009, Chicago, USA. Neuroscience 2009, Chicago, USA. 2009/10/18 Disclose to all
Tashiro Y, Inoue H, Yamazaki M, Abe M, Misawa H, Sakimura K, Takahashi R Tashiro Y, Inoue H, Yamazaki M, Abe M, Misawa H, Sakimura K, Takahashi R Tashiro Y, Inoue H, Yamazaki M, Abe M, Misawa H, Sakimura K, Takahashi R The analysis of 26S proteasome conditional knockout mice for motor neuron degenerative model The analysis of 26S proteasome conditional knockout mice for motor neuron degenerative model The analysis of 26S proteasome conditional knockout mice for motor neuron degenerative model Neuroscience 2009, Chicago, USA. Neuroscience 2009, Chicago, USA. Neuroscience 2009, Chicago, USA. 2009/10/18 Disclose to all
Tashiro Y, Inoue H, Yamazaki M, Abe M, Misawa H, Sakimura K, Takahashi R Tashiro Y, Inoue H, Yamazaki M, Abe M, Misawa H, Sakimura K, Takahashi R Tashiro Y, Inoue H, Yamazaki M, Abe M, Misawa H, Sakimura K, Takahashi R The establishment and analysis of 26S proteasome conditional knockout mice for exploring the mechanisms of neurodegenerative diseases The establishment and analysis of 26S proteasome conditional knockout mice for exploring the mechanisms of neurodegenerative diseases The establishment and analysis of 26S proteasome conditional knockout mice for exploring the mechanisms of neurodegenerative diseases The 32nd Annual Meeting of the Japan Neuroscience Society, Nagoya, Japan. The 32nd Annual Meeting of the Japan Neuroscience Society, Nagoya, Japan. The 32nd Annual Meeting of the Japan Neuroscience Society, Nagoya, Japan. 2009/09/18 Disclose to all
Yamada M, Kitamura N, Sahara N, Takashima A, Inoue H, Takahashi R, Mishina Y Yamada M, Kitamura N, Sahara N, Takashima A, Inoue H, Takahashi R, Mishina Y Yamada M, Kitamura N, Sahara N, Takashima A, Inoue H, Takahashi R, Mishina Y BMP signaling through BMPIRA regulate gliosis in the sub-acute phase. BMP signaling through BMPIRA regulate gliosis in the sub-acute phase. BMP signaling through BMPIRA regulate gliosis in the sub-acute phase. The 32nd Annual Meeting of the Japan Neuroscience Society, Nagoya, Japan. The 32nd Annual Meeting of the Japan Neuroscience Society, Nagoya, Japan. The 32nd Annual Meeting of the Japan Neuroscience Society, Nagoya, Japan. 2009/09/16 Disclose to all
Murakami G, Inoue H, Tsukita K, Asai Y, Aiba K, Amagai Y, Uesugi M, Nakatsuji N, Takahashi R Murakami G, Inoue H, Tsukita K, Asai Y, Aiba K, Amagai Y, Uesugi M, Nakatsuji N, Takahashi R Murakami G, Inoue H, Tsukita K, Asai Y, Aiba K, Amagai Y, Uesugi M, Nakatsuji N, Takahashi R Development of a high-throughput screening assay for drug discovery in SOD1-mediated ALS Development of a high-throughput screening assay for drug discovery in SOD1-mediated ALS Development of a high-throughput screening assay for drug discovery in SOD1-mediated ALS The 32nd Annual Meeting of the Japan Neuroscience Society, Nagoya. The 32nd Annual Meeting of the Japan Neuroscience Society, Nagoya. The 32nd Annual Meeting of the Japan Neuroscience Society, Nagoya. 2009/09/16 Disclose to all
Matsui H, Ito H, Taniguchi Y, Inoue H, Takeda S, Takahahsi R Matsui H, Ito H, Taniguchi Y, Inoue H, Takeda S, Takahahsi R Matsui H, Ito H, Taniguchi Y, Inoue H, Takeda S, Takahahsi R Various models for Parkinson’s disease using mutant medaka and toxin-treated medaka Various models for Parkinson’s disease using mutant medaka and toxin-treated medaka Various models for Parkinson’s disease using mutant medaka and toxin-treated medaka The 32nd Annual Meeting of the Japan Neuroscience Society, Nagoya. The 32nd Annual Meeting of the Japan Neuroscience Society, Nagoya. The 32nd Annual Meeting of the Japan Neuroscience Society, Nagoya. 2009/09/16 Disclose to all
Egawa N, Yamamoto K, Inoue H, Nishi K, Mori K, Takahashi R Egawa N, Yamamoto K, Inoue H, Nishi K, Mori K, Takahashi R Egawa N, Yamamoto K, Inoue H, Nishi K, Mori K, Takahashi R The role of ER stress sensor ATF6α in the pathogenesis of Parkinson's disease The role of ER stress sensor ATF6α in the pathogenesis of Parkinson's disease The role of ER stress sensor ATF6α in the pathogenesis of Parkinson's disease The 32nd Annual Meeting of the Japan Neuroscience Society, Nagoya. The 32nd Annual Meeting of the Japan Neuroscience Society, Nagoya. The 32nd Annual Meeting of the Japan Neuroscience Society, Nagoya. 2009/09/16 Disclose to all
Takeuchi H, Inoue H, Higuchi M, Tsukita K, Ji B, Trojanowski JQ, Lee Virginia MY, Takahashi R, Suhara T Takeuchi H, Inoue H, Higuchi M, Tsukita K, Ji B, Trojanowski JQ, Lee Virginia MY, Takahashi R, Suhara T Takeuchi H, Inoue H, Higuchi M, Tsukita K, Ji B, Trojanowski JQ, Lee Virginia MY, Takahashi R, Suhara T Immunization therapies toward tauopathies Immunization therapies toward tauopathies Immunization therapies toward tauopathies 2009 4th China Medical Biotech Forum, Dailan, China. 2009 4th China Medical Biotech Forum, Dailan, China. 2009 4th China Medical Biotech Forum, Dailan, China. 2009/08/09 Disclose to all
高野真, 井上治久, 辻輝之, 大川克也, 川田明広, 高橋良輔 高野真, 井上治久, 辻輝之, 大川克也, 川田明広, 高橋良輔 高野真, 井上治久, 辻輝之, 大川克也, 川田明広, 高橋良輔 筋萎縮性側索硬化症坐骨神経のプロテオーム解析 筋萎縮性側索硬化症坐骨神経のプロテオーム解析 筋萎縮性側索硬化症坐骨神経のプロテオーム解析 50th Annual Meeting of the Japanese Society of Neurology, Sendai. 50th Annual Meeting of the Japanese Society of Neurology, Sendai. 50th Annual Meeting of the Japanese Society of Neurology, Sendai. 2009/05/20 Disclose to all
松井秀彰, 谷口善仁, 小林芳人, 井上治久, 武田俊一, 高橋良輔 松井秀彰, 谷口善仁, 小林芳人, 井上治久, 武田俊一, 高橋良輔 松井秀彰, 谷口善仁, 小林芳人, 井上治久, 武田俊一, 高橋良輔 Parkin 変異メダカとATP13A2変異メダカの解析 Parkin 変異メダカとATP13A2変異メダカの解析 Parkin 変異メダカとATP13A2変異メダカの解析 50th Annual Meeting of the Japanese Society of Neurology, Sendai. 50th Annual Meeting of the Japanese Society of Neurology, Sendai. 50th Annual Meeting of the Japanese Society of Neurology, Sendai. 2009/05/20 Disclose to all
Yamada M, Kitamura N, Sahara N, Takashima A, Inoue H, Takahashi R, Mishina Y Yamada M, Kitamura N, Sahara N, Takashima A, Inoue H, Takahashi R, Mishina Y Yamada M, Kitamura N, Sahara N, Takashima A, Inoue H, Takahashi R, Mishina Y BMP signaling through BMPIRA regulate gliosis in the sub-acute phase BMP signaling through BMPIRA regulate gliosis in the sub-acute phase BMP signaling through BMPIRA regulate gliosis in the sub-acute phase Neuroscience Research, Volume 65, Supplement 1, S101 Neuroscience Research, Volume 65, Supplement 1, S101 Neuroscience Research, Volume 65, Supplement 1, S101 2009 Disclose to all
Egawa N, Yamamoto K, Inoue H, Nishi K, Mori K, Takahashi R Egawa N, Yamamoto K, Inoue H, Nishi K, Mori K, Takahashi R Egawa N, Yamamoto K, Inoue H, Nishi K, Mori K, Takahashi R The role of ER stress sensor ATF6α in the pathogenesis of Parkinson's disease The role of ER stress sensor ATF6α in the pathogenesis of Parkinson's disease The role of ER stress sensor ATF6α in the pathogenesis of Parkinson's disease Neuroscience Research, Volume 65, Supplement 1, S118 Neuroscience Research, Volume 65, Supplement 1, S118 Neuroscience Research, Volume 65, Supplement 1, S118 2009 Disclose to all
Matsui H, Taniguchi Y, Inoue H, Takeda S, Takahashi R Matsui H, Taniguchi Y, Inoue H, Takeda S, Takahashi R Matsui H, Taniguchi Y, Inoue H, Takeda S, Takahashi R Various models for Parkinson's disease using mutant medaka and toxin-treated medaka Various models for Parkinson's disease using mutant medaka and toxin-treated medaka Various models for Parkinson's disease using mutant medaka and toxin-treated medaka Neuroscience Research, Volume 65, Supplement 1, S118-S119 Neuroscience Research, Volume 65, Supplement 1, S118-S119 Neuroscience Research, Volume 65, Supplement 1, S118-S119 2009 Disclose to all
Tashiro Y, Inoue H, Yamazaki M, Abe M, Misawa H, Sakimura K, Takahashi R Tashiro Y, Inoue H, Yamazaki M, Abe M, Misawa H, Sakimura K, Takahashi R Tashiro Y, Inoue H, Yamazaki M, Abe M, Misawa H, Sakimura K, Takahashi R The establishment and analysis of 26S proteasome conditional knockout mice for the mechanisms of neurodegenerative diseases The establishment and analysis of 26S proteasome conditional knockout mice for the mechanisms of neurodegenerative diseases The establishment and analysis of 26S proteasome conditional knockout mice for the mechanisms of neurodegenerative diseases Neuroscience Research, Volume 65, Supplement 1, S248-E96 Neuroscience Research, Volume 65, Supplement 1, S248-E96 Neuroscience Research, Volume 65, Supplement 1, S248-E96 2009 English Summary of the papers read (international conference) Disclose to all
Takeuchi H, Inoue H, Akaike A, Sawada H, Shimohama S, Takahashi R Takeuchi H, Inoue H, Akaike A, Sawada H, Shimohama S, Takahashi R Takeuchi H, Inoue H, Akaike A, Sawada H, Shimohama S, Takahashi R Neuroprotective effects of nicotic receptor stimulation by ER stress and autophagy regulation Neuroprotective effects of nicotic receptor stimulation by ER stress and autophagy regulation Neuroprotective effects of nicotic receptor stimulation by ER stress and autophagy regulation Neuroscience Research, Volume 65, Supplement 1, S118 Neuroscience Research, Volume 65, Supplement 1, S118 Neuroscience Research, Volume 65, Supplement 1, S118 2009 Disclose to all
Murakami G, Inoue H, Tsukita K, Asai Y, Aiba K, Amagai Y, Uesugi M, Nakatsuji N, Takahashi R Murakami G, Inoue H, Tsukita K, Asai Y, Aiba K, Amagai Y, Uesugi M, Nakatsuji N, Takahashi R Murakami G, Inoue H, Tsukita K, Asai Y, Aiba K, Amagai Y, Uesugi M, Nakatsuji N, Takahashi R Development of a high-throughput screening assay for drug discovery in SOD1-mediated ALS. Neuroscience Research Development of a high-throughput screening assay for drug discovery in SOD1-mediated ALS. Neuroscience Research Development of a high-throughput screening assay for drug discovery in SOD1-mediated ALS. Neuroscience Research Neuroscience Research, Volume 65, Supplement 1, S120 Neuroscience Research, Volume 65, Supplement 1, S120 Neuroscience Research, Volume 65, Supplement 1, S120 2009 Disclose to all
Inoue H, Kitaoka S, Naitoh M, Takahashi K, Yoshikawa K, Yamawaki S, Suzuki S, Nakahata T, Takahashi R, Yamanaka S Inoue H, Kitaoka S, Naitoh M, Takahashi K, Yoshikawa K, Yamawaki S, Suzuki S, Nakahata T, Takahashi R, Yamanaka S Inoue H, Kitaoka S, Naitoh M, Takahashi K, Yoshikawa K, Yamawaki S, Suzuki S, Nakahata T, Takahashi R, Yamanaka S Neurodegenerative disease-specific induced pluripotent Stem cells research Neurodegenerative disease-specific induced pluripotent Stem cells research Neurodegenerative disease-specific induced pluripotent Stem cells research Neuroscience Research, Volume 65, Supplement 1, S10 Neuroscience Research, Volume 65, Supplement 1, S10 Neuroscience Research, Volume 65, Supplement 1, S10 2009 Disclose to all
橋田徳康、伊藤重雄、長谷川利英、梶田鉄平、森藤寛子、山崎裕子、坂上憲史、横谷繁郎、田中健寛、遠藤文司、江川斉宏、井上治久、冨本秀和、高橋良輔 橋田徳康、伊藤重雄、長谷川利英、梶田鉄平、森藤寛子、山崎裕子、坂上憲史、横谷繁郎、田中健寛、遠藤文司、江川斉宏、井上治久、冨本秀和、高橋良輔 橋田徳康、伊藤重雄、長谷川利英、梶田鉄平、森藤寛子、山崎裕子、坂上憲史、横谷繁郎、田中健寛、遠藤文司、江川斉宏、井上治久、冨本秀和、高橋良輔 視神経炎様症状を呈した遺伝性血管性白質脳症(CARASIL)の1例 視神経炎様症状を呈した遺伝性血管性白質脳症(CARASIL)の1例 視神経炎様症状を呈した遺伝性血管性白質脳症(CARASIL)の1例 日本眼科学会雑誌, 113, 4, 505-512 日本眼科学会雑誌, 113, 4, 505-512 日本眼科学会雑誌, 113, 4, 505-512 2009 Disclose to all
松井秀彰, 谷口善仁, 井上治久, 竹内秀明, 植村健吾, 武田俊一, 高橋良輔 松井秀彰, 谷口善仁, 井上治久, 竹内秀明, 植村健吾, 武田俊一, 高橋良輔 松井秀彰, 谷口善仁, 井上治久, 竹内秀明, 植村健吾, 武田俊一, 高橋良輔 『メダカを利用したパーキンソン病研究』 『メダカを利用したパーキンソン病研究』 『メダカを利用したパーキンソン病研究』 脳21, 12, 3, 379 脳21, 12, 3, 379 脳21, 12, 3, 379 2009 Japanese Disclose to all
高橋 良輔, Shen Jie, 井上 治久 高橋 良輔, Shen Jie, 井上 治久 高橋 良輔, Shen Jie, 井上 治久 Round Table Discussion 座談会 パーキンソン病基礎研究の進歩と展望 Round Table Discussion 座談会 パーキンソン病基礎研究の進歩と展望 Round Table Discussion 座談会 パーキンソン病基礎研究の進歩と展望 Frontiers in Parkinson disease, 2, 1, 5-14 Frontiers in Parkinson disease, 2, 1, 5-14 Frontiers in Parkinson disease, 2, 1, 5-14 2009 Japanese Disclose to all
江川 斉宏, 山本 敬祐, 井上 治久, 植村 健吾, 小川 智, 西 克典, 森 和俊, 高橋 良輔 江川 斉宏, 山本 敬祐, 井上 治久, 植村 健吾, 小川 智, 西 克典, 森 和俊, 高橋 良輔 江川 斉宏, 山本 敬祐, 井上 治久, 植村 健吾, 小川 智, 西 克典, 森 和俊, 高橋 良輔 パーキンソン病における小胞体ストレスセンサーATF6αの機能 パーキンソン病における小胞体ストレスセンサーATF6αの機能 パーキンソン病における小胞体ストレスセンサーATF6αの機能 臨床神経学, 49, 12, 1074 臨床神経学, 49, 12, 1074 臨床神経学, 49, 12, 1074 2009 Disclose to all
松井 秀彰, 谷口 善仁, 井上 治久, 小林 芳人, 植村 健吾, 竹内 秀明, 武田 俊一, 高橋 良輔 松井 秀彰, 谷口 善仁, 井上 治久, 小林 芳人, 植村 健吾, 竹内 秀明, 武田 俊一, 高橋 良輔 松井 秀彰, 谷口 善仁, 井上 治久, 小林 芳人, 植村 健吾, 竹内 秀明, 武田 俊一, 高橋 良輔 Parkin変異メダカとATP13A2変異メダカの解析 Parkin変異メダカとATP13A2変異メダカの解析 Parkin変異メダカとATP13A2変異メダカの解析 臨床神経学, 49, 12, 1005 臨床神経学, 49, 12, 1005 臨床神経学, 49, 12, 1005 2009 Disclose to all
村上 学, 井上治久, 高橋良輔 村上 学, 井上治久, 高橋良輔 村上 学, 井上治久, 高橋良輔 筋萎縮性側索硬化症(ALS)の治療戦略 筋萎縮性側索硬化症(ALS)の治療戦略 筋萎縮性側索硬化症(ALS)の治療戦略 ファルマシア, 45, 1009-1112 ファルマシア, 45, 1009-1112 ファルマシア, 45, 1009-1112 2009 Japanese Disclose to all
井上治久, 高橋良輔, Ling Lin, Sha Mi, Ole Isacson 井上治久, 高橋良輔, Ling Lin, Sha Mi, Ole Isacson 井上治久, 高橋良輔, Ling Lin, Sha Mi, Ole Isacson パーキンソン病における中脳ドーパミン作動性神経機能障害治療標的としての軸索再生 パーキンソン病における中脳ドーパミン作動性神経機能障害治療標的としての軸索再生 パーキンソン病における中脳ドーパミン作動性神経機能障害治療標的としての軸索再生 第6回神経科学研究会, 東京. 第6回神経科学研究会, 東京. 第6回神経科学研究会, 東京. 2008/09/20 Disclose to all
Murakami G, Inoue H, Tsukita K, Asai Y, Aiba K, Amagai Y, Uesugi M, Nakatsuji N, Takahashi R Murakami G, Inoue H, Tsukita K, Asai Y, Aiba K, Amagai Y, Uesugi M, Nakatsuji N, Takahashi R Murakami G, Inoue H, Tsukita K, Asai Y, Aiba K, Amagai Y, Uesugi M, Nakatsuji N, Takahashi R Development of a high-throughput screening assay for drug discovery in SOD1-mediated ALS Development of a high-throughput screening assay for drug discovery in SOD1-mediated ALS Development of a high-throughput screening assay for drug discovery in SOD1-mediated ALS The 31st Annual Meeting of the Japan Neuroscience Society, Tokyo, Japan. The 31st Annual Meeting of the Japan Neuroscience Society, Tokyo, Japan. The 31st Annual Meeting of the Japan Neuroscience Society, Tokyo, Japan. 2008/07/11 Disclose to all
Matsui H, Taniguchi Y, Takeuchi H, Kobayashi Y, Inoue H, Uemura K, Takeda S, Takahahsi R Matsui H, Taniguchi Y, Takeuchi H, Kobayashi Y, Inoue H, Uemura K, Takeda S, Takahahsi R Matsui H, Taniguchi Y, Takeuchi H, Kobayashi Y, Inoue H, Uemura K, Takeda S, Takahahsi R Features of PINK1 KO medaka Features of PINK1 KO medaka Features of PINK1 KO medaka The 31st Annual Meeting of the Japan Neuroscience Society, Tokyo, Japan. The 31st Annual Meeting of the Japan Neuroscience Society, Tokyo, Japan. The 31st Annual Meeting of the Japan Neuroscience Society, Tokyo, Japan. 2008/07/10 Disclose to all
井上治久, 村上学, 月田香代子, 淺井康行, 饗庭一博, 天貝裕地, 上杉志成, 中辻憲夫, 高橋良輔 井上治久, 村上学, 月田香代子, 淺井康行, 饗庭一博, 天貝裕地, 上杉志成, 中辻憲夫, 高橋良輔 井上治久, 村上学, 月田香代子, 淺井康行, 饗庭一博, 天貝裕地, 上杉志成, 中辻憲夫, 高橋良輔 家族性筋萎縮性側索硬化症治療標的分子の標的細胞における発現モニタリングシステムの確立 家族性筋萎縮性側索硬化症治療標的分子の標的細胞における発現モニタリングシステムの確立 家族性筋萎縮性側索硬化症治療標的分子の標的細胞における発現モニタリングシステムの確立 The 26th Annual Meeting of Japanese Society of Neurological Therapeutics, Yokohama. The 26th Annual Meeting of Japanese Society of Neurological Therapeutics, Yokohama. The 26th Annual Meeting of Japanese Society of Neurological Therapeutics, Yokohama. 2008/06/26 Disclose to all
Inoue H, Takahashi R, Lin L, Mi S, Isacson O Inoue H, Takahashi R, Lin L, Mi S, Isacson O Inoue H, Takahashi R, Lin L, Mi S, Isacson O Blocking of LINGO-1 activity using LINGO-1-Fc decoy protein enhances survival of dopaminergic neurons in Parkinson’s disease models Blocking of LINGO-1 activity using LINGO-1-Fc decoy protein enhances survival of dopaminergic neurons in Parkinson’s disease models Blocking of LINGO-1 activity using LINGO-1-Fc decoy protein enhances survival of dopaminergic neurons in Parkinson’s disease models The 14th Annual Meeting of Japan Society of Gene Therapy 2008, Sapporo, Japan. The 14th Annual Meeting of Japan Society of Gene Therapy 2008, Sapporo, Japan. The 14th Annual Meeting of Japan Society of Gene Therapy 2008, Sapporo, Japan. 2008/06/13 Disclose to all
井上治久, 高橋良輔, Lin Ling, Mi Sha, Isacson Ole 井上治久, 高橋良輔, Lin Ling, Mi Sha, Isacson Ole 井上治久, 高橋良輔, Lin Ling, Mi Sha, Isacson Ole パーキンソン病における中脳ドーパミン神経機能障害治療標的としての軸索再生 パーキンソン病における中脳ドーパミン神経機能障害治療標的としての軸索再生 パーキンソン病における中脳ドーパミン神経機能障害治療標的としての軸索再生 49th Annual Meeting of the Japanese Society of Neurology, Yokohama. 49th Annual Meeting of the Japanese Society of Neurology, Yokohama. 49th Annual Meeting of the Japanese Society of Neurology, Yokohama. 2008/05/17 Disclose to all
川又純, 井上治久, 高橋良輔, 富和清隆, 沼部博直, 小杉真司 川又純, 井上治久, 高橋良輔, 富和清隆, 沼部博直, 小杉真司 川又純, 井上治久, 高橋良輔, 富和清隆, 沼部博直, 小杉真司 京大神経内科における神経筋疾患の遺伝子診断の現状と課題 京大神経内科における神経筋疾患の遺伝子診断の現状と課題 京大神経内科における神経筋疾患の遺伝子診断の現状と課題 49th Annual Meeting of the Japanese Society of Neurology, Yokohama. 49th Annual Meeting of the Japanese Society of Neurology, Yokohama. 49th Annual Meeting of the Japanese Society of Neurology, Yokohama. 2008/05/17 Disclose to all
麓直浩, 井上治久, 松本理器, 野村明成, 高橋幸利, 池田昭夫, 高橋良輔 麓直浩, 井上治久, 松本理器, 野村明成, 高橋幸利, 池田昭夫, 高橋良輔 麓直浩, 井上治久, 松本理器, 野村明成, 高橋幸利, 池田昭夫, 高橋良輔 高齢でてんかん重積で初発し対抗GluR抗体陽性の担癌患者の検討 高齢でてんかん重積で初発し対抗GluR抗体陽性の担癌患者の検討 高齢でてんかん重積で初発し対抗GluR抗体陽性の担癌患者の検討 49th Annual Meeting of the Japanese Society of Neurology, Yokohama. 49th Annual Meeting of the Japanese Society of Neurology, Yokohama. 49th Annual Meeting of the Japanese Society of Neurology, Yokohama. 2008/05/17 Disclose to all
小林芳人, 松井秀彰, 谷口善仁, 植村健吾, 井上治久, 武田俊一, 高橋良輔 小林芳人, 松井秀彰, 谷口善仁, 植村健吾, 井上治久, 武田俊一, 高橋良輔 小林芳人, 松井秀彰, 谷口善仁, 植村健吾, 井上治久, 武田俊一, 高橋良輔 メダカにおけるParkinノックアウトモデルの作製 メダカにおけるParkinノックアウトモデルの作製 メダカにおけるParkinノックアウトモデルの作製 49th Annual Meeting of the Japanese Society of Neurology, Yokohama. 49th Annual Meeting of the Japanese Society of Neurology, Yokohama. 49th Annual Meeting of the Japanese Society of Neurology, Yokohama. 2008/05/17 Disclose to all
松井秀彰, 谷口善仁, 武田俊一, 植村健吾, 小林芳人, 井上治久, 高橋良輔 松井秀彰, 谷口善仁, 武田俊一, 植村健吾, 小林芳人, 井上治久, 高橋良輔 松井秀彰, 谷口善仁, 武田俊一, 植村健吾, 小林芳人, 井上治久, 高橋良輔 パーキンソン病メダカモデルの作製 パーキンソン病メダカモデルの作製 パーキンソン病メダカモデルの作製 49th Annual Meeting of the Japanese Society of Neurology, Yokohama. 49th Annual Meeting of the Japanese Society of Neurology, Yokohama. 49th Annual Meeting of the Japanese Society of Neurology, Yokohama. 2008/05/17 Disclose to all
白樫義知, 本城靖之, 井上治久, 河本泰裕, 冨本秀和, 高橋良輔 白樫義知, 本城靖之, 井上治久, 河本泰裕, 冨本秀和, 高橋良輔 白樫義知, 本城靖之, 井上治久, 河本泰裕, 冨本秀和, 高橋良輔 変異型ヒトSOD1(G93A)過剰発現マウスにおける14-3-3蛋白の免疫組織化学的検討 変異型ヒトSOD1(G93A)過剰発現マウスにおける14-3-3蛋白の免疫組織化学的検討 変異型ヒトSOD1(G93A)過剰発現マウスにおける14-3-3蛋白の免疫組織化学的検討 49th Annual Meeting of the Japanese Society of Neurology, Yokohama. 49th Annual Meeting of the Japanese Society of Neurology, Yokohama. 49th Annual Meeting of the Japanese Society of Neurology, Yokohama. 2008/05/16 Disclose to all
村上学, 井上治久, 月田香代子, 淺井康行, 饗庭一博, 天貝裕地, 上杉志成, 中辻憲夫, 高橋良輔 村上学, 井上治久, 月田香代子, 淺井康行, 饗庭一博, 天貝裕地, 上杉志成, 中辻憲夫, 高橋良輔 村上学, 井上治久, 月田香代子, 淺井康行, 饗庭一博, 天貝裕地, 上杉志成, 中辻憲夫, 高橋良輔 転写を標的とした家族性筋萎縮性側索硬化症新規治療法の開発 転写を標的とした家族性筋萎縮性側索硬化症新規治療法の開発 転写を標的とした家族性筋萎縮性側索硬化症新規治療法の開発 49th Annual Meeting of the Japanese Society of Neurology, Yokohama. 49th Annual Meeting of the Japanese Society of Neurology, Yokohama. 49th Annual Meeting of the Japanese Society of Neurology, Yokohama. 2008/05/16 Disclose to all
竹内啓喜, 植村健吾, 井上治久, 高橋良輔, 北村佳久, 谷口隆之, 赤池昭紀, 澤田秀幸, 下濱俊 竹内啓喜, 植村健吾, 井上治久, 高橋良輔, 北村佳久, 谷口隆之, 赤池昭紀, 澤田秀幸, 下濱俊 竹内啓喜, 植村健吾, 井上治久, 高橋良輔, 北村佳久, 谷口隆之, 赤池昭紀, 澤田秀幸, 下濱俊 ニコチンの中脳ドーパミン(DA)神経保護と凝集体形成への効果 ニコチンの中脳ドーパミン(DA)神経保護と凝集体形成への効果 ニコチンの中脳ドーパミン(DA)神経保護と凝集体形成への効果 49th Annual Meeting of the Japanese Society of Neurology, Yokohama. 49th Annual Meeting of the Japanese Society of Neurology, Yokohama. 49th Annual Meeting of the Japanese Society of Neurology, Yokohama. 2008/05/16 Disclose to all
山門穂高, 森脇康博, 栗栖純子, 常川直子, 宮川剛, 植村健吾, 井上治久, 高橋良輔 山門穂高, 森脇康博, 栗栖純子, 常川直子, 宮川剛, 植村健吾, 井上治久, 高橋良輔 山門穂高, 森脇康博, 栗栖純子, 常川直子, 宮川剛, 植村健吾, 井上治久, 高橋良輔 PARK4マウスモデルの作製 PARK4マウスモデルの作製 PARK4マウスモデルの作製 49th Annual Meeting of the Japanese Society of Neurology, Yokohama. 49th Annual Meeting of the Japanese Society of Neurology, Yokohama. 49th Annual Meeting of the Japanese Society of Neurology, Yokohama. 2008/05/16 Disclose to all
近藤孝之, 澤本伸克, 井上治久, 松本理器, 川又純, 池田昭夫, 福山秀直, 高橋良輔 近藤孝之, 澤本伸克, 井上治久, 松本理器, 川又純, 池田昭夫, 福山秀直, 高橋良輔 近藤孝之, 澤本伸克, 井上治久, 松本理器, 川又純, 池田昭夫, 福山秀直, 高橋良輔 筋萎縮性側索硬化症における白質路の障害:磁気刺激と拡散強調画像による検討 筋萎縮性側索硬化症における白質路の障害:磁気刺激と拡散強調画像による検討 筋萎縮性側索硬化症における白質路の障害:磁気刺激と拡散強調画像による検討 49th Annual Meeting of the Japanese Society of Neurology, Yokohama. 49th Annual Meeting of the Japanese Society of Neurology, Yokohama. 49th Annual Meeting of the Japanese Society of Neurology, Yokohama. 2008/05/15 Disclose to all
江川斉宏, 山本敬祐, 井上治久, 植村健吾, 小川智, 森和俊, 高橋良輔 江川斉宏, 山本敬祐, 井上治久, 植村健吾, 小川智, 森和俊, 高橋良輔 江川斉宏, 山本敬祐, 井上治久, 植村健吾, 小川智, 森和俊, 高橋良輔 パ エル受容体による小胞体ストレスに対する小胞体ストレスマーカーATF6の関与 パ エル受容体による小胞体ストレスに対する小胞体ストレスマーカーATF6の関与 パ エル受容体による小胞体ストレスに対する小胞体ストレスマーカーATF6の関与 49th Annual Meeting of the Japanese Society of Neurology, Yokohama. 49th Annual Meeting of the Japanese Society of Neurology, Yokohama. 49th Annual Meeting of the Japanese Society of Neurology, Yokohama. 2008/05/15 Disclose to all
麓直浩、冨本秀和、井上治久、福山秀直、高橋良輔 麓直浩、冨本秀和、井上治久、福山秀直、高橋良輔 麓直浩、冨本秀和、井上治久、福山秀直、高橋良輔 下肢単麻痺を呈した延髄内側梗塞の1例 下肢単麻痺を呈した延髄内側梗塞の1例 下肢単麻痺を呈した延髄内側梗塞の1例 神経内科, 68, 92-94 神経内科, 68, 92-94 神経内科, 68, 92-94 2008 Disclose to all
近藤孝之, 澤本伸克, 井上治久, 松本理器, 川又純, 池田昭夫, 福山秀直, 高橋良輔 近藤孝之, 澤本伸克, 井上治久, 松本理器, 川又純, 池田昭夫, 福山秀直, 高橋良輔 近藤孝之, 澤本伸克, 井上治久, 松本理器, 川又純, 池田昭夫, 福山秀直, 高橋良輔 筋萎縮性側索硬化症における白質変性の評価 筋萎縮性側索硬化症における白質変性の評価 筋萎縮性側索硬化症における白質変性の評価 49th Annual Meeting of the Japanese Society of Neurology, Yokohama. Program・Abstract., 49th, 157 49th Annual Meeting of the Japanese Society of Neurology, Yokohama. Program・Abstract., 49th, 157 49th Annual Meeting of the Japanese Society of Neurology, Yokohama. Program・Abstract., 49th, 157 2008 Japanese Disclose to all
小林勝哉, 近藤孝之, 井上治久, 西山慶, 横山勝教, 瀬川一, 川又純, 高橋良輔 小林勝哉, 近藤孝之, 井上治久, 西山慶, 横山勝教, 瀬川一, 川又純, 高橋良輔 小林勝哉, 近藤孝之, 井上治久, 西山慶, 横山勝教, 瀬川一, 川又純, 高橋良輔 横紋筋融解症を合併したニセクロハツ中毒の1例 横紋筋融解症を合併したニセクロハツ中毒の1例 横紋筋融解症を合併したニセクロハツ中毒の1例 臨床神経学, 48, 6, 455 臨床神経学, 48, 6, 455 臨床神経学, 48, 6, 455 2008 Japanese Disclose to all
松井 秀彰, 谷口 善仁, 武田 俊一, 植村 健吾, 小林 芳人, 井上 治久, 高橋 良輔 松井 秀彰, 谷口 善仁, 武田 俊一, 植村 健吾, 小林 芳人, 井上 治久, 高橋 良輔 松井 秀彰, 谷口 善仁, 武田 俊一, 植村 健吾, 小林 芳人, 井上 治久, 高橋 良輔 パーキンソン病メダカモデルの作製 パーキンソン病メダカモデルの作製 パーキンソン病メダカモデルの作製 臨床神経学, 48, 12, 1186-1186 臨床神経学, 48, 12, 1186-1186 臨床神経学, 48, 12, 1186-1186 2008 Japanese Disclose to all
小林 芳人, 松井 秀彰, 谷口 善仁, 植村 健吾, 井上 治久, 武田 俊一, 高橋 良輔 小林 芳人, 松井 秀彰, 谷口 善仁, 植村 健吾, 井上 治久, 武田 俊一, 高橋 良輔 小林 芳人, 松井 秀彰, 谷口 善仁, 植村 健吾, 井上 治久, 武田 俊一, 高橋 良輔 メダカにおけるParkinノックアウトモデルの作製 メダカにおけるParkinノックアウトモデルの作製 メダカにおけるParkinノックアウトモデルの作製 臨床神経学, 48, 12, 1186-1186 臨床神経学, 48, 12, 1186-1186 臨床神経学, 48, 12, 1186-1186 2008 Japanese Disclose to all
川又純, 井上治久, 高橋良輔, 富和清隆, 沼部博直, 小杉眞司 川又純, 井上治久, 高橋良輔, 富和清隆, 沼部博直, 小杉眞司 川又純, 井上治久, 高橋良輔, 富和清隆, 沼部博直, 小杉眞司 京大神経内科における神経筋疾患の遺伝子診断の現状と課題 京大神経内科における神経筋疾患の遺伝子診断の現状と課題 京大神経内科における神経筋疾患の遺伝子診断の現状と課題 49th Annual Meeting of the Japanese Society of Neurology, Yokohama. Program・Abstract., 329 49th Annual Meeting of the Japanese Society of Neurology, Yokohama. Program・Abstract., 329 49th Annual Meeting of the Japanese Society of Neurology, Yokohama. Program・Abstract., 329 2008 Japanese Disclose to all
川又 純, 井上 治久, 高橋 良輔, 富和 清隆, 沼部 博直, 小杉 眞司 川又 純, 井上 治久, 高橋 良輔, 富和 清隆, 沼部 博直, 小杉 眞司 川又 純, 井上 治久, 高橋 良輔, 富和 清隆, 沼部 博直, 小杉 眞司 京大神経内科における神経筋疾患の遺伝子診断の現状と課題 京大神経内科における神経筋疾患の遺伝子診断の現状と課題 京大神経内科における神経筋疾患の遺伝子診断の現状と課題 臨床神経学, 48, 12, 1239-1239 臨床神経学, 48, 12, 1239-1239 臨床神経学, 48, 12, 1239-1239 2008 Japanese Disclose to all
麓 直浩, 冨本秀和, 井上治久, 福山秀直, 高橋良輔 麓 直浩, 冨本秀和, 井上治久, 福山秀直, 高橋良輔 麓 直浩, 冨本秀和, 井上治久, 福山秀直, 高橋良輔 下肢単麻痺を呈した延髄内側梗塞の1例 下肢単麻痺を呈した延髄内側梗塞の1例 下肢単麻痺を呈した延髄内側梗塞の1例 神経内科, 68, 92-94 神経内科, 68, 92-94 神経内科, 68, 92-94 2008 Japanese Disclose to all
小林勝哉, 近藤孝之, 井上治久, 西山慶, 横山勝教, 瀬川一, 川又純, 高橋良輔 小林勝哉, 近藤孝之, 井上治久, 西山慶, 横山勝教, 瀬川一, 川又純, 高橋良輔 小林勝哉, 近藤孝之, 井上治久, 西山慶, 横山勝教, 瀬川一, 川又純, 高橋良輔 横紋筋融解症を合併したニセクロハツ中毒の1例 横紋筋融解症を合併したニセクロハツ中毒の1例 横紋筋融解症を合併したニセクロハツ中毒の1例 Japanese Society of Neurology 87th Kinki Branch, Osaka. Japanese Society of Neurology 87th Kinki Branch, Osaka. Japanese Society of Neurology 87th Kinki Branch, Osaka. 2007/12/01 Disclose to all
Iwasato T, Katoh H, Nishimaru H, Ishikawa Y, Inoue H, Saito MY, Ando R, Iwama M, Takahashi R, Negishi M, Itohara S Iwasato T, Katoh H, Nishimaru H, Ishikawa Y, Inoue H, Saito MY, Ando R, Iwama M, Takahashi R, Negishi M, Itohara S Iwasato T, Katoh H, Nishimaru H, Ishikawa Y, Inoue H, Saito MY, Ando R, Iwama M, Takahashi R, Negishi M, Itohara S Rac-GAP α-Chimerin regulates motor-circuit formation as a key mediator of EphrinB3/EphA4 forward signaling Rac-GAP α-Chimerin regulates motor-circuit formation as a key mediator of EphrinB3/EphA4 forward signaling Rac-GAP α-Chimerin regulates motor-circuit formation as a key mediator of EphrinB3/EphA4 forward signaling The 37th Annual meeting of Society for Neuroscience, San Diego, USA. The 37th Annual meeting of Society for Neuroscience, San Diego, USA. The 37th Annual meeting of Society for Neuroscience, San Diego, USA. 2007/11/03 Disclose to all
Kondo K, Suda K, Inoue H, Tomimoto H, Takahashi R, Usui T, Mimori T, Vernino S Kondo K, Suda K, Inoue H, Tomimoto H, Takahashi R, Usui T, Mimori T, Vernino S Kondo K, Suda K, Inoue H, Tomimoto H, Takahashi R, Usui T, Mimori T, Vernino S Autoimmune autonomic neuropathy with Sjögren syndrome: significance of anti ganglionic acetylcholine receptor antibody Autoimmune autonomic neuropathy with Sjögren syndrome: significance of anti ganglionic acetylcholine receptor antibody Autoimmune autonomic neuropathy with Sjögren syndrome: significance of anti ganglionic acetylcholine receptor antibody 5th congress of the international society for autonomic neuroscience, Kyoto, Japan. 5th congress of the international society for autonomic neuroscience, Kyoto, Japan. 5th congress of the international society for autonomic neuroscience, Kyoto, Japan. 2007/10/06 Disclose to all
Wang HQ, Imai Y, Inoue H, Kataoka A, Iita S, Nukina N, Takahashi R Wang HQ, Imai Y, Inoue H, Kataoka A, Iita S, Nukina N, Takahashi R Wang HQ, Imai Y, Inoue H, Kataoka A, Iita S, Nukina N, Takahashi R Pael-R Transgenic Mouse Crossed With Parkin Deficient Mouse Displays Persistent Endoplasmic Reticulum Stress, Reduction In Mitochondrial Complex I Activity And Selective Dopaminergic Neuronal Death Pael-R Transgenic Mouse Crossed With Parkin Deficient Mouse Displays Persistent Endoplasmic Reticulum Stress, Reduction In Mitochondrial Complex I Activity And Selective Dopaminergic Neuronal Death Pael-R Transgenic Mouse Crossed With Parkin Deficient Mouse Displays Persistent Endoplasmic Reticulum Stress, Reduction In Mitochondrial Complex I Activity And Selective Dopaminergic Neuronal Death FASEB Summer Research Conferences, Indian Wells, USA. FASEB Summer Research Conferences, Indian Wells, USA. FASEB Summer Research Conferences, Indian Wells, USA. 2007/07/31 Disclose to all
遠藤文司, 冨本秀和, 井上治久, 池田昭夫, 高橋良輔 遠藤文司, 冨本秀和, 井上治久, 池田昭夫, 高橋良輔 遠藤文司, 冨本秀和, 井上治久, 池田昭夫, 高橋良輔 禿頭と腰痛を伴う遺伝性血管性白質脳症(CARASIL)における頭部MRIの側頭極病変の意義 禿頭と腰痛を伴う遺伝性血管性白質脳症(CARASIL)における頭部MRIの側頭極病変の意義 禿頭と腰痛を伴う遺伝性血管性白質脳症(CARASIL)における頭部MRIの側頭極病変の意義 Japanese Society of Neurology 86th Kinki Branch, Osaka. Japanese Society of Neurology 86th Kinki Branch, Osaka. Japanese Society of Neurology 86th Kinki Branch, Osaka. 2007/06/23 Disclose to all
Iwasato T, Katoh H, Nishimaru H, Ishikawa Y, Inoue H, Saito YM, Ando R, Iwama M, Takahashi R, Negishi M, Itohara S Iwasato T, Katoh H, Nishimaru H, Ishikawa Y, Inoue H, Saito YM, Ando R, Iwama M, Takahashi R, Negishi M, Itohara S Iwasato T, Katoh H, Nishimaru H, Ishikawa Y, Inoue H, Saito YM, Ando R, Iwama M, Takahashi R, Negishi M, Itohara S How does ephrinB3/EphA4 signaling regulate motor-circuit formation? How does ephrinB3/EphA4 signaling regulate motor-circuit formation? How does ephrinB3/EphA4 signaling regulate motor-circuit formation? Neuroscience Research, Volume 58, Supplement 1, S204 Neuroscience Research, Volume 58, Supplement 1, S204 Neuroscience Research, Volume 58, Supplement 1, S204 2007 Disclose to all
Takahashi R, Wang HQ, Imai Y, Inoue H, Kataoka A, Iita S, Nukina N Takahashi R, Wang HQ, Imai Y, Inoue H, Kataoka A, Iita S, Nukina N Takahashi R, Wang HQ, Imai Y, Inoue H, Kataoka A, Iita S, Nukina N Pael-R transgenic mouse crossed with parkin null mouse displays persistent endoplasmic reticulum stress, reduction in complex I activity and dopaminergic neuronal death Pael-R transgenic mouse crossed with parkin null mouse displays persistent endoplasmic reticulum stress, reduction in complex I activity and dopaminergic neuronal death Pael-R transgenic mouse crossed with parkin null mouse displays persistent endoplasmic reticulum stress, reduction in complex I activity and dopaminergic neuronal death Neuroscience Research, Volume 58, Supplement 1, S6 Neuroscience Research, Volume 58, Supplement 1, S6 Neuroscience Research, Volume 58, Supplement 1, S6 2007 Disclose to all
麓直浩、冨本秀和、井上治久、高橋良輔 麓直浩、冨本秀和、井上治久、高橋良輔 麓直浩、冨本秀和、井上治久、高橋良輔 脳梗塞のearly CT sign 脳梗塞のearly CT sign 脳梗塞のearly CT sign 神経内科, 67, 197-198 神経内科, 67, 197-198 神経内科, 67, 197-198 2007 Disclose to all
高橋良輔, 王華芹, 今居譲, 井上治久, 片岡綾音, 祖田真理子, 貫名信行 高橋良輔, 王華芹, 今居譲, 井上治久, 片岡綾音, 祖田真理子, 貫名信行 高橋良輔, 王華芹, 今居譲, 井上治久, 片岡綾音, 祖田真理子, 貫名信行 パーキンソン病モデルマウスの開発 パーキンソン病モデルマウスの開発 パーキンソン病モデルマウスの開発 47th Annual Meeting of the Japanese Society of Neurology, Tokyo. 47th Annual Meeting of the Japanese Society of Neurology, Tokyo. 47th Annual Meeting of the Japanese Society of Neurology, Tokyo. 2006/05/11 Disclose to all
須田 謙史, 人見 健文, 井上 治久, 冨本 秀和, 高橋 良輔 須田 謙史, 人見 健文, 井上 治久, 冨本 秀和, 高橋 良輔 須田 謙史, 人見 健文, 井上 治久, 冨本 秀和, 高橋 良輔 上位頸椎レベルより髄液漏を来たした低髄液圧症候群の一症例 上位頸椎レベルより髄液漏を来たした低髄液圧症候群の一症例 上位頸椎レベルより髄液漏を来たした低髄液圧症候群の一症例 日本頭痛学会誌, 33, 2, 110-110 日本頭痛学会誌, 33, 2, 110-110 日本頭痛学会誌, 33, 2, 110-110 2006 Japanese Disclose to all
Takahashi R, Wang HQ, Imai Y, Inoue H, Kataoka A, Soda M, Nukina N Takahashi R, Wang HQ, Imai Y, Inoue H, Kataoka A, Soda M, Nukina N Takahashi R, Wang HQ, Imai Y, Inoue H, Kataoka A, Soda M, Nukina N Crossbreeding of Pael-R/GPR37 transgenic mice with parkin knockout mice Crossbreeding of Pael-R/GPR37 transgenic mice with parkin knockout mice Crossbreeding of Pael-R/GPR37 transgenic mice with parkin knockout mice The 35th Annual Meeting of Society for Neuroscience, Washington, DC, USA. The 35th Annual Meeting of Society for Neuroscience, Washington, DC, USA. The 35th Annual Meeting of Society for Neuroscience, Washington, DC, USA. 2005/11/15 Disclose to all
Inoue H, Suzuki Y, Nagao M, Takahashi R Inoue H, Suzuki Y, Nagao M, Takahashi R Inoue H, Suzuki Y, Nagao M, Takahashi R Caspase-independent cell death pathway in a transgenic mouse model of amyotrophic lateral sclerosis Caspase-independent cell death pathway in a transgenic mouse model of amyotrophic lateral sclerosis Caspase-independent cell death pathway in a transgenic mouse model of amyotrophic lateral sclerosis World Congress of Neurology, Sydney, Australia World Congress of Neurology, Sydney, Australia World Congress of Neurology, Sydney, Australia 2005/11/08 Disclose to all
井上 治久, 舘野 美成子, 高橋 良輔 井上 治久, 舘野 美成子, 高橋 良輔 井上 治久, 舘野 美成子, 高橋 良輔 これからの疾患モデル動物(第6回)筋萎縮性側索硬化症:変異SOD1マウス これからの疾患モデル動物(第6回)筋萎縮性側索硬化症:変異SOD1マウス これからの疾患モデル動物(第6回)筋萎縮性側索硬化症:変異SOD1マウス Molecular Medicine, 42, 10, 1146-1150 Molecular Medicine, 42, 10, 1146-1150 Molecular Medicine, 42, 10, 1146-1150 2005 Japanese Disclose to all
Hedlund E, Cizkova D, Kakinohana O, Inoue H, Hefferan M, Ferree A, Marsala M, Isacson O Hedlund E, Cizkova D, Kakinohana O, Inoue H, Hefferan M, Ferree A, Marsala M, Isacson O Hedlund E, Cizkova D, Kakinohana O, Inoue H, Hefferan M, Ferree A, Marsala M, Isacson O Implantation of pre-differentiated embryonic stem (ES) cells or primary spinal cord precursors to restore function in the SOD1G93A rat model of ALS Implantation of pre-differentiated embryonic stem (ES) cells or primary spinal cord precursors to restore function in the SOD1G93A rat model of ALS Implantation of pre-differentiated embryonic stem (ES) cells or primary spinal cord precursors to restore function in the SOD1G93A rat model of ALS 7th International Congress of the Cell Transplant Society, Boston, USA 7th International Congress of the Cell Transplant Society, Boston, USA 7th International Congress of the Cell Transplant Society, Boston, USA 2004/11/17 Disclose to all
Hedlund E, Cizkova D, Ferree A, Kakinohana O, Hefferan M, Inoue H, Marsala M, Isacson O Hedlund E, Cizkova D, Ferree A, Kakinohana O, Hefferan M, Inoue H, Marsala M, Isacson O Hedlund E, Cizkova D, Ferree A, Kakinohana O, Hefferan M, Inoue H, Marsala M, Isacson O Implantation of pre-differentiated embryonic stem (ES) cells or primary spinal cord recursors to restore function in the SOD1G93A rat model of ALS Implantation of pre-differentiated embryonic stem (ES) cells or primary spinal cord recursors to restore function in the SOD1G93A rat model of ALS Implantation of pre-differentiated embryonic stem (ES) cells or primary spinal cord recursors to restore function in the SOD1G93A rat model of ALS he 34th Annual meeting of Society for Neuroscience, San Diego, USA he 34th Annual meeting of Society for Neuroscience, San Diego, USA he 34th Annual meeting of Society for Neuroscience, San Diego, USA 2004/10/23 Disclose to all
高橋良輔, 井上治久, 長尾雅裕, 川田明広 高橋良輔, 井上治久, 長尾雅裕, 川田明広 高橋良輔, 井上治久, 長尾雅裕, 川田明広 カスパーゼ-9はALSモデルマウスの症状進行に寄与する カスパーゼ-9はALSモデルマウスの症状進行に寄与する カスパーゼ-9はALSモデルマウスの症状進行に寄与する 45th Annual Meeting of the Japanese Society of Neurology, Tokyo. 45th Annual Meeting of the Japanese Society of Neurology, Tokyo. 45th Annual Meeting of the Japanese Society of Neurology, Tokyo. 2004/05/11 Disclose to all
村上哲郎, 瓦林毅, 松原悦朗, 永野功, 東海林幹夫, 阿部康二, 今井譲, 井上治久, 高橋良輔 村上哲郎, 瓦林毅, 松原悦朗, 永野功, 東海林幹夫, 阿部康二, 今井譲, 井上治久, 高橋良輔 村上哲郎, 瓦林毅, 松原悦朗, 永野功, 東海林幹夫, 阿部康二, 今井譲, 井上治久, 高橋良輔 パーキンソン病患者のレビー小体におけるPael-R,ParkinおよびGlupの 関与 パーキンソン病患者のレビー小体におけるPael-R,ParkinおよびGlupの 関与 パーキンソン病患者のレビー小体におけるPael-R,ParkinおよびGlupの 関与 Prog. Med, 24,2983-3091 Prog. Med, 24,2983-3091 Prog. Med, 24,2983-3091 2004 Disclose to all
井上治久, 高橋良輔 井上治久, 高橋良輔 井上治久, 高橋良輔 caspase-9とALS caspase-9とALS caspase-9とALS 臨床検査, 48, 1577-1580 臨床検査, 48, 1577-1580 臨床検査, 48, 1577-1580 2004 Japanese Disclose to all
高橋良輔, 鈴木泰行, 井上治久 高橋良輔, 鈴木泰行, 井上治久 高橋良輔, 鈴木泰行, 井上治久 ミトコンドリアから放出されるセリンプロテアーゼHtrA2と神経細胞死 ミトコンドリアから放出されるセリンプロテアーゼHtrA2と神経細胞死 ミトコンドリアから放出されるセリンプロテアーゼHtrA2と神経細胞死 The 26th Annual Meeting of the Japan Neuroscience Society Symposium, Nagoya. The 26th Annual Meeting of the Japan Neuroscience Society Symposium 「ミトコンドリアの機能・動態と神経細胞死」, Nagoya. The 26th Annual Meeting of the Japan Neuroscience Society Symposium, Nagoya. 2003/07/25 Disclose to all
井上治久, 岩里琢治, 月田香代子, 糸原重美, 三浦正幸, 三澤日出巳, 高橋良輔 井上治久, 岩里琢治, 月田香代子, 糸原重美, 三浦正幸, 三澤日出巳, 高橋良輔 井上治久, 岩里琢治, 月田香代子, 糸原重美, 三浦正幸, 三澤日出巳, 高橋良輔 抗アポトーシス分子p35はALSマウスの発症時期を遅延させ生存期間を延長する 抗アポトーシス分子p35はALSマウスの発症時期を遅延させ生存期間を延長する 抗アポトーシス分子p35はALSマウスの発症時期を遅延させ生存期間を延長する 44th Annual Meeting of the Japanese Society of Neurology, Yokohama. 44th Annual Meeting of the Japanese Society of Neurology, Yokohama. 44th Annual Meeting of the Japanese Society of Neurology, Yokohama. 2003/05/16 Disclose to all
Inoue H, Urushitani M, Suzuki Y, Tateno M, Usami T, Sakamoto K, Misawa H, Takahashi R Inoue H, Urushitani M, Suzuki Y, Tateno M, Usami T, Sakamoto K, Misawa H, Takahashi R Inoue H, Urushitani M, Suzuki Y, Tateno M, Usami T, Sakamoto K, Misawa H, Takahashi R XIAP inhibits the mitochondria-dependent apoptotic pathway and prolongs the lifespan in a transgenic animal model of amyotrophic lateral sclerosis XIAP inhibits the mitochondria-dependent apoptotic pathway and prolongs the lifespan in a transgenic animal model of amyotrophic lateral sclerosis XIAP inhibits the mitochondria-dependent apoptotic pathway and prolongs the lifespan in a transgenic animal model of amyotrophic lateral sclerosis The 32nd Annual meeting of Society for Neuroscience, Orlando, USA The 32nd Annual meeting of Society for Neuroscience, Orlando, USA The 32nd Annual meeting of Society for Neuroscience, Orlando, USA 2002/11/02 Disclose to all
井上治久, 宇佐美智子, 三澤日出巳, 高橋良輔 井上治久, 宇佐美智子, 三澤日出巳, 高橋良輔 井上治久, 宇佐美智子, 三澤日出巳, 高橋良輔 コリン作動性神経特異的p35 発現マウスの作製 コリン作動性神経特異的p35 発現マウスの作製 コリン作動性神経特異的p35 発現マウスの作製 43rd Annual Meeting of the Japanese Society of Neurology, Sapporo. 43rd Annual Meeting of the Japanese Society of Neurology, Sapporo. 43rd Annual Meeting of the Japanese Society of Neurology, Sapporo. 2002/05/29 Disclose to all
今居譲, 井上治久, 高橋良輔 今居譲, 井上治久, 高橋良輔 今居譲, 井上治久, 高橋良輔 常染色体劣性若年性パーキンソン病におけるPael recepter、ER ストレスについての検討 常染色体劣性若年性パーキンソン病におけるPael recepter、ER ストレスについての検討 常染色体劣性若年性パーキンソン病におけるPael recepter、ER ストレスについての検討 43rd Annual Meeting of the Japanese Society of Neurology, Sapporo. 43rd Annual Meeting of the Japanese Society of Neurology, Sapporo. 43rd Annual Meeting of the Japanese Society of Neurology, Sapporo. 2002/05/29 Disclose to all
Takanashi M, Hattori N, Imai Y, Inoue H, Takahashi R, Mizuno Y Takanashi M, Hattori N, Imai Y, Inoue H, Takahashi R, Mizuno Y Takanashi M, Hattori N, Imai Y, Inoue H, Takahashi R, Mizuno Y Immunohistochemical study for ER stress and accumulation of Pael-r in autosomal recessive juvenile parkinsonism with Parkin gene mutations Immunohistochemical study for ER stress and accumulation of Pael-r in autosomal recessive juvenile parkinsonism with Parkin gene mutations Immunohistochemical study for ER stress and accumulation of Pael-r in autosomal recessive juvenile parkinsonism with Parkin gene mutations Movement Disorders, 17, Suppl. 5, 453 Movement Disorders, 17, Suppl. 5, 453 Movement Disorders, 17, Suppl. 5, 453 2002 Disclose to all
高梨 雅史, 服部 信孝, 森 秀生, 水野 美邦, 今居 譲, 井上 治久, 高橋 良輔 高梨 雅史, 服部 信孝, 森 秀生, 水野 美邦, 今居 譲, 井上 治久, 高橋 良輔 高梨 雅史, 服部 信孝, 森 秀生, 水野 美邦, 今居 譲, 井上 治久, 高橋 良輔 常染色体劣性若年性パーキンソン病におけるPael recepter, ERストレスについての検討(平成13年度順天堂大学老人性疾患病態・治療研究センター発表会抄録) 常染色体劣性若年性パーキンソン病におけるPael recepter, ERストレスについての検討(平成13年度順天堂大学老人性疾患病態・治療研究センター発表会抄録) 常染色体劣性若年性パーキンソン病におけるPael recepter, ERストレスについての検討(平成13年度順天堂大学老人性疾患病態・治療研究センター発表会抄録) 順天堂医学, 48, 3, 416-417 順天堂医学, 48, 3, 416-417 順天堂医学, 48, 3, 416-417 2002 Disclose to all
Inoue H, Iwasato T, Misawa H, Usami T, Tateno M, Itohara S, Takahashi R Inoue H, Iwasato T, Misawa H, Usami T, Tateno M, Itohara S, Takahashi R Inoue H, Iwasato T, Misawa H, Usami T, Tateno M, Itohara S, Takahashi R Cholinergic neuronspecific expression of CRE recombinase in the mouse Cholinergic neuronspecific expression of CRE recombinase in the mouse Cholinergic neuronspecific expression of CRE recombinase in the mouse The 31st Annual meeting of Society for Neuroscience, San Diego, USA The 31st Annual meeting of Society for Neuroscience, San Diego, USA The 31st Annual meeting of Society for Neuroscience, San Diego, USA 2001/11/10 Disclose to all
井上治久, 岩里琢治, 舘野美成子, 三澤日出巳, 糸原重美, 高橋良輔 井上治久, 岩里琢治, 舘野美成子, 三澤日出巳, 糸原重美, 高橋良輔 井上治久, 岩里琢治, 舘野美成子, 三澤日出巳, 糸原重美, 高橋良輔 Cholinergic neuron-specific expression of Cre recombinase in the mouse Cholinergic neuron-specific expression of Cre recombinase in the mouse Cholinergic neuron-specific expression of Cre recombinase in the mouse 第24回・第44回日本神経化学合同大会(Neuro2001), 京都. 第24回・第44回日本神経化学合同大会(Neuro2001), 京都. 第24回・第44回日本神経化学合同大会(Neuro2001), 京都. 2001/09/28 Disclose to all
井上治久, 岩里琢治, 舘野美成子, 三澤日出巳, 糸原重美, 高橋良輔 井上治久, 岩里琢治, 舘野美成子, 三澤日出巳, 糸原重美, 高橋良輔 井上治久, 岩里琢治, 舘野美成子, 三澤日出巳, 糸原重美, 高橋良輔 コリン作動性神経特異的遺伝子発現制御システムの確立 コリン作動性神経特異的遺伝子発現制御システムの確立 コリン作動性神経特異的遺伝子発現制御システムの確立 42nd Annual Meeting of the Japanese Society of Neurology, Tokyo. 42nd Annual Meeting of the Japanese Society of Neurology, Tokyo. 42nd Annual Meeting of the Japanese Society of Neurology, Tokyo. 2001/05/11 Disclose to all
井上治久, 高橋慶吉, 棚橋浩, 田平武, 澤田誠, 梁明秀, 羽田亮之, 若月徹, 近藤信夫, 山本三毅夫, 錫村明生 井上治久, 高橋慶吉, 棚橋浩, 田平武, 澤田誠, 梁明秀, 羽田亮之, 若月徹, 近藤信夫, 山本三毅夫, 錫村明生 井上治久, 高橋慶吉, 棚橋浩, 田平武, 澤田誠, 梁明秀, 羽田亮之, 若月徹, 近藤信夫, 山本三毅夫, 錫村明生 SAGE法によるミクログリア/マクロフアージの遺伝子解析 SAGE法によるミクログリア/マクロフアージの遺伝子解析 SAGE法によるミクログリア/マクロフアージの遺伝子解析 40th Annual Meeting of the Japanese Society of Neurology, Tokyo. 40th Annual Meeting of the Japanese Society of Neurology, Tokyo. 40th Annual Meeting of the Japanese Society of Neurology, Tokyo. 1999/05/19 Disclose to all
和泉唯信, 宇高不可思, 林幼偉, 植村健吾, 藤澤道子, 高橋牧郎, 井上治久, 西中和人, 亀山正邦, 松山善次郎, 川上秀史, 中村重信 和泉唯信, 宇高不可思, 林幼偉, 植村健吾, 藤澤道子, 高橋牧郎, 井上治久, 西中和人, 亀山正邦, 松山善次郎, 川上秀史, 中村重信 和泉唯信, 宇高不可思, 林幼偉, 植村健吾, 藤澤道子, 高橋牧郎, 井上治久, 西中和人, 亀山正邦, 松山善次郎, 川上秀史, 中村重信 当院における脊髄小脳変性症 当院における脊髄小脳変性症 当院における脊髄小脳変性症 38th Annual Meeting of the Japanese Society of Neurology, Yokohama. 38th Annual Meeting of the Japanese Society of Neurology, Yokohama. 38th Annual Meeting of the Japanese Society of Neurology, Yokohama. 1997/05/15 Disclose to all
宇高不可思, 西中和人, 藤澤道子, 井上治久, 和泉唯信, 植村健吾, 高橋牧郎, 林幼偉, 亀山正邦 宇高不可思, 西中和人, 藤澤道子, 井上治久, 和泉唯信, 植村健吾, 高橋牧郎, 林幼偉, 亀山正邦 宇高不可思, 西中和人, 藤澤道子, 井上治久, 和泉唯信, 植村健吾, 高橋牧郎, 林幼偉, 亀山正邦 脳内小梗塞巣のMRIと病理像との対比 脳内小梗塞巣のMRIと病理像との対比 脳内小梗塞巣のMRIと病理像との対比 38th Annual Meeting of the Japanese Society of Neurology, Yokohama. 38th Annual Meeting of the Japanese Society of Neurology, Yokohama. 38th Annual Meeting of the Japanese Society of Neurology, Yokohama. 1997/05/14 Disclose to all
西中和人, 藤澤道子, 井上治久, 和泉唯信, 植村健吾, 高橋牧郎, 林幼偉, 宇高不可思, 亀山正邦, 阪口勝彦 西中和人, 藤澤道子, 井上治久, 和泉唯信, 植村健吾, 高橋牧郎, 林幼偉, 宇高不可思, 亀山正邦, 阪口勝彦 西中和人, 藤澤道子, 井上治久, 和泉唯信, 植村健吾, 高橋牧郎, 林幼偉, 宇高不可思, 亀山正邦, 阪口勝彦 透析患者における脳梗塞の経時的観察とその増悪因子についての検討 透析患者における脳梗塞の経時的観察とその増悪因子についての検討 透析患者における脳梗塞の経時的観察とその増悪因子についての検討 38th Annual Meeting of the Japanese Society of Neurology, Yokohama. 38th Annual Meeting of the Japanese Society of Neurology, Yokohama. 38th Annual Meeting of the Japanese Society of Neurology, Yokohama. 1997/05/14 Disclose to all
井上治久、宇高不可思、西中和人、亀山正邦、天野殖 井上治久、宇高不可思、西中和人、亀山正邦、天野殖 井上治久、宇高不可思、西中和人、亀山正邦、天野殖 下腿の高度な筋萎縮を呈したneurenteric cyst の成人期発症例 下腿の高度な筋萎縮を呈したneurenteric cyst の成人期発症例 下腿の高度な筋萎縮を呈したneurenteric cyst の成人期発症例 臨床神経学, 37, 536-539 臨床神経学, 37, 536-539 臨床神経学, 37, 536-539 1997 Disclose to all
井上治久、宇高不可思、迫田寛、亀山正邦、天野殖 井上治久、宇高不可思、迫田寛、亀山正邦、天野殖 井上治久、宇高不可思、迫田寛、亀山正邦、天野殖 胸髄髄内原発悪性リンパ腫 胸髄髄内原発悪性リンパ腫 胸髄髄内原発悪性リンパ腫 神経内科, 47, 513-516 神経内科, 47, 513-516 神経内科, 47, 513-516 1997 Disclose to all
井上治久、宇高不可思、高橋牧郎、亀山正邦 井上治久、宇高不可思、高橋牧郎、亀山正邦 井上治久、宇高不可思、高橋牧郎、亀山正邦 4年間,きわめて軽微な症候で経過した脳表ヘモジデリン沈着症 4年間,きわめて軽微な症候で経過した脳表ヘモジデリン沈着症 4年間,きわめて軽微な症候で経過した脳表ヘモジデリン沈着症 神経内科, 47, 521-523 神経内科, 47, 521-523 神経内科, 47, 521-523 1997 Disclose to all
井上治久、宇高不可思、林幼偉、植村健吾、和泉唯信、高橋牧郎、西中和人、亀山正邦 井上治久、宇高不可思、林幼偉、植村健吾、和泉唯信、高橋牧郎、西中和人、亀山正邦 井上治久、宇高不可思、林幼偉、植村健吾、和泉唯信、高橋牧郎、西中和人、亀山正邦 神経梅毒の1例 神経梅毒の1例 神経梅毒の1例 住友病院医学雑誌, 24, 39-41 住友病院医学雑誌, 24, 39-41 住友病院医学雑誌, 24, 39-41 1997 Disclose to all
井上治久、宇高不可思、高橋牧郎、西中和人、亀山正邦 井上治久、宇高不可思、高橋牧郎、西中和人、亀山正邦 井上治久、宇高不可思、高橋牧郎、西中和人、亀山正邦 中脳出血の後,対側上下肢にパーキンソン病様症候を呈した1例 中脳出血の後,対側上下肢にパーキンソン病様症候を呈した1例 中脳出血の後,対側上下肢にパーキンソン病様症候を呈した1例 臨床神経学, 37, 266-269 臨床神経学, 37, 266-269 臨床神経学, 37, 266-269 1997 Disclose to all
宇高不可思, 西中和人, 川村和之, 井上治久, 藤澤道子, 和泉唯信, 高橋牧朗, 亀山正邦, 児玉光生, 漆谷真, 景山卓, 澤田秀幸 宇高不可思, 西中和人, 川村和之, 井上治久, 藤澤道子, 和泉唯信, 高橋牧朗, 亀山正邦, 児玉光生, 漆谷真, 景山卓, 澤田秀幸 宇高不可思, 西中和人, 川村和之, 井上治久, 藤澤道子, 和泉唯信, 高橋牧朗, 亀山正邦, 児玉光生, 漆谷真, 景山卓, 澤田秀幸 肝性脳症のT1強調MRI所見とマンガン(Mn) 仮説の検討 肝性脳症のT1強調MRI所見とマンガン(Mn) 仮説の検討 肝性脳症のT1強調MRI所見とマンガン(Mn) 仮説の検討 37th Annual Meeting of the Japanese Society of Neurology, Omiya. 37th Annual Meeting of the Japanese Society of Neurology, Omiya. 37th Annual Meeting of the Japanese Society of Neurology, Omiya. 1996/05/17 Disclose to all
漆谷真、井上治久、川村和之、景山卓、藤澤道子、西中和人、宇高不可思、亀山正邦 漆谷真、井上治久、川村和之、景山卓、藤澤道子、西中和人、宇高不可思、亀山正邦 漆谷真、井上治久、川村和之、景山卓、藤澤道子、西中和人、宇高不可思、亀山正邦 橋底部梗塞により本態性頸部振戦が消失した1例 橋底部梗塞により本態性頸部振戦が消失した1例 橋底部梗塞により本態性頸部振戦が消失した1例 脳神経, 48, 753-756 脳神経, 48, 753-756 脳神経, 48, 753-756 1996 Disclose to all
漆谷真、井上治久、宇高不可思、亀山正邦 漆谷真、井上治久、宇高不可思、亀山正邦 漆谷真、井上治久、宇高不可思、亀山正邦 左内頸動脈閉塞に伴う血管新生性緑内障の前駆症状として光視症を呈した1例 左内頸動脈閉塞に伴う血管新生性緑内障の前駆症状として光視症を呈した1例 左内頸動脈閉塞に伴う血管新生性緑内障の前駆症状として光視症を呈した1例 臨床神経学, 36, 481-484 臨床神経学, 36, 481-484 臨床神経学, 36, 481-484 1996 Disclose to all
井上治久、西中和人、漆谷真、宇高不可思、亀山正邦 井上治久、西中和人、漆谷真、宇高不可思、亀山正邦 井上治久、西中和人、漆谷真、宇高不可思、亀山正邦 右上下肢の筋力低下を呈し,手術により改善をみた胸椎硬膜外くも膜嚢腫の1例 右上下肢の筋力低下を呈し,手術により改善をみた胸椎硬膜外くも膜嚢腫の1例 右上下肢の筋力低下を呈し,手術により改善をみた胸椎硬膜外くも膜嚢腫の1例 臨床神経学, 36, 47-51 臨床神経学, 36, 47-51 臨床神経学, 36, 47-51 1996 Disclose to all
西中和人, 井上治久, 宇高不可思, 漆谷真, 景山卓, 川村和之, 藤澤道子, 亀山正邦, 児玉光生 西中和人, 井上治久, 宇高不可思, 漆谷真, 景山卓, 川村和之, 藤澤道子, 亀山正邦, 児玉光生 西中和人, 井上治久, 宇高不可思, 漆谷真, 景山卓, 川村和之, 藤澤道子, 亀山正邦, 児玉光生 肝性脳症のT1強調MRI所見とマンガン(Mn)仮説の検討 肝性脳症のT1強調MRI所見とマンガン(Mn)仮説の検討 肝性脳症のT1強調MRI所見とマンガン(Mn)仮説の検討 36th Annual Meeting of the Japanese Society of Neurology, Nagoya. 36th Annual Meeting of the Japanese Society of Neurology, Nagoya. 36th Annual Meeting of the Japanese Society of Neurology, Nagoya. 1995/05/17 Disclose to all
西中和人、井上治久、宇高不可思、漆谷真、景山卓、川村和之、藤澤道子、亀山正邦、児玉光生 西中和人、井上治久、宇高不可思、漆谷真、景山卓、川村和之、藤澤道子、亀山正邦、児玉光生 西中和人、井上治久、宇高不可思、漆谷真、景山卓、川村和之、藤澤道子、亀山正邦、児玉光生 透析患者における無症候性脳梗塞の頻度とその危険因子 透析患者における無症候性脳梗塞の頻度とその危険因子 透析患者における無症候性脳梗塞の頻度とその危険因子 36th Annual Meeting of the Japanese Society of Neurology, Nagoya. 36th Annual Meeting of the Japanese Society of Neurology, Nagoya. 36th Annual Meeting of the Japanese Society of Neurology, Nagoya. 1995/03 Disclose to all
景山卓、漆谷真、井上治久、藤澤道子、川村和之、西中和人、宇高不可思、亀山正邦 景山卓、漆谷真、井上治久、藤澤道子、川村和之、西中和人、宇高不可思、亀山正邦 景山卓、漆谷真、井上治久、藤澤道子、川村和之、西中和人、宇高不可思、亀山正邦 パーキンソン病の日内変動に対するL-dopa単剤およびL-dopa・DCI合剤の併用療法について パーキンソン病の日内変動に対するL-dopa単剤およびL-dopa・DCI合剤の併用療法について パーキンソン病の日内変動に対するL-dopa単剤およびL-dopa・DCI合剤の併用療法について 大阪神経筋難病研究会, 大阪. 大阪神経筋難病研究会, 大阪. 大阪神経筋難病研究会, 大阪. 1995/03 Disclose to all
児玉光生、藤澤道子、井上治久、川村和之、景山卓、漆谷真、西中和人、宇高不可思、亀山正邦 児玉光生、藤澤道子、井上治久、川村和之、景山卓、漆谷真、西中和人、宇高不可思、亀山正邦 児玉光生、藤澤道子、井上治久、川村和之、景山卓、漆谷真、西中和人、宇高不可思、亀山正邦 ミエロパチーで発症した進行性足多巣性白質脳症 (PML) の1例 ミエロパチーで発症した進行性足多巣性白質脳症 (PML) の1例 ミエロパチーで発症した進行性足多巣性白質脳症 (PML) の1例 住友病院医学雑誌, 22, 84-88 住友病院医学雑誌, 22, 84-88 住友病院医学雑誌, 22, 84-88 1995 Disclose to all
井上治久、西中和人、漆谷真、宇高不可思、亀山正邦 井上治久、西中和人、漆谷真、宇高不可思、亀山正邦 井上治久、西中和人、漆谷真、宇高不可思、亀山正邦 腸チフス罹患後に小脳性運動失調が遷延した1例 腸チフス罹患後に小脳性運動失調が遷延した1例 腸チフス罹患後に小脳性運動失調が遷延した1例 臨床神経学, 35, 1151-1154 臨床神経学, 35, 1151-1154 臨床神経学, 35, 1151-1154 1995 Disclose to all
川村和之、藤澤道子、井上治久、景山卓、漆谷真、児玉光生、西中和人、宇高不可思、新藤高士、亀山正邦 川村和之、藤澤道子、井上治久、景山卓、漆谷真、児玉光生、西中和人、宇高不可思、新藤高士、亀山正邦 川村和之、藤澤道子、井上治久、景山卓、漆谷真、児玉光生、西中和人、宇高不可思、新藤高士、亀山正邦 抗癌剤内服中に発症したリステリア髄膜炎の1例 抗癌剤内服中に発症したリステリア髄膜炎の1例 抗癌剤内服中に発症したリステリア髄膜炎の1例 住友病院医学雑誌, 22, 41-44 住友病院医学雑誌, 22, 41-44 住友病院医学雑誌, 22, 41-44 1995 Disclose to all
井上治久、宇高不可思、亀山正邦 井上治久、宇高不可思、亀山正邦 井上治久、宇高不可思、亀山正邦 一側性外転神経麻痺を呈した頸動脈海綿静脈洞瘻 一側性外転神経麻痺を呈した頸動脈海綿静脈洞瘻 一側性外転神経麻痺を呈した頸動脈海綿静脈洞瘻 神経内科, 43, 262-264 神経内科, 43, 262-264 神経内科, 43, 262-264 1995 Disclose to all
井上治久、漆谷真、宇高不可思、亀山正邦 井上治久、漆谷真、宇高不可思、亀山正邦 井上治久、漆谷真、宇高不可思、亀山正邦 頭部外傷によるヘミコレア・ ヘミバリスム の1例 頭部外傷によるヘミコレア・ ヘミバリスム の1例 頭部外傷によるヘミコレア・ ヘミバリスム の1例 神経内科, 42, 84-86 神経内科, 42, 84-86 神経内科, 42, 84-86 1995 Disclose to all
西中和人、井上治久、宇高不可思、亀山正邦、阪口勝彦 西中和人、井上治久、宇高不可思、亀山正邦、阪口勝彦 西中和人、井上治久、宇高不可思、亀山正邦、阪口勝彦 血液透析患者における脳MRI 血液透析患者における脳MRI 血液透析患者における脳MRI 43rd Osaka Society for Dialysis Therapy, Osaka. 43rd Osaka Society for Dialysis Therapy, Osaka. 43rd Osaka Society for Dialysis Therapy, Osaka. 1994/09 Disclose to all
宇高不可思、西中和人、児玉光生、漆谷真、景山卓、川村和之、井上治久、亀山正邦 宇高不可思、西中和人、児玉光生、漆谷真、景山卓、川村和之、井上治久、亀山正邦 宇高不可思、西中和人、児玉光生、漆谷真、景山卓、川村和之、井上治久、亀山正邦 低酸素性脳症の重症度と画像診断所見 低酸素性脳症の重症度と画像診断所見 低酸素性脳症の重症度と画像診断所見 35th Annual Meeting of the Japanese Society of Neurology, Fukuoka. 35th Annual Meeting of the Japanese Society of Neurology, Fukuoka. 35th Annual Meeting of the Japanese Society of Neurology, Fukuoka. 1994/05/20 Disclose to all
児玉光生、井上治久、川村和之、景山卓、漆谷真、西中和人、宇高不可思、亀山正邦 児玉光生、井上治久、川村和之、景山卓、漆谷真、西中和人、宇高不可思、亀山正邦 児玉光生、井上治久、川村和之、景山卓、漆谷真、西中和人、宇高不可思、亀山正邦 各種神経疾患における骨塩量の計測 各種神経疾患における骨塩量の計測 各種神経疾患における骨塩量の計測 35th Annual Meeting of the Japanese Society of Neurology, Fukuoka. 35th Annual Meeting of the Japanese Society of Neurology, Fukuoka. 35th Annual Meeting of the Japanese Society of Neurology, Fukuoka. 1994/05/19 Disclose to all
井上治久、宇高不可思、川村和之、景山卓、漆谷真、児玉光生、西中和人、亀山正邦 井上治久、宇高不可思、川村和之、景山卓、漆谷真、児玉光生、西中和人、亀山正邦 井上治久、宇高不可思、川村和之、景山卓、漆谷真、児玉光生、西中和人、亀山正邦 一過性全健忘様の発作を呈した左視床動静脈奇形の1例 一過性全健忘様の発作を呈した左視床動静脈奇形の1例 一過性全健忘様の発作を呈した左視床動静脈奇形の1例 住友病院医学雑誌, 21, 81-86 住友病院医学雑誌, 21, 81-86 住友病院医学雑誌, 21, 81-86 1994 Disclose to all

  • <<
  • >>
Title language:
Conference Activities & Talks
Title Title(Japanese) Title(English) Conference Conference(Japanese) Conference(English) Promotor Promotor(Japanese) Promotor(English) Date Language Assortment Disclose
幹細胞を用いた神経疾患研究[Invited] 幹細胞を用いた神経疾患研究 [Invited] 幹細胞を用いた神経疾患研究 [Invited] iPS細胞研究の最前線, 第41回 日本炎症・再生医学会, 東京 iPS細胞研究の最前線, 第41回 日本炎症・再生医学会, 東京 iPS細胞研究の最前線, 第41回 日本炎症・再生医学会, 東京 2020/07/08 Disclose to all
Basic and translational disease modeling with patient iPSC-derived neural cells[Invited] Basic and translational disease modeling with patient iPSC-derived neural cells [Invited] Basic and translational disease modeling with patient iPSC-derived neural cells [Invited] ISSCR 2020 VIRTUAL, Modeling Development and Disease: Neural ISSCR 2020 VIRTUAL, Modeling Development and Disease: Neural ISSCR 2020 VIRTUAL, Modeling Development and Disease: Neural 2020/06/25 English Disclose to all
幹細胞を用いた神経疾患研究[Invited] 幹細胞を用いた神経疾患研究 [Invited] 幹細胞を用いた神経疾患研究 [Invited] iPS細胞を用いた神経疾患に対する病態解明と治療戦略, 第19回日本再生医療学会総会 iPS細胞を用いた神経疾患に対する病態解明と治療戦略, 第19回日本再生医療学会総会 iPS細胞を用いた神経疾患に対する病態解明と治療戦略, 第19回日本再生医療学会総会 2020/05/18 Disclose to all
Translational neuroscience using neurodegenerative disease iPSCs[Invited] 神経変性疾患iPS細胞を用いた神経科学研究 [Invited] Translational neuroscience using neurodegenerative disease iPSCs [Invited] NEURO2019, The 42nd Annual Meeting of the Japan Neuroscience Society, The 62nd Annual Meeting of the Japanese Society for Neurochemistry. Niigata, Japan. 第42回日本神経科学大会, 第62回日本神経化学会大会、新潟 NEURO2019, The 42nd Annual Meeting of the Japan Neuroscience Society, The 62nd Annual Meeting of the Japanese Society for Neurochemistry. Niigata, Japan. 2019/07/28 Disclose to all
From rare to common neurological diseases using iPSCs[Invited] オールジャパンブレインネットワーク構築に基づく難治性精神・神経疾患根治療法開発,iPS細胞を用いた希少神経難病の研究 [Invited] From rare to common neurological diseases using iPSCs [Invited] NEURO2019, The 42nd Annual Meeting of the Japan Neuroscience Society, The 62nd Annual Meeting of the Japanese Society for Neurochemistry. Niigata, Japan. 第42回日本神経科学大会, 第62回日本神経化学会大会、新潟 NEURO2019, The 42nd Annual Meeting of the Japan Neuroscience Society, The 62nd Annual Meeting of the Japanese Society for Neurochemistry. Niigata, Japan. 2019/07/25 Disclose to all
Update Brain iPSC research: Review and Update[Invited] 脳神経疾患iPS細胞研究 [Invited] Update Brain iPSC research: Review and Update [Invited] NEURO2019, The 42nd Annual Meeting of the Japan Neuroscience Society, The 62nd Annual Meeting of the Japanese Society for Neurochemistry. Nigata, Japan 第42回日本神経科学大会, 第62回日本神経化学会大会、新潟 NEURO2019, The 42nd Annual Meeting of the Japan Neuroscience Society, The 62nd Annual Meeting of the Japanese Society for Neurochemistry. Nigata, Japan 2019/07/25 Disclose to all
iPSCs for neurological disorders: A decade of progress, hurdles, and beyond[Invited] iPSCs for neurological disorders: A decade of progress, hurdles, and beyond [Invited] iPSCs for neurological disorders: A decade of progress, hurdles, and beyond [Invited] International Symposium on NEW FRONTIER in NEUROSCIENCE, Kanazawa, Japan International Symposium on NEW FRONTIER in NEUROSCIENCE, Kanazawa, Japan International Symposium on NEW FRONTIER in NEUROSCIENCE, Kanazawa, Japan 2019/02/07 Disclose to all
Neurological disease modeling and drug discovery using human iPSC platform[Invited] Neurological disease modeling and drug discovery using human iPSC platform [Invited] Neurological disease modeling and drug discovery using human iPSC platform [Invited] 第40回日本生物学的精神医学会・第61回日本神経化学会大会 合同年会 Symposium 10、神戸 第40回日本生物学的精神医学会・第61回日本神経化学会大会 合同年会 Symposium 10、神戸 第40回日本生物学的精神医学会・第61回日本神経化学会大会 合同年会 Symposium 10、神戸 2018/09/06 Disclose to all
Human pluripotent stem cells in neurological disease modeling and drug discovery[Invited] Human pluripotent stem cells in neurological disease modeling and drug discovery [Invited] Human pluripotent stem cells in neurological disease modeling and drug discovery [Invited] The 18th World Congress of Basic and Clinical Pharmacology (WCP2018). Kyoto, Japan The 18th World Congress of Basic and Clinical Pharmacology (WCP2018). Kyoto, Japan The 18th World Congress of Basic and Clinical Pharmacology (WCP2018). Kyoto, Japan 2018/07/04 Disclose to all
Drug Discovery using iPSC Platforms :Human Pluripotent Stem Cells in Neurological Drug Discovery[Invited] Drug Discovery using iPSC Platforms :Human Pluripotent Stem Cells in Neurological Drug Discovery [Invited] Drug Discovery using iPSC Platforms :Human Pluripotent Stem Cells in Neurological Drug Discovery [Invited] Keystone Symposia Conference, “iPSCs: A decade of Progress and Beyond”. California, USA. Keystone Symposia Conference, “iPSCs: A decade of Progress and Beyond”. California, USA. Keystone Symposia Conference, “iPSCs: A decade of Progress and Beyond”. California, USA. 2018/03/26 Disclose to all
Modeling dementia using patient iPSCs[Invited] Modeling dementia using patient iPSCs [Invited] Modeling dementia using patient iPSCs [Invited] 第36回日本認知症学会学術集会 シンポジウム4「ヒトにおけるオリゴマー仮説のエビデンス」 金沢 第36回日本認知症学会学術集会 シンポジウム4「ヒトにおけるオリゴマー仮説のエビデンス」 金沢 第36回日本認知症学会学術集会 シンポジウム4「ヒトにおけるオリゴマー仮説のエビデンス」 金沢 2017/11/24 Disclose to all
Modeling neurodegenerative diseases for drug discovery using human iPSCs[Invited] Modeling neurodegenerative diseases for drug discovery using human iPSCs [Invited] Modeling neurodegenerative diseases for drug discovery using human iPSCs [Invited] The XXIII World Congress of Neurology. Kyoto, Japan The XXIII World Congress of Neurology. Kyoto, Japan The XXIII World Congress of Neurology. Kyoto, Japan 2017/09/21 Disclose to all
ALZHEIMER’s and RELATED DEMENTIA Human pluripotent stem cells in neurological drug discovery[Invited] ALZHEIMER’s and RELATED DEMENTIA Human pluripotent stem cells in neurological drug discovery [Invited] ALZHEIMER’s and RELATED DEMENTIA Human pluripotent stem cells in neurological drug discovery [Invited] Cold Spring Harbor Laboratory - Scientific Meeting, Neuropharmacology and Human Stem Cell Models Session IV. New York, USA. Cold Spring Harbor Laboratory - Scientific Meeting, Neuropharmacology and Human Stem Cell Models Session IV. New York, USA. Cold Spring Harbor Laboratory - Scientific Meeting, Neuropharmacology and Human Stem Cell Models Session IV. New York, USA. 2017/09/12 Disclose to all
ヒトiPS細胞の薬剤応答性からみたアルツハイマー病薬開発の可能性[Invited] ヒトiPS細胞の薬剤応答性からみたアルツハイマー病薬開発の可能性 [Invited] ヒトiPS細胞の薬剤応答性からみたアルツハイマー病薬開発の可能性 [Invited] 第35回日本認知症学会 シンポジウム27「創薬からみたアルツハイマー病の治療戦略」 東京 第35回日本認知症学会 シンポジウム27「創薬からみたアルツハイマー病の治療戦略」 東京 第35回日本認知症学会 シンポジウム27「創薬からみたアルツハイマー病の治療戦略」 東京 2016/12/03 Disclose to all
病理所見とiPS細胞から分化した運動ニューロンの対比[Invited] 病理所見とiPS細胞から分化した運動ニューロンの対比 [Invited] 病理所見とiPS細胞から分化した運動ニューロンの対比 [Invited] 第57回日本神経学会学術大会 Neuro CPC 神戸 第57回日本神経学会学術大会 Neuro CPC 神戸 第57回日本神経学会学術大会 Neuro CPC 神戸 2016/05/19 Disclose to all
Dissecting Neurodegenerative Diseases with iPSC Technology[Invited] Dissecting Neurodegenerative Diseases with iPSC Technology [Invited] Dissecting Neurodegenerative Diseases with iPSC Technology [Invited] UC San Diego - Kyoto University Joint Symposium. San Diego, USA. UC San Diego - Kyoto University Joint Symposium. San Diego, USA. UC San Diego - Kyoto University Joint Symposium. San Diego, USA. 2016/03/15 Disclose to all
iPS細胞を用いた神経変性疾患研究[Invited] iPS細胞を用いた神経変性疾患研究 [Invited] iPS細胞を用いた神経変性疾患研究 [Invited] 第5回日本認知症予防学会学術集会 神戸 第5回日本認知症予防学会学術集会 神戸 第5回日本認知症予防学会学術集会 神戸 2015/09/26 Disclose to all
iPS細胞を用いたALS再生医療研究[Invited] iPS細胞を用いたALS再生医療研究 [Invited] iPS細胞を用いたALS再生医療研究 [Invited] シンポジウム5 神経系・感覚器の再生医療と幹細胞生物学, 第14回 日本再生医療学会総会 横浜 シンポジウム5 神経系・感覚器の再生医療と幹細胞生物学, 第14回 日本再生医療学会総会 横浜 シンポジウム5 神経系・感覚器の再生医療と幹細胞生物学, 第14回 日本再生医療学会総会 横浜 2015/03/19 Disclose to all
iPS細胞を用いた神経変性疾患研究[Invited] iPS細胞を用いた神経変性疾患研究 [Invited] iPS細胞を用いた神経変性疾患研究 [Invited] シンポジウム1 疾患iPS細胞研究の最前線, 第14回 日本再生医療学会総会 横浜 シンポジウム1 疾患iPS細胞研究の最前線, 第14回 日本再生医療学会総会 横浜 シンポジウム1 疾患iPS細胞研究の最前線, 第14回 日本再生医療学会総会 横浜 2015/03/19 Disclose to all
Disease Modeling Using Pluripotent Stem Cells I. The use of iPS cells toward the treatment of neurodegenerative diseases[Invited] Disease Modeling Using Pluripotent Stem Cells I. The use of iPS cells toward the treatment of neurodegenerative diseases [Invited] Disease Modeling Using Pluripotent Stem Cells I. The use of iPS cells toward the treatment of neurodegenerative diseases [Invited] Society for Neuroscience 2014. Washington DC, USA. Society for Neuroscience 2014. Washington DC, USA. Society for Neuroscience 2014. Washington DC, USA. 2014/11/18 Disclose to all
iPS cells for the study of neurodegenerative diseases[Invited] iPS cells for the study of neurodegenerative diseases [Invited] iPS cells for the study of neurodegenerative diseases [Invited] Brain Conference 2014. Seoul, Korea. Brain Conference 2014. Seoul, Korea. Brain Conference 2014. Seoul, Korea. 2014/11/08 Disclose to all
Using iPSCs to study neurological disorders[Invited] Using iPSCs to study neurological disorders [Invited] Using iPSCs to study neurological disorders [Invited] 14th International College of Geriatric Psychoneuropharmacology & Joint Congress of 19th Japan Congress of Neuropsychiatry. Ibaraki, Japan. 14th International College of Geriatric Psychoneuropharmacology & Joint Congress of 19th Japan Congress of Neuropsychiatry. Ibaraki, Japan. 14th International College of Geriatric Psychoneuropharmacology & Joint Congress of 19th Japan Congress of Neuropsychiatry. Ibaraki, Japan. 2014/10/02 Disclose to all
The use of iPS cells toward the treatment of neurodegenerative diseases[Invited] The use of iPS cells toward the treatment of neurodegenerative diseases [Invited] The use of iPS cells toward the treatment of neurodegenerative diseases [Invited] Integrated Symposium of Basic and Clinical Neuroscience:Induced pluripotent stem (iPS) cells: from basic research to clinical application. Yokohama Japan. Integrated Symposium of Basic and Clinical Neuroscience:Induced pluripotent stem (iPS) cells: from basic research to clinical application. Yokohama Japan. Integrated Symposium of Basic and Clinical Neuroscience:Induced pluripotent stem (iPS) cells: from basic research to clinical application. Yokohama Japan. 2014/09/11 Disclose to all
iPSC technology for the study of Neural degeneration and regeneration[Invited] iPSC technology for the study of Neural degeneration and regeneration [Invited] iPSC technology for the study of Neural degeneration and regeneration [Invited] Cold Spring Harbor Asia Conference Disease Modeling & Drug Discovery. Suzhou, China. Cold Spring Harbor Asia Conference Disease Modeling & Drug Discovery. Suzhou, China. Cold Spring Harbor Asia Conference Disease Modeling & Drug Discovery. Suzhou, China. 2014/08/26 Disclose to all
iPS cells: from research to medical application[Invited] iPS cells: from research to medical application [Invited] iPS cells: from research to medical application [Invited] 第7回上肢の神経機能回復セミナー Kakunodate, Japan 第7回上肢の神経機能回復セミナー Kakunodate, Japan 第7回上肢の神経機能回復セミナー Kakunodate, Japan 2014/05/31 Disclose to all
iPS細胞技術を用いた神経変性疾患の研究[Invited] iPS細胞技術を用いた神経変性疾患の研究 [Invited] iPS細胞技術を用いた神経変性疾患の研究 [Invited] 第55回日本神経学会学術大会 福岡 第55回日本神経学会学術大会 福岡 第55回日本神経学会学術大会 福岡 2014/05/24 Disclose to all
Unraveling neurodegenerative diseases by iPS cell technology[Invited] Unraveling neurodegenerative diseases by iPS cell technology [Invited] Unraveling neurodegenerative diseases by iPS cell technology [Invited] Stem Cell Summit 2014, 11th Stem Cell Research & Regenerative Medicine Conference. Cambridge, MA, USA. Stem Cell Summit 2014, 11th Stem Cell Research & Regenerative Medicine Conference. Cambridge, MA, USA. Stem Cell Summit 2014, 11th Stem Cell Research & Regenerative Medicine Conference. Cambridge, MA, USA. 2014/04/24 Disclose to all
Unraveling neurodegenerative-disease mechanisms using patient-specific iPSCs[Invited] Unraveling neurodegenerative-disease mechanisms using patient-specific iPSCs [Invited] Unraveling neurodegenerative-disease mechanisms using patient-specific iPSCs [Invited] The 5th East Asia Neurology Forum (EANF). Kaohsiung, Taiwan. The 5th East Asia Neurology Forum (EANF). Kaohsiung, Taiwan. The 5th East Asia Neurology Forum (EANF). Kaohsiung, Taiwan. 2014/04/11 Disclose to all
Unraveling neurodegenerative diseases by somatic cell reprogramming[Invited] Unraveling neurodegenerative diseases by somatic cell reprogramming [Invited] Unraveling neurodegenerative diseases by somatic cell reprogramming [Invited] International symposium“New Frontier of Molecular Neuropathology 2014” Tokyo. Tokyo, Japan. International symposium“New Frontier of Molecular Neuropathology 2014” Tokyo. Tokyo, Japan. International symposium“New Frontier of Molecular Neuropathology 2014” Tokyo. Tokyo, Japan. 2014/03/16 Disclose to all
iPS細胞技術を用いた神経変性疾患の研究[Invited] iPS細胞技術を用いた神経変性疾患の研究 [Invited] iPS細胞技術を用いた神経変性疾患の研究 [Invited] シンポジウム SY-20 疾患特異的iPS細胞. 第13回日本再生医療学会総会 京都 シンポジウム SY-20 疾患特異的iPS細胞. 第13回日本再生医療学会総会 京都 シンポジウム SY-20 疾患特異的iPS細胞. 第13回日本再生医療学会総会 京都 2014/03/05 Disclose to all
The use of iPS cells toward drug development for neurodegenerative diseases[Invited] The use of iPS cells toward drug development for neurodegenerative diseases [Invited] The use of iPS cells toward drug development for neurodegenerative diseases [Invited] The 7th Takeda Science Foundation Symposium on PharmaSciences iPS Cells in Drug Discovery & Development, Session 1: Neurological disease (1). Osaka, Japan. The 7th Takeda Science Foundation Symposium on PharmaSciences iPS Cells in Drug Discovery & Development, Session 1: Neurological disease (1). Osaka, Japan. The 7th Takeda Science Foundation Symposium on PharmaSciences iPS Cells in Drug Discovery & Development, Session 1: Neurological disease (1). Osaka, Japan. 2014/01/16 Disclose to all
Unraveling neurodegenerative diseases using patient-specific iPSCs[Invited] Unraveling neurodegenerative diseases using patient-specific iPSCs [Invited] Unraveling neurodegenerative diseases using patient-specific iPSCs [Invited] CAMBRIDGE STEM CELL CLUB, Cambridge Stem Cell Institute. London, U.K. CAMBRIDGE STEM CELL CLUB, Cambridge Stem Cell Institute. London, U.K. CAMBRIDGE STEM CELL CLUB, Cambridge Stem Cell Institute. London, U.K. 2013/10/24 Disclose to all
Unraveling neurodegenerative diseases using patient-specific iPSCs[Invited] Unraveling neurodegenerative diseases using patient-specific iPSCs [Invited] Unraveling neurodegenerative diseases using patient-specific iPSCs [Invited] MRC-CRM, The University of Edinburgh. Edinburgh, U.K. MRC-CRM, The University of Edinburgh. Edinburgh, U.K. MRC-CRM, The University of Edinburgh. Edinburgh, U.K. 2013/10/22 Disclose to all
Stem cells: from research to medical application[Invited] Stem cells: from research to medical application [Invited] Stem cells: from research to medical application [Invited] BioUANL 2013 From biotechnology to bioeconomy in Mexico. Monterrey, Nuevo Leon, Mexico. BioUANL 2013 From biotechnology to bioeconomy in Mexico. Monterrey, Nuevo Leon, Mexico. BioUANL 2013 From biotechnology to bioeconomy in Mexico. Monterrey, Nuevo Leon, Mexico. 2013/10/14 Disclose to all
iPS細胞技術を用いた神経変性疾患の研究[Invited] iPS細胞技術を用いた神経変性疾患の研究 [Invited] iPS細胞技術を用いた神経変性疾患の研究 [Invited] 第202回日本神経学会九州地方会 ランチョンセミナー 佐賀 第202回日本神経学会九州地方会 ランチョンセミナー 佐賀 第202回日本神経学会九州地方会 ランチョンセミナー 佐賀 2013/06/29 Disclose to all
Neurodegenerative disease-specific iPS cell research. The 36th Annual Meeting of the Japan Neuroscience Society[Invited] Neurodegenerative disease-specific iPS cell research. The 36th Annual Meeting of the Japan Neuroscience Society [Invited] Neurodegenerative disease-specific iPS cell research. The 36th Annual Meeting of the Japan Neuroscience Society [Invited] Human Induced Neuronal Cells and Neurodegenerative Diseases -The Next Stage of iPS and iN Cells in Neurosicence Field- Kyoto. Kyoto, Japan. Human Induced Neuronal Cells and Neurodegenerative Diseases -The Next Stage of iPS and iN Cells in Neurosicence Field- Kyoto. Kyoto, Japan. Human Induced Neuronal Cells and Neurodegenerative Diseases -The Next Stage of iPS and iN Cells in Neurosicence Field- Kyoto. Kyoto, Japan. 2013/06/22 Disclose to all
Unraveling neurodegenerative-disease mechanisms using patient-specific iPSCs[Invited] Unraveling neurodegenerative-disease mechanisms using patient-specific iPSCs [Invited] Unraveling neurodegenerative-disease mechanisms using patient-specific iPSCs [Invited] ISSCR 11th Annual Meeting, Session Plenary III: Disease Modeling. Boston, MA, USA. ISSCR 11th Annual Meeting, Session Plenary III: Disease Modeling. Boston, MA, USA. ISSCR 11th Annual Meeting, Session Plenary III: Disease Modeling. Boston, MA, USA. 2013/06/13 Disclose to all
Modeling Alzheimer's disease using patient-specific iPSCs reveals stress phenotypes[Invited] Modeling Alzheimer's disease using patient-specific iPSCs reveals stress phenotypes [Invited] Modeling Alzheimer's disease using patient-specific iPSCs reveals stress phenotypes [Invited] Stem Cells & Cell Signaling - 2013 Meeting on 'Assays to Regenerative Medicine, Tissue Engineering & Therapeutics’ Waltham. USA. Stem Cells & Cell Signaling - 2013 Meeting on 'Assays to Regenerative Medicine, Tissue Engineering & Therapeutics’ Waltham. USA. Stem Cells & Cell Signaling - 2013 Meeting on 'Assays to Regenerative Medicine, Tissue Engineering & Therapeutics’ Waltham. USA. 2013/05/01 Disclose to all
人工多能性幹細胞(induced pluripotent stem cell: iPS細胞)と神経変性疾患[Invited] 人工多能性幹細胞(induced pluripotent stem cell: iPS細胞)と神経変性疾患 [Invited] 人工多能性幹細胞(induced pluripotent stem cell: iPS細胞)と神経変性疾患 [Invited] 第110 回 日本内科学会総会 東京 第110 回 日本内科学会総会 東京 第110 回 日本内科学会総会 東京 2013/04/13 Disclose to all
iPS細胞作製技術を用いた認知症研究[Invited] iPS細胞作製技術を用いた認知症研究 [Invited] iPS細胞作製技術を用いた認知症研究 [Invited] 第31回日本認知症学会学術集会 教育講演 3 つくば 第31回日本認知症学会学術集会 教育講演 3 つくば 第31回日本認知症学会学術集会 教育講演 3 つくば 2012/10/27 Disclose to all
Cellular and molecular analysis of ALS motor neurons using patient-specific iPS cells.[Invited] Cellular and molecular analysis of ALS motor neurons using patient-specific iPS cells. [Invited] Cellular and molecular analysis of ALS motor neurons using patient-specific iPS cells. [Invited] 2012年度 包括脳ネットワーク夏のワークショップ 「シナプス病態」「脳内環境」「自己制御精神」脳疾患関連3領域合同シンポジウム Sendai, Japan 2012年度 包括脳ネットワーク夏のワークショップ 「シナプス病態」「脳内環境」「自己制御精神」脳疾患関連3領域合同シンポジウム Sendai, Japan 2012年度 包括脳ネットワーク夏のワークショップ 「シナプス病態」「脳内環境」「自己制御精神」脳疾患関連3領域合同シンポジウム Sendai, Japan 2012/07/25 Disclose to all
筋萎縮性側索硬化症(ALS)由来iPS細胞[Invited] 筋萎縮性側索硬化症(ALS)由来iPS細胞 [Invited] 筋萎縮性側索硬化症(ALS)由来iPS細胞 [Invited] 第53回日本神経学会学術大会 シンポジウムS(2)-9:神経疾患iPS細胞の現状と展望 東京 第53回日本神経学会学術大会 シンポジウムS(2)-9:神経疾患iPS細胞の現状と展望 東京 第53回日本神経学会学術大会 シンポジウムS(2)-9:神経疾患iPS細胞の現状と展望 東京 2012/05/24 Disclose to all
Disease-specific iPSC research for neurodegenerative diseases.[Invited] Disease-specific iPSC research for neurodegenerative diseases. [Invited] Disease-specific iPSC research for neurodegenerative diseases. [Invited] CiRA International Symposium 2012 Advances in Nuclear Reprogramming and Stem Cell Research. Kyoto, Japan. CiRA International Symposium 2012 Advances in Nuclear Reprogramming and Stem Cell Research. Kyoto, Japan. CiRA International Symposium 2012 Advances in Nuclear Reprogramming and Stem Cell Research. Kyoto, Japan. 2012/02/23 Disclose to all
iPS細胞作製技術を用いた神経変性疾患の研究[Invited] iPS細胞作製技術を用いた神経変性疾患の研究 [Invited] iPS細胞作製技術を用いた神経変性疾患の研究 [Invited] 第52回日本神経学会学術大会 名古屋 第52回日本神経学会学術大会 名古屋 第52回日本神経学会学術大会 名古屋 2011/05/20 Disclose to all
iPS Cell Technology and Motor Neuron Disease.[Invited] iPS Cell Technology and Motor Neuron Disease. [Invited] iPS Cell Technology and Motor Neuron Disease. [Invited] International Symposium on Motor Neuron Disease and Perry Syndrome in Tokyo. Tokyo, Japan. International Symposium on Motor Neuron Disease and Perry Syndrome in Tokyo. Tokyo, Japan. International Symposium on Motor Neuron Disease and Perry Syndrome in Tokyo. Tokyo, Japan. 2011/02/22 Disclose to all
iPSC Cell Banking facilitating Disease-specific iPSC research.[Invited] iPSC Cell Banking facilitating Disease-specific iPSC research. [Invited] iPSC Cell Banking facilitating Disease-specific iPSC research. [Invited] CIRM iPS Cell Banking Workshop. San Francisco, USA. CIRM iPS Cell Banking Workshop. San Francisco, USA. CIRM iPS Cell Banking Workshop. San Francisco, USA. 2010/11/17 Disclose to all
変性疾患モデルとしてのiPS 細胞[Invited] 変性疾患モデルとしてのiPS 細胞 [Invited] 変性疾患モデルとしてのiPS 細胞 [Invited] 第29 回日本認知症学会学術集会, シンポジウム3「神経変性症としての前頭側頭葉変性症: 症候から分子病態解明の新展開まで」 名古屋 第29 回日本認知症学会学術集会, シンポジウム3「神経変性症としての前頭側頭葉変性症: 症候から分子病態解明の新展開まで」 名古屋 第29 回日本認知症学会学術集会, シンポジウム3「神経変性症としての前頭側頭葉変性症: 症候から分子病態解明の新展開まで」 名古屋 2010/11/05 Disclose to all
Neurodegenerative disease-specific induced Pluripotent Stem cells research.[Invited] Neurodegenerative disease-specific induced Pluripotent Stem cells research. [Invited] Neurodegenerative disease-specific induced Pluripotent Stem cells research. [Invited] Kick off symposium Science Research on Innovative Area ”Foundation of Synapse and Neurocircuit Pathology.” Tokyo, Japan. Kick off symposium Science Research on Innovative Area ”Foundation of Synapse and Neurocircuit Pathology.” Tokyo, Japan. Kick off symposium Science Research on Innovative Area ”Foundation of Synapse and Neurocircuit Pathology.” Tokyo, Japan. 2010/10/27 Disclose to all
Neurodegenerative disease-specific induced Pluripotent Stem cells research.[Invited] Neurodegenerative disease-specific induced Pluripotent Stem cells research. [Invited] Neurodegenerative disease-specific induced Pluripotent Stem cells research. [Invited] Personalized Stem Cell Medicine- A Canada-California-Japan discussion workshop. San Francisco, USA. Personalized Stem Cell Medicine- A Canada-California-Japan discussion workshop. San Francisco, USA. Personalized Stem Cell Medicine- A Canada-California-Japan discussion workshop. San Francisco, USA. 2010/03/25 Disclose to all
Neurodegenerative disease-specific induced Pluripotent Stem cells research.[Invited] Neurodegenerative disease-specific induced Pluripotent Stem cells research. [Invited] Neurodegenerative disease-specific induced Pluripotent Stem cells research. [Invited] Joint iPS Meeting. Toronto, Canada. Joint iPS Meeting. Toronto, Canada. Joint iPS Meeting. Toronto, Canada. 2009/10/28 Disclose to all
Neurodegenerative disease-specific induced Pluripotent Stem cells research.[Invited] Neurodegenerative disease-specific induced Pluripotent Stem cells research. [Invited] Neurodegenerative disease-specific induced Pluripotent Stem cells research. [Invited] Gladstone Institute of Cardiovascular Disease Seminar. San Francisco, USA. Gladstone Institute of Cardiovascular Disease Seminar. San Francisco, USA. Gladstone Institute of Cardiovascular Disease Seminar. San Francisco, USA. 2009/10/26 Disclose to all
Neurodegenerative disease-specific induced Pluripotent Stem cells research.[Invited] Neurodegenerative disease-specific induced Pluripotent Stem cells research. [Invited] Neurodegenerative disease-specific induced Pluripotent Stem cells research. [Invited] 5th Symposium of the André -Delambre Foundation: Amyotrophic Lateral Sclerosis: Causes and Therapeutic Perspectives. Québec, Canada. 5th Symposium of the André -Delambre Foundation: Amyotrophic Lateral Sclerosis: Causes and Therapeutic Perspectives. Québec, Canada. 5th Symposium of the André -Delambre Foundation: Amyotrophic Lateral Sclerosis: Causes and Therapeutic Perspectives. Québec, Canada. 2009/09/25 Disclose to all
Neurodegenerative disease-specific induced Pluripotent Stem cells research.[Invited] Neurodegenerative disease-specific induced Pluripotent Stem cells research. [Invited] Neurodegenerative disease-specific induced Pluripotent Stem cells research. [Invited] The 32nd Annual Meeting of the Japan Neuroscience Society. Nagoya, Japan. The 32nd Annual Meeting of the Japan Neuroscience Society. Nagoya, Japan. The 32nd Annual Meeting of the Japan Neuroscience Society. Nagoya, Japan. 2009/09/16 Disclose to all
Neurodegenerative disease-specific induced Pluripotent Stem cells research. Sweden-Japan Joint Colloquium[Invited] Neurodegenerative disease-specific induced Pluripotent Stem cells research. Sweden-Japan Joint Colloquium [Invited] Neurodegenerative disease-specific induced Pluripotent Stem cells research. Sweden-Japan Joint Colloquium [Invited] Advances in Cellular Reprogramming and Stem Cell Biology. Stockholm, Sweden. Advances in Cellular Reprogramming and Stem Cell Biology. Stockholm, Sweden. Advances in Cellular Reprogramming and Stem Cell Biology. Stockholm, Sweden. 2009/09/05 Disclose to all
Neurodegenerative disease-specific induced Pluripotent Stem cells research.[Invited] Neurodegenerative disease-specific induced Pluripotent Stem cells research. [Invited] Neurodegenerative disease-specific induced Pluripotent Stem cells research. [Invited] New Approach for Molecular Neuropathology. Tokyo, Japan. New Approach for Molecular Neuropathology. Tokyo, Japan. New Approach for Molecular Neuropathology. Tokyo, Japan. 2009/08/13 Disclose to all
Neurodegenerative disease-specific induced Pluripotent Stem cells research.[Invited] Neurodegenerative disease-specific induced Pluripotent Stem cells research. [Invited] Neurodegenerative disease-specific induced Pluripotent Stem cells research. [Invited] The JST-CIRM Workshop. San Francisco, USA. The JST-CIRM Workshop. San Francisco, USA. The JST-CIRM Workshop. San Francisco, USA. 2009/06/08 Disclose to all
Axonal regeneration as a therapeutic target toward Parkinson’s disease.[Invited] Axonal regeneration as a therapeutic target toward Parkinson’s disease. [Invited] Axonal regeneration as a therapeutic target toward Parkinson’s disease. [Invited] The 31st Annual Meeting of the Japan Neuroscience Society. Tokyo, Japan. The 31st Annual Meeting of the Japan Neuroscience Society. Tokyo, Japan. The 31st Annual Meeting of the Japan Neuroscience Society. Tokyo, Japan. 2008/07/09 Disclose to all
Differential roles of caspases in the clinical course of ALS-mouse model.[Invited] Differential roles of caspases in the clinical course of ALS-mouse model. [Invited] Differential roles of caspases in the clinical course of ALS-mouse model. [Invited] NeuroRegeneration and Molecular Neurobiology Lab Seminar and Journal Club Series in McLean Hospital/Harvard Medical School. Belmont, USA. NeuroRegeneration and Molecular Neurobiology Lab Seminar and Journal Club Series in McLean Hospital/Harvard Medical School. Belmont, USA. NeuroRegeneration and Molecular Neurobiology Lab Seminar and Journal Club Series in McLean Hospital/Harvard Medical School. Belmont, USA. 2003/07/16 Disclose to all

  • <<
  • >>
Title language:
Books etc
Author Author(Japanese) Author(English) Title Title(Japanese) Title(English) Publisher Publisher(Japanese) Publisher(English) Publication date Language Type Disclose
井上治久 井上治久 ALS(筋萎縮性側索硬化症)治療の最前線 ALS(筋萎縮性側索硬化症)治療の最前線 医歯薬出版株式会社、東京 医歯薬出版株式会社、東京 2020/02 Editor Disclose to all
Inoue H, Nakamura Y Inoue H, Nakamura Y Inoue H, Nakamura Y Medical Applications of iPS Cells-Inovation in Medical Sciences Medical Applications of iPS Cells-Inovation in Medical Sciences Medical Applications of iPS Cells-Inovation in Medical Sciences Springer, Singapore Springer, Singapore Springer, Singapore 2019/04 English Editor Disclose to all
村上 永尚, 和泉 唯信, 梶 龍兒, 井上 治久 村上 永尚, 和泉 唯信, 梶 龍兒, 井上 治久 村上 永尚, 和泉 唯信, 梶 龍兒, 井上 治久 【最新遺伝医学研究と遺伝カウンセリング シリーズ2 最新精神・神経遺伝医学研究と遺伝カウンセリング】 (第1章)総論 iPS細胞を用いた神経・精神疾患解析と創薬研究 【最新遺伝医学研究と遺伝カウンセリング シリーズ2 最新精神・神経遺伝医学研究と遺伝カウンセリング】 (第1章)総論 iPS細胞を用いた神経・精神疾患解析と創薬研究 【最新遺伝医学研究と遺伝カウンセリング シリーズ2 最新精神・神経遺伝医学研究と遺伝カウンセリング】 (第1章)総論 iPS細胞を用いた神経・精神疾患解析と創薬研究 Medicaldo, Osaka メディカルドゥ, 大阪 Medicaldo, Osaka 2017/04 Joint Work Disclose to all
井上治久 井上治久 病態を再現・解明し、創薬へとつなぐ 疾患iPS細胞 樹立より10年の時を経て難治疾患へ挑む 病態を再現・解明し、創薬へとつなぐ 疾患iPS細胞 樹立より10年の時を経て難治疾患へ挑む 羊土社, 東京 羊土社, 東京 2016/02 Editor Disclose to all
村上 永尚, 和泉 唯信, 梶 龍兒, 井上 治久 村上 永尚, 和泉 唯信, 梶 龍兒, 井上 治久 村上 永尚, 和泉 唯信, 梶 龍兒, 井上 治久 【iPS細胞を用いた難病研究-臨床病態解明と創薬に向けた研究の最新知見】 (第1章)中枢神経疾患 iPS細胞を用いたアルツハイマー病モデルと小胞体ストレス 【iPS細胞を用いた難病研究-臨床病態解明と創薬に向けた研究の最新知見】 (第1章)中枢神経疾患 iPS細胞を用いたアルツハイマー病モデルと小胞体ストレス 【iPS細胞を用いた難病研究-臨床病態解明と創薬に向けた研究の最新知見】 (第1章)中枢神経疾患 iPS細胞を用いたアルツハイマー病モデルと小胞体ストレス Medicaldo, Osaka メディカルドゥ, 大阪 Medicaldo, Osaka 2015/02 Joint Work Disclose to all
森井芙貴子, 水野敏樹, 中川正法, 井上治久 森井芙貴子, 水野敏樹, 中川正法, 井上治久 iPS細胞を用いた神経変性疾患病態解析, 第4章 発生・再生研究を支える基盤技術, 脳神経系の再生医学 発生と再生の融合的新展開 iPS細胞を用いた神経変性疾患病態解析, 第4章 発生・再生研究を支える基盤技術, 脳神経系の再生医学 発生と再生の融合的新展開 診断と治療社, 東京 診断と治療社, 東京 2015/01 Joint Work Disclose to all
近藤孝之, 井上治久 近藤孝之, 井上治久 ヒト多能性幹細胞を用いた疾患研究と創薬開発の展開, V 創薬スクリーニング, ES・iPS細胞実験スタンダード 再生・創薬・疾患研究のプロトコールと臨床応用の必須知識 ヒト多能性幹細胞を用いた疾患研究と創薬開発の展開, V 創薬スクリーニング, ES・iPS細胞実験スタンダード 再生・創薬・疾患研究のプロトコールと臨床応用の必須知識 羊土社、東京 羊土社、東京 2014/02 Joint Work Disclose to all
近藤孝之, 井上治久, 高橋良輔 近藤孝之, 井上治久, 高橋良輔 大脳皮質神経細胞への分化誘導, Ⅲ 分化誘導のプロトコール, ES・iPS細胞実験スタンダード 再生・創薬・疾患研究のプロトコールと臨床応用の必須知識 大脳皮質神経細胞への分化誘導, Ⅲ 分化誘導のプロトコール, ES・iPS細胞実験スタンダード 再生・創薬・疾患研究のプロトコールと臨床応用の必須知識 羊土社、東京 羊土社、東京 2014/02 Joint Work Disclose to all
近藤孝之, 井上治久 近藤孝之, 井上治久 神経再生医療の現状, VII.神経・精神疾患の治療の進歩, 神経・精神疾患診療マニュアル 神経再生医療の現状, VII.神経・精神疾患の治療の進歩, 神経・精神疾患診療マニュアル 日本医師会雑誌、東京 日本医師会雑誌、東京 2013/10 Joint Work Disclose to all
八幡直樹, 井上治久 八幡直樹, 井上治久 八幡直樹, 井上治久 各種病態モデルと創薬研究 1.神経疾患 7)iPS細胞作製技術を利用した神経疾患病因機構の解明と創薬開発への取り組み 各種病態モデルと創薬研究 1.神経疾患 7)iPS細胞作製技術を利用した神経疾患病因機構の解明と創薬開発への取り組み 各種病態モデルと創薬研究 1.神経疾患 7)iPS細胞作製技術を利用した神経疾患病因機構の解明と創薬開発への取り組み Medicaldo, Osaka メディカルドゥ、大阪 Medicaldo, Osaka 2012/07 Joint Work Disclose to all
近藤孝之, 井上治久, 高橋良輔 近藤孝之, 井上治久, 高橋良輔 iPS細胞を用いた神経・精神疾患研究 iPS細胞を用いた神経・精神疾患研究 朝倉書店、東京 朝倉書店、東京 2012 Joint Work Disclose to all
Kondo T, Takahashi R, Inoue H Kondo T, Takahashi R, Inoue H Kondo T, Takahashi R, Inoue H Cellular Replacement Therapy in Neurodegenerative Diseases Using Induced Pluripotent Stem Cells Cellular Replacement Therapy in Neurodegenerative Diseases Using Induced Pluripotent Stem Cells Cellular Replacement Therapy in Neurodegenerative Diseases Using Induced Pluripotent Stem Cells Springer, New York Springer, New York Springer, New York 2012/01 Joint Work Disclose to all
八幡直樹, 井上治久 八幡直樹, 井上治久 八幡直樹, 井上治久 認知症学(上)その解明と治療の最新知見, 基礎編 認知症研究に用いられる動物・細胞実験モデル, Induced pluripotent stem cell 認知症学(上)その解明と治療の最新知見, 基礎編 認知症研究に用いられる動物・細胞実験モデル, Induced pluripotent stem cell 認知症学(上)その解明と治療の最新知見, 基礎編 認知症研究に用いられる動物・細胞実験モデル, Induced pluripotent stem cell 日本臨床社、大阪 日本臨床社、大阪 日本臨床社、大阪 2011/10 Joint Work Disclose to all
Kitaoka S, Kondoh H, Inoue H Kitaoka S, Kondoh H, Inoue H Kitaoka S, Kondoh H, Inoue H Induced Pluripotent Stem Cell Technology for the Study of Neurodegenerative Diseases Induced Pluripotent Stem Cell Technology for the Study of Neurodegenerative Diseases Induced Pluripotent Stem Cell Technology for the Study of Neurodegenerative Diseases Nova Science Publishers Inc, New York Nova Science Publishers Inc, New York Nova Science Publishers Inc, New York 2011 Joint Work Disclose to all
Kondoh H, Inoue H, Takaori-Kondo A, Minami M Kondoh H, Inoue H, Takaori-Kondo A, Minami M Kondoh H, Inoue H, Takaori-Kondo A, Minami M Regulational role of mitochondria on ageing and senescence Regulational role of mitochondria on ageing and senescence Regulational role of mitochondria on ageing and senescence Nova Science Publishers Inc, UK Nova Science Publishers Inc, UK Nova Science Publishers Inc, UK 2010 Joint Work Disclose to all
Inoue H, Kondo T, Lin L, Mi S, Isacson O, Takahashi R Inoue H, Kondo T, Lin L, Mi S, Isacson O, Takahashi R Inoue H, Kondo T, Lin L, Mi S, Isacson O, Takahashi R Protein misfolding and axonal protection in neurodegenerative diseases Protein misfolding and axonal protection in neurodegenerative diseases Protein misfolding and axonal protection in neurodegenerative diseases Springer, Dordrecht Springer, Dordrecht Springer, Dordrecht 2009 Joint Work Disclose to all
井上治久, 宇高不可思, 亀山正邦 井上治久, 宇高不可思, 亀山正邦 チフス菌, B. リケッチア感染症, 第II編 炎症性疾患 ( 含感染性疾患 ), 領域別症候群シリーズ No.26 神経症候群 I その他の神経疾患を含めて 血管障害 炎症性疾患 チフス菌, B. リケッチア感染症, 第II編 炎症性疾患 ( 含感染性疾患 ), 領域別症候群シリーズ No.26 神経症候群 I その他の神経疾患を含めて 血管障害 炎症性疾患 日本臨牀社, 大阪 日本臨牀社, 大阪 1999 Joint Work Disclose to all

  • <<
  • >>
Title language:
Awards
Title(Japanese) Title(English) Organization name(Japanese) Organization name(English) Date
CiRA賞 CiRA Award 京都大学iPS細胞研究所 Center for iPS Cell Research and Application, Kyoto University 2014/01/06
第21回読売テクノ・フォーラム ゴールド・メダル賞受賞 21st Yomiuri Techno Forum Gold Medal 読売テクノ・フォーラム Yomiuri Techno Forum 2015/04/16
第8回臨床薬理研究振興財団研究大賞 8th Japan Research Foundation for Clinical Pharmacology Research Award 公益財団法人 臨床薬理研究振興財団 Japan Research Foundation for Clinical Pharmacology 2016/02/10
External funds: competitive funds and Grants-in-Aid for Scientific Research (Kakenhi)
Type Position Title(Japanese) Title(English) Period
奨励研究(A)→若手研究(B) 独立行政法人日本学術振興会 Representative 抗アポトーシス分子を用いた筋萎縮性側索硬化症の治療法に関する研究 2001-2002
若手研究(B) 独立行政法人日本学術振興会 Representative 抗アポトーシス分子を用いた筋萎縮性側索硬化症の治療法に関する研究 2003-2004
分子イメージング研究プログラム 独立行政法人 科学技術振興機構 Representative タウオパチー型認知症の治療とモニタリング技術の開発 2007-2009
厚生労働省厚生労働科学研究費補助金(難治性疾患克服研究事業) Assignment パーキンソン病および類縁疾患患者iPS細胞を用いた病態解明 2009-2009
科学技術振興機構 戦略的創造研究推進事業 CREST Representative 「人工多能性幹細胞(iPS細胞)作製・制御等の医療基盤技術」研究領域 iPS細胞を駆使した神経変性疾患病因機構の解明と個別化予防医療開発 2009-2015
新学術領域研究 独立行政法人日本学術振興会 Representative シナプス・ニューロサーキットパソロジーの創成 人工多能性幹細胞作製技術を応用した神経変性疾患細胞機能・回路異常病理の解明 2010-2115
厚生労働科学研究費補助金(こころの健康科学研究事業・障害者対策総合研究事業) Assignment 筋萎縮性側索硬化症患者由来疾患モデル細胞を用いた病態解明と治療法開発 2009-2011
厚生労働科学研究費補助金(難治性疾患克服研究事業) Assignment 疾患特異的iPS細胞を用いた難治性疾患の画期的診断・治療法に関する研究 2009-2011
文部科学省科学研究費補助金(基盤研究C) Representative 患者由来誘導多能性幹細胞を用いた家族性筋萎縮性側索硬化症治療法の開発 2009-2011
文部科学省 再生医療の実現化プロジェクト Assignment 京都大学iPS細胞研究統合推進拠点 ヒトiPS細胞を用いた神経再生医療実現化のための技術開発 2010-2012
精神・神経疾患研究開発費研究事業 Assignment 精神・神経疾患のiPS細胞を用いた診断・治療法の開発に関する戦略的研究 2012-2014
再生医療実現拠点ネットワークプログラム「疾患特異的iPS 細胞を活用した難病研究」 Representative 高品質な分化細胞・組織を用いた神経系および視覚系難病のin vitroモデル化と治療法の開発 2012-2015
医療施設運営費等補助金(臨床研究拠点等整備事業) Representative iPS細胞を利用した創薬研究支援事業 2012-2012
厚生労働省科学研究費補助金(難病・がん等の疾患分野の医療の実用化研究事業) Representative 難治性疾患創薬シーズの探索と薬剤安全性評価法の開発 2013-2018
平成26年度厚生労働科学研究委託費(難治性疾患等実用化研究事業) Assignment ジストニアの分子病態解明と新規治療法開発 2014-2014
平成29年度第二期GAPファンドプログラム Representative 筋萎縮性側索硬化症モデルマウスにおけるボスチニブ有効血中濃度の同定 2017-2018
平成30年度 再生医療実用化研究事業(二次公募) Representative ドラックリポジショニングによるALS治療薬開発のための薬物動態評価 2018-2019
平成30年度再生医療実現拠点ネットワークプログラム 再生医療用iPS 細胞ストック開発拠点 Assignment 初期化メカニズムの解明、安全性の確立 2018-2019
平成30年度京都大学「橋渡し研究戦略的推進プログラム」シーズA Representative タウタンパク質を標的とした認知症治療薬の開発 2018-2019
平成30年度科学研究費助成 基盤研究B Representative 生体内リプログラミングによるALS 神経再生研究 2018-2020
平成30年度 臨床研究・治験推進研究事業(一次公募) Representative 患者レジストリを活用した筋萎縮性側索硬化症治療薬開発のための医師主導治験 2018-2020
平成30年度科学研究費助成 挑戦的研究(萌芽) Representative Deep learningによる神経変性画像解析の研究 2018-2020
挑戦的研究(萌芽) Representative Deep learningによる神経変性画像解析の研究 (2019年度分) 2019/04/01-2020/03/31
基盤研究(B) Representative 生体内リプログラミングによるALS 神経再生研究 (2019年度分) 2019/04/01-2020/03/31

  • <<
  • >>
Faculty management (title, position)
Title Period
組換えDNA実験安全委員会1号委員、委員長 -
安全衛生委員会1号委員、衛生管理者 -
発明委員会1号委員 2015/04/01-2022/03/31